QUARTERLY REPORT

Q2 2023 — Quarterly report (Form 10-Q)

Q2 2023PDF · 111 pages834 KB
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
☑ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from 	to
Commission file number 001-13908
Invesco Ltd.
(Exact Name of Registrant as Specified in Its Charter)
Bermuda 	98-0557567
(State or Other Jurisdiction of Incorporation or Organization) 	(I.R.S. Employer Identification No.)
1331 Spring Street, Suite 2500, 	Atlanta, 	GA 	30309
(Address of Principal Executive Offices) 	(Zip Code)
(404) 892-0896
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common stock, $0.20 par value 	IVZ 	New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☑ 	Accelerated filer ☐ 	Non-accelerated filer ☐ 	Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No ☑
As of June 30, 2023, the most recent practicable date, the number of Common Shares outstanding was 448,620,544.

-- 1 of 111 --

Table of Contents
TABLE OF CONTENTS
We include cross references to captions elsewhere in this Quarterly Report on Form 10-Q, which we refer to as this “Report,” where you can find related
additional information. The following table of contents tells you where to find these captions.
Page
TABLE OF CONTENTS
Glossary of Defined Terms 	i
PART I. Financial Information
Item 1. Financial Statements (unaudited) 	1
Condensed Consolidated Balance Sheets 	1
Condensed Consolidated Statements of Income 	2
Condensed Consolidated Statements of Comprehensive Income 	3
Condensed Consolidated Statements of Cash Flows 	4
Condensed Consolidated Statements of Changes in Equity 	5
Notes to the Condensed Consolidated Financial Statements 	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 	17
Item 3. Quantitative and Qualitative Disclosures About Market Risk 	48
Item 4. Controls and Procedures 	49
PART II. Other Information
Item 1. Legal Proceedings 	50
Item 1A. Risk Factors 	50
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 	50
Item 5. Other Information 	50
Item 6. Exhibits 	51
Signatures 	52

-- 2 of 111 --

Table of Contents
GLOSSARY OF DEFINED TERMS
APAC 	— Asia-Pacific
AUM 	— Assets under management
bps 	— Basis points
CEO 	— Chief Executive Officer
CIP 	— Consolidated investment products
CLOs 	— Collateralized loan obligations
Covenant Adjusted EBITDA 	— Earnings before income tax, depreciation, amortization, interest expense, common share-based compensation
expense, unrealized (gains)/losses from investments, net, and unusual or otherwise non-recurring gains and losses as
defined in our credit agreement
EMEA 	— Europe, Middle East and Africa
EPS 	— Earnings per common share
ETFs 	— Exchange-traded funds
IGW or Invesco Great Wall 	— Invesco Great Wall Fund Management Company Limited
LIBOR 	— The London Inter-Bank Offered Rate
MassMutual 	— Massachusetts Mutual Life Insurance Company
NAV 	— Net asset value
Report 	— this Form 10-Q
S&P 	— Standard & Poor's
SEC 	— U.S. Securities and Exchange Commission
SOFR 	— Secured Overnight Financing Rate
the company 	— Invesco Ltd. and its consolidated entities
the Parent 	— Invesco Ltd.
TRS 	— Total return swaps
UITs 	— Unit Investment Trusts
U.K. 	— United Kingdom
U.S. GAAP 	— Accounting principles generally accepted in the United States
VIEs 	— Variable interest entities
i

-- 3 of 111 --

Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Invesco Ltd.
Condensed Consolidated Balance Sheets
(Unaudited)
As of
$ in millions, except per share data 	June 30, 2023 	December 31, 2022
ASSETS
Cash and cash equivalents 	1,009.9 	1,234.7
Accounts receivable 	703.2 	801.8
Investments 	992.1 	996.6
Assets of consolidated investment products (CIP):
Cash and cash equivalents of CIP 	277.2 	199.4
Accounts receivable and other assets of CIP 	197.6 	203.7
Investments of CIP 	8,611.3 	8,531.4
Assets held for policyholders 	444.0 	668.7
Other assets 	844.2 	860.5
Property, equipment and software, net 	585.3 	561.1
Intangible assets, net 	7,118.0 	7,141.2
Goodwill 	8,675.0 	8,557.7
Total assets 	29,457.8 	29,756.8
LIABILITIES
Accrued compensation and benefits 	570.6 	860.8
Accounts payable and accrued expenses 	1,360.7 	1,314.8
Liabilities of CIP:
Debt of CIP 	6,884.5 	6,590.4
Other liabilities of CIP 	357.3 	329.6
Policyholder payables 	444.0 	668.7
Debt 	1,488.6 	1,487.6
Deferred tax liabilities, net 	1,643.5 	1,662.7
Total liabilities 	12,749.2 	12,914.6
Commitments and contingencies (See Note 10)
TEMPORARY EQUITY
Redeemable noncontrolling interests in consolidated entities 	841.9 	998.7
PERMANENT EQUITY
Equity attributable to Invesco Ltd.:
Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized, issued and outstanding as of
June 30, 2023 and December 31, 2022) 	4,010.5 	4,010.5
Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of June 30, 2023 and
December 31, 2022) 	113.2 	113.2
Additional paid-in-capital 	7,433.0 	7,554.9
Treasury shares 	(3,027.4) 	(3,040.9)
Retained earnings 	7,617.9 	7,518.3
Accumulated other comprehensive income/(loss), net of tax 	(818.3) 	(942.4)
Total equity attributable to Invesco Ltd. 	15,328.9 	15,213.6
Equity attributable to nonredeemable noncontrolling interests in consolidated entities 	537.8 	629.9
Total permanent equity 	15,866.7 	15,843.5
Total liabilities, temporary and permanent equity 	29,457.8 	29,756.8
See accompanying notes.
1

-- 4 of 111 --

Table of Contents
Invesco Ltd.
Condensed Consolidated Statements of Income
(Unaudited)
Three months ended June 30, 	Six months ended June 30,
$ in millions, except per common share data 	2023 	2022 	2023 	2022
Operating revenues:
Investment management fees 	1,033.5 	1,113.5 	2,061.4 	2,294.0
Service and distribution fees 	342.3 	353.8 	676.5 	732.8
Performance fees 	19.6 	9.2 	25.2 	10.2
Other 	47.4 	53.9 	97.9 	122.8
Total operating revenues 	1,442.8 	1,530.4 	2,861.0 	3,159.8
Operating expenses:
Third-party distribution, service and advisory 	462.5 	475.0 	917.6 	987.6
Employee compensation 	475.7 	407.2 	938.5 	840.1
Marketing 	29.0 	33.8 	54.0 	55.5
Property, office and technology 	137.1 	135.0 	271.5 	267.0
General and administrative 	121.6 	119.7 	197.3 	221.9
Transaction, integration and restructuring 	— 	0.2 	41.6 	35.4
Amortization of intangibles 	13.1 	14.8 	27.2 	29.9
Total operating expenses 	1,239.0 	1,185.7 	2,447.7 	2,437.4
Operating income 	203.8 	344.7 	413.3 	722.4
Other income/(expense):
Equity in earnings of unconsolidated affiliates 	19.2 	24.7 	45.3 	58.1
Interest and dividend income 	7.1 	2.1 	15.7 	3.3
Interest expense 	(18.4) 	(25.8) 	(36.4) 	(49.0)
Other gains/(losses), net 	20.9 	(90.0) 	48.3 	(135.5)
Other income/(expense) of CIP, net 	(2.7) 	26.2 	(20.6) 	2.9
Income before income taxes 	229.9 	281.9 	465.6 	602.2
Income tax provision 	(65.5) 	(63.0) 	(135.4) 	(145.8)
Net income 	164.4 	218.9 	330.2 	456.4
Net (income)/loss attributable to noncontrolling interests in consolidated entities 	27.0 	(38.7) 	65.4 	(19.3)
Dividends declared on preferred shares 	(59.2) 	(59.2) 	(118.4) 	(118.4)
Net income attributable to Invesco Ltd. 	132.2 	121.0 	277.2 	318.7
Earnings per common share:
-basic 	$0.29 	$0.27 	$0.61 	$0.70
-diluted 	$0.29 	$0.26 	$0.60 	$0.69
See accompanying notes.
2

-- 5 of 111 --

Table of Contents
Invesco Ltd.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
Three months ended June 30, 	Six months ended June 30,
$ in millions 	2023 	2022 	2023 	2022
Net income 	164.4 	218.9 	330.2 	456.4
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries 	63.8 	(292.9) 	118.9 	(360.1)
Other comprehensive income/(loss), net of tax 	0.8 	0.3 	5.2 	0.5
Other comprehensive income/(loss) 	64.6 	(292.6) 	124.1 	(359.6)
Total comprehensive income/(loss) 	229.0 	(73.7) 	454.3 	96.8
Comprehensive loss/(income) attributable to noncontrolling interests in
consolidated entities 	27.0 	(38.7) 	65.4 	(19.3)
Dividends declared on preferred shares 	(59.2) 	(59.2) 	(118.4) 	(118.4)
Comprehensive income/(loss) attributable to Invesco Ltd. 	196.8 	(171.6) 	401.3 	(40.9)
See accompanying notes.
3

-- 6 of 111 --

Table of Contents
Invesco Ltd.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Six months ended June 30,
$ in millions 	2023 	2022
Operating activities:
Net income 	330.2 	456.4
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:
Amortization and depreciation 	94.2 	98.8
Common share-based compensation expense 	69.8 	57.1
Other (gains)/losses, net 	(48.3) 	135.5
Other (gains)/losses of CIP, net 	120.0 	66.7
Equity in earnings of unconsolidated affiliates 	(45.3) 	(58.1)
Distributions from equity method investees 	6.5 	70.3
Changes in operating assets and liabilities:
(Purchase)/sale of investments by CIP, net 	(164.3) 	(299.7)
(Purchase)/sale of investments, net 	5.8 	(25.2)
(Increase)/decrease in receivables 	397.0 	509.3
Increase/(decrease) in payables 	(533.2) 	(1,263.4)
Net cash provided by/(used in) operating activities 	232.4 	(252.3)
Investing activities:
Purchase of property, equipment and software 	(84.8) 	(57.1)
Purchase of investments by CIP 	(1,190.9) 	(1,709.2)
Sale of investments by CIP 	1,251.7 	1,653.9
Purchase of investments 	(62.0) 	(119.9)
Sale of investments 	35.1 	54.9
Capital distribution from equity method investees 	12.3 	16.9
Net cash inflows/(outflows) upon consolidation/deconsolidation of CIP 	(10.6) 	4.7
Net cash provided by/(used in) investing activities 	(49.2) 	(155.8)
Financing activities:
Purchases of treasury shares 	(179.2) 	(234.4)
Dividends paid - preferred 	(118.4) 	(118.4)
Dividends paid - common 	(177.6) 	(163.4)
Third-party capital invested into CIP 	51.5 	446.8
Third-party capital distributed by CIP 	(150.0) 	(130.3)
Borrowings of debt of CIP 	251.8 	84.9
Repayments of debt of CIP 	(27.7) 	(2.8)
Net borrowings/(repayments) under credit facility 	— 	184.6
Repayments of senior notes 	— 	(600.0)
Net cash provided by/(used in) financing activities 	(349.6) 	(533.0)
Increase/(decrease) in cash and cash equivalents 	(166.4) 	(941.1)
Foreign exchange movement on cash and cash equivalents 	18.2 	(65.4)
Foreign exchange movement on cash and cash equivalents of CIP 	1.2 	(7.8)
Cash and cash equivalents, beginning of period 	1,434.1 	2,147.1
Cash and cash equivalents, end of period 	1,287.1 	1,132.8
Cash and cash equivalents 	1,009.9 	936.8
Cash and cash equivalents of CIP 	277.2 	196.0
Total cash and cash equivalents per condensed consolidated statement of cash flows 	1,287.1 	1,132.8
See accompanying notes.
4

-- 7 of 111 --

Table of Contents
Invesco Ltd.
Condensed Consolidated Statements of Changes in Equity
(Unaudited)
Three months ended June 30, 2023
Equity Attributable to Invesco Ltd.
$ in millions, except per share data
Preferred
Shares Common
Shares
Additional
Paid-in-
Capital Treasury
Shares Retained
Earnings
Accumulated
Other
Comprehensive
Income/(Loss)
Total Equity
Attributable
to Invesco
Ltd.
Nonredeemable
Noncontrolling
Interests in
Consolidated
Entities
Total
Permanent
Equity
Redeemable
Noncontrolling
Interests in
Consolidated
Entities Temporary
Equity
April 1, 2023 	4,010.5 	113.2 	7,412.6 (2,888.0) 7,577.6 	(882.9) 	15,343.0 	587.2 	15,930.2 	879.6
Net income 	— 	— 	— 	— 	191.4 	— 	191.4 	(13.9) 	177.5 	(13.1)
Other comprehensive
income/(loss) 	— 	— 	— 	— 	— 	64.6 	64.6 	— 	64.6 	—
Change in noncontrolling
interests in consolidated entities,
net 	— 	— 	— 	— 	— 	— 	— 	(35.5) 	(35.5) 	(24.6)
Dividends declared - preferred
($14.75 per share) 	— 	— 	— 	— 	(59.2) 	— 	(59.2) 	— 	(59.2) 	—
Dividends declared - common
($0.20 per share) 	— 	— 	— 	— 	(91.9) 	— 	(91.9) 	— 	(91.9) 	—
Employee common share plans:
Common share-based
compensation 	— 	— 	32.0 	— 	— 	— 	32.0 	— 	32.0 	—
Vested common shares 	— 	— 	(7.7) 	7.7 	— 	— 	— 	— 	— 	—
Other common share awards 	— 	— 	(3.9) 	4.4 	— 	— 	0.5 	— 	0.5 	—
Purchase of common shares 	— 	— 	— 	(151.5) 	— 	— 	(151.5) 	— 	(151.5) 	—
June 30, 2023 	4,010.5 	113.2 	7,433.0 (3,027.4) 7,617.9 	(818.3) 	15,328.9 	537.8 	15,866.7 	841.9
Three months ended June 30, 2022
Equity Attributable to Invesco Ltd.
$ in millions, except per share data
Preferred
Shares
Common
Shares
Additional
Paid-in-
Capital
Treasury
Shares
Retained
Earnings
Accumulated
Other
Comprehensive
Income/(Loss)
Total Equity
Attributable
to Invesco
Ltd.
Nonredeemable
Noncontrolling
Interests in
Consolidated
Entities
Total
Permanent
Equity
Redeemable
Noncontrolling
Interests in
Consolidated
Entities Temporary
Equity
April 1, 2022 	4,010.5 	113.2 	7,547.0 (3,105.1) 7,287.9 	(508.5) 	15,345.0 	641.2 	15,986.2 	801.1
Net income 	— 	— 	— 	— 	180.2 	— 	180.2 	60.9 	241.1 	(22.2)
Other comprehensive
income/(loss) 	— 	— 	— 	— 	— 	(292.6) 	(292.6) 	— 	(292.6) 	—
Change in noncontrolling
interests in consolidated entities,
net 	— 	— 	— 	— 	— 	— 	— 	(21.0) 	(21.0) 	113.9
Dividends declared - preferred
($14.75 per share) 	— 	— 	— 	— 	(59.2) 	— 	(59.2) 	— 	(59.2) 	—
Dividends declared - common
($0.1875 per share) 	— 	— 	— 	— 	(85.7) 	— 	(85.7) 	— 	(85.7) 	—
Employee common share plans:
Common share-based
compensation 	— 	— 	27.6 	— 	— 	— 	27.6 	— 	27.6 	—
Vested common shares 	— 	— 	(11.7) 	11.7 	— 	— 	— 	— 	— 	—
Other common share awards 	— 	— 	0.3 	— 	— 	— 	0.3 	— 	0.3 	—
Purchase of common shares 	— 	— 	— 	(1.9) 	— 	— 	(1.9) 	— 	(1.9) 	—
June 30, 2022 	4,010.5 	113.2 	7,563.2 (3,095.3) 7,323.2 	(801.1) 	15,113.7 	681.1 	15,794.8 	892.8
See accompanying notes.
5

-- 8 of 111 --

Table of Contents
Invesco Ltd.
Condensed Consolidated Statements of Changes in Equity
(Unaudited)
Six months ended June 30, 2023
Equity Attributable to Invesco Ltd.
$ in millions, except per share data
Preferred
Shares
Common
Shares
Additional
Paid-in-
Capital
Treasury
Shares
Retained
Earnings
Accumulated
Other
Comprehensive
Income/(Loss)
Total Equity
Attributable
to Invesco
Ltd.
Nonredeemable
Noncontrolling
Interests in
Consolidated
Entities
Total
Permanent
Equity
Redeemable
Noncontrolling
Interests in
Consolidated
Entities Temporary
Equity
January 1, 2023 	4,010.5 	113.2 	7,554.9 (3,040.9) 7,518.3 	(942.4) 	15,213.6 	629.9 	15,843.5 	998.7
Net income 	— 	— 	— 	— 	395.6 	— 	395.6 	(38.7) 	356.9 	(26.7)
Other comprehensive
income/(loss) 	— 	— 	— 	— 	— 	124.1 	124.1 	— 	124.1 	—
Change in noncontrolling
interests in consolidated entities,
net 	— 	— 	— 	— 	— 	— 	— 	(53.4) 	(53.4) 	(130.1)
Dividends declared - preferred (
$29.50 per share) 	— 	— 	— 	— 	(118.4) 	— 	(118.4) 	— 	(118.4) 	—
Dividends declared - common
($0.3875 per share) 	— 	— 	— 	— 	(177.6) 	— 	(177.6) 	— 	(177.6) 	—
Employee common share plans:
Common share-based
compensation 	— 	— 	69.8 	— 	— 	— 	69.8 	— 	69.8 	—
Vested common shares 	— 	— 	(188.3) 	188.3 	— 	— 	— 	— 	— 	—
Other common share awards 	— 	— 	(3.4) 	4.4 	— 	— 	1.0 	— 	1.0 	—
Purchase of common shares 	— 	— 	— 	(179.2) 	— 	— 	(179.2) 	— 	(179.2) 	—
June 30, 2023 	4,010.5 	113.2 	7,433.0 (3,027.4) 7,617.9 	(818.3) 	15,328.9 	537.8 	15,866.7 	841.9
Six months ended June 30, 2022
Equity Attributable to Invesco Ltd.
$ in millions, except per share data
Preferred
Shares
Common
Shares
Additional
Paid-in-
Capital
Treasury
Shares
Retained
Earnings
Accumulated
Other
Comprehensive
Income/(Loss)
Total Equity
Attributable
to Invesco
Ltd.
Nonredeemable
Noncontrolling
Interests in
Consolidated
Entities
Total
Permanent
Equity
Redeemable
Noncontrolling
Interests in
Consolidated
Entities Temporary
Equity
January 1, 2022 	4,010.5 	113.2 	7,688.0 (3,043.6) 7,169.2 	(441.5) 	15,495.8 	672.2 	16,168.0 	510.8
Net income 	— 	— 	— 	— 	437.1 	— 	437.1 	52.7 	489.8 	(33.4)
Other comprehensive
income/(loss) 	— 	— 	— 	— 	— 	(359.6) 	(359.6) 	— 	(359.6) 	—
Change in noncontrolling interests
in consolidated entities, net 	— 	— 	— 	— 	— 	— 	— 	(43.8) 	(43.8) 	415.4
Dividends declared - preferred
($29.50 per share) 	— 	— 	— 	— 	(118.4) 	— 	(118.4) 	— 	(118.4) 	—
Dividends declared - common
($0.3575 per share) 	— 	— 	— 	— 	(164.7) 	— 	(164.7) 	— 	(164.7) 	—
Employee common share plans:
Common share-based
compensation 	— 	— 	57.1 	— 	— 	— 	57.1 	— 	57.1 	—
Vested common shares 	— 	— 	(182.7) 	182.7 	— 	— 	— 	— 	— 	—
Other common share awards 	— 	— 	0.8 	— 	— 	— 	0.8 	— 	0.8 	—
Purchase of common shares 	— 	— 	— 	(234.4) 	— 	— 	(234.4) 	— 	(234.4) 	—
June 30, 2022 	4,010.5 	113.2 	7,563.2 (3,095.3) 7,323.2 	(801.1) 	15,113.7 	681.1 	15,794.8 	892.8
See accompanying notes.
6

-- 9 of 111 --

Table of Contents
Invesco Ltd.
Notes to the Condensed Consolidated Financial Statements
(Unaudited)
1. ACCOUNTING POLICIES
Corporate Information
Invesco Ltd. (the Parent) and its consolidated entities (collectively, the company or Invesco) provide retail and institutional clients with an array of investment
management capabilities. The company operates globally and its sole business is investment management.
Certain disclosures included in the company’s annual report on Form 10-K for the year ended December 31, 2022 (annual report or Form 10-K) are not
required to be included on an interim basis in the company’s quarterly reports on Forms 10-Q (Report). The company has condensed or omitted these
disclosures. Therefore, this Report should be read in conjunction with the company’s annual report.
Basis of Accounting and Consolidation
The unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United
States (U.S. GAAP) for interim financial information and with rules and regulations of the U.S. Securities and Exchange Commission (SEC) and consolidate
the financial statements of the Parent and all of its controlled subsidiaries. In the opinion of management, the Condensed Consolidated Financial Statements
reflect all adjustments, consisting of normal recurring accruals, which are necessary for the fair presentation of the financial condition and results of operations
for the periods presented. All significant intercompany transactions, balances, revenues and expenses are eliminated upon consolidation. The preparation of
financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures
in the financial statements. Actual results could differ from those estimates.
Accounting Pronouncements Recently Adopted
None.
Pending Accounting Pronouncements
None.
2. FAIR VALUE OF ASSETS AND LIABILITIES
The fair value of financial instruments are presented in the below summary table. The fair value of financial instruments held by CIP are presented in Note
11, "Consolidated Investment Products". See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.
June 30, 2023 	December 31, 2022
$ in millions 	Fair Value 	Fair Value
Cash and cash equivalents 	1,009.9 	1,234.7
Equity investments 	282.9 	325.0
Foreign time deposits 	15.1 	25.7
Assets held for policyholders 	444.0 	668.7
Policyholder payables 	(444.0) 	(668.7)
Total return swaps related to deferred compensation plans 	19.3 	(1.6)
____________
(1) These financial instruments are not measured at fair value on a recurring basis. Foreign time deposits are measured at cost plus accrued interest, which approximates fair
value, and are accordingly classified as Level 2 securities. Policyholder payables are indexed to the value of the assets held for policyholders and changes in fair value are
recorded and offset to zero in other operating revenues.
(1)
(1)
7

-- 10 of 111 --

Table of Contents
The following table presents, by hierarchy levels, the carrying value of the company’s assets and liabilities, including major security type for equity and debt
securities, which are measured at fair value on the company’s Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022,
respectively:
As of June 30, 2023
$ in millions
Fair Value
Measurements
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds 	565.4 	565.4 	— 	—
Investments:
Equity investments:
Seed capital 	96.2 	96.2 	— 	—
Investments related to deferred compensation plans 	185.8 	185.8 	— 	—
Other equity securities 	0.9 	0.9 	— 	—
Assets held for policyholders 	444.0 	444.0 	— 	—
Total return swaps related to deferred compensation plans 	19.3 	— 	19.3 	—
Total 	1,311.6 	1,292.3 	19.3 	—
Liabilities:
Contingent consideration liability 	(1.3) 	— 	— 	(1.3)
Total 	(1.3) 	— 	— 	(1.3)
As of December 31, 2022
$ in millions
Fair Value
Measurements
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets:
Cash equivalents:
Money market funds 	760.8 	760.8 	— 	—
Investments :
Equity investments:
Seed capital 	177.9 	177.9 	— 	—
Investments related to deferred compensation plans 	146.1 	146.1 	— 	—
Other equity securities 	1.0 	1.0 	— 	—
Assets held for policyholders 	668.7 	668.7 	— 	—
Total 	1,754.5 	1,754.5 	— 	—
Liabilities:
Total return swaps related to deferred compensation plans 	(1.6) 	— 	(1.6) 	—
Contingent consideration liability 	(1.3) 	— 	— 	(1.3)
Total 	(2.9) 	— 	(1.6) 	(1.3)
____________
(1) The balance primarily represents cash held in affiliated money market funds.
(2) Foreign time deposits of $15.1 million (December 31, 2022: $25.7 million) are excluded from this table. Equity method and other investments of $669.5 million and $24.6
million, respectively, (December 31, 2022: $621.2 million and $24.7 million, respectively) are also excluded from this table. These investments are not measured at fair
value, in accordance with applicable accounting standards.
(3) The majority of assets held for policyholders are held in affiliated funds.
(1)
(2)
(3)
(1)
(2)
(3)
8

-- 11 of 111 --

Table of Contents
Total Return Swaps (TRS)
In addition to holding equity investments, the company has TRS to hedge economically certain deferred compensation liabilities. The notional value of the
TRS at June 30, 2023 was $389.2 million, and the fair value of the TRS was an asset of $19.3 million (December 31, 2022 notional value was $326.6 million
and the fair value was a liability of $1.6 million). During the three months and six months ended June 30, 2023, market valuation gains related to the TRS of
$7.3 million and $20.3 million were recognized in Other gains/(losses), net (three and six months ended June 30, 2022: $50.3 million and $72.1 million net
losses).
3. INVESTMENTS
The disclosures below include details of the company’s investments. Investments held by CIP are detailed in Note 11, "Consolidated Investment Products".
$ in millions 	June 30, 2023 	December 31, 2022
Equity investments:
Seed capital 	96.2 	177.9
Investments related to deferred compensation plans 	185.8 	146.1
Other equity securities 	0.9 	1.0
Equity method investments 	669.5 	621.2
Foreign time deposits 	15.1 	25.7
Other 	24.6 	24.7
Total investments 	992.1 	996.6
____________
(1) The majority of the company’s investment balances relate to balances held in affiliated funds and equity method investees.
Equity investments
The unrealized gains and losses for the three and six months ended June 30, 2023 that relate to equity investments still held at June 30, 2023, were a $9.6
million net gain and $22.9 million net gain (three and six months ended June 30, 2022: $40.6 million net loss and $69.7 million net loss).
(1)
9

-- 12 of 111 --

Table of Contents
4. DEBT
The disclosures below include details of the company’s debt. Debt of CIP is detailed in Note 11, "Consolidated Investment Products".
June 30, 2023 	December 31, 2022
$ in millions 	Carrying Value 	Fair Value 	Carrying Value 	Fair Value
$2.0 billion floating rate credit facility expiring April 26, 2028 	— 	— 	— 	—
Unsecured Senior Notes:
$600 million 4.000% - due January 30, 2024 	599.4 	594.2 	598.8 	591.5
$500 million 3.750% - due January 15, 2026 	498.2 	483.7 	497.9 	486.4
$400 million 5.375% - due November 30, 2043 	391.0 	387.1 	390.9 	397.3
Debt 	1,488.6 	1,465.0 	1,487.6 	1,475.2
____________
(1) On April 26, 2023, Invesco Ltd. and its indirect subsidiary, Invesco Finance PLC, amended and restated the $1.5 billion floating rate credit facility, increasing the facility’s
capacity to $2.0 billion, extending the expiration date from April 26, 2026 to April 26, 2028, and changing the base interest rate from LIBOR to SOFR.
(2) The company’s senior note indentures contain certain restrictions on mergers or consolidations. Beyond these items, there are no other restrictive covenants in the
indentures.
(3) The difference between the principal amounts and the carrying values of the senior notes in the table above reflect the unamortized debt issuance costs and discounts.
5. SHARE CAPITAL
The number of preferred shares issued and outstanding is represented in the table below:
As of
in millions 	June 30, 2023 	December 31, 2022
Preferred shares issued 	4.0 	4.0
Preferred shares outstanding 	4.0 	4.0
__________
(1) Preferred shares are held by Massachusetts Mutual Life Insurance Company (MassMutual) and are subject to a lock-up period of five years, which prohibits the sale of the
preferred shares by MassMutual until May 24, 2024.
The number of common shares and common share equivalents issued are represented in the table below:
As of
in millions 	June 30, 2023 	December 31, 2022
Common shares issued 	566.1 	566.1
Less: Treasury shares for which dividend and voting rights do not apply 	(117.5) 	(111.3)
Common shares outstanding 	448.6 	454.8
(3) 	(3)
(1)
(2)
(1)
(1)
10

-- 13 of 111 --

Table of Contents
6. OTHER COMPREHENSIVE INCOME/(LOSS)
The components of accumulated other comprehensive income/(loss) were as follows:
For the three months ended June 30, 2023
$ in millions
Foreign
currency
translation Employee
benefit plans 	Total
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries 	63.8 	— 	63.8
Other comprehensive income/(loss), net 	— 	0.8 	0.8
Other comprehensive income/(loss), net of tax 	63.8 	0.8 	64.6
Beginning balance 	(759.9) 	(123.0) 	(882.9)
Other comprehensive income/(loss), net of tax 	63.8 	0.8 	64.6
Ending balance 	(696.1) 	(122.2) 	(818.3)
For the three months ended June 30, 2022
$ in millions
Foreign
currency
translation
Employee
benefit plans 	Total
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries 	(292.9) 	— 	(292.9)
Other comprehensive income/(loss), net 	0.3 	0.3
Other comprehensive income/(loss), net of tax 	(292.9) 	0.3 	(292.6)
Beginning balance 	(419.1) 	(89.4) 	(508.5)
Other comprehensive income/(loss), net of tax 	(292.9) 	0.3 	(292.6)
Ending balance 	(712.0) 	(89.1) 	(801.1)
For the six months ended June 30, 2023
$ in millions
Foreign
currency
translation
Employee
benefit plans 	Total
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries 	118.9 	— 	118.9
Other comprehensive income/(loss), net 	— 	5.2 	5.2
Other comprehensive income/(loss), net of tax 	118.9 	5.2 	124.1
Beginning balance 	(815.0) 	(127.4) 	(942.4)
Other comprehensive income/(loss), net of tax 	118.9 	5.2 	124.1
Ending balance 	(696.1) 	(122.2) 	(818.3)
For the six months ended June 30, 2022
$ in millions
Foreign
currency
translation
Employee
benefit plans 	Total
Other comprehensive income/(loss), net of tax:
Currency translation differences on investments in foreign subsidiaries 	(360.1) 	— 	(360.1)
Other comprehensive income/(loss), net 	0.5 	0.5
Other comprehensive income/(loss), net of tax 	(360.1) 	0.5 	(359.6)
Beginning balance 	(351.9) 	(89.6) 	(441.5)
Other comprehensive income/(loss), net of tax 	(360.1) 	0.5 	(359.6)
Ending balance 	(712.0) 	(89.1) 	(801.1)
11

-- 14 of 111 --

Table of Contents
7. REVENUE
The geographic disaggregation of revenue for the three and six months ended June 30, 2023 and 2022 are presented below. There are no revenues attributed
to the company’s country of domicile, Bermuda.
For the three months ended June 30,
$ in millions 	2023 	2022
Americas 	1,108.1 	1,183.3
Asia-Pacific (APAC) 	63.7 	70.3
Europe, Middle East and Africa (EMEA) 	271.0 	276.8
Total operating revenues 	1,442.8 	1,530.4
For the six months ended June 30,
$ in millions 	2023 	2022
Americas 	2,191.5 	2,428.1
Asia-Pacific (APAC) 	133.6 	155.5
Europe, Middle East and Africa (EMEA) 	535.9 	576.2
Total operating revenues 	2,861.0 	3,159.8
8. COMMON SHARE-BASED COMPENSATION
The company recognized total compensation expense of $69.8 million and $57.1 million related to equity-settled common share-based payment transactions
in the six months ended June 30, 2023 and 2022, respectively.
Movements on employee common share awards during the periods ended June 30 are detailed below:
For the six months ended June 30, 2023 	For the six months ended June 30, 2022
In millions of common shares, except fair values 	Time- Vested Performance-
Vested
Weighted Average
Grant Date Fair
Value ($) 	Time- Vested 	Performance- Vested
Unvested at the beginning of period 	10.3 	2.1 	19.03 	13.5 	1.9
Granted during the period 	4.3 	0.7 	17.73 	3.6 	1.0
Forfeited during the period 	(0.1) 	(0.2) 	15.90 	(0.2) 	(0.1)
Vested and distributed during the period 	(4.8) 	(0.5) 	18.01 	(5.1) 	(0.4)
Unvested at the end of the period 	9.7 	2.1 	19.02 	11.8 	2.4
The total fair value of common shares that vested during the six months ended June 30, 2023 was $91.3 million (six months ended June 30, 2022: $116.8
million). The weighted average grant date fair value of the U.S. dollar share awards that were granted during the six months ended June 30, 2023 was $17.73
(six months ended June 30, 2022: $21.23).
At June 30, 2023, there was $153.2 million of total unrecognized compensation cost related to non-vested common share awards; that cost is expected to be
recognized over a weighted average period of 2.69 years.
12

-- 15 of 111 --

Table of Contents
9. EARNINGS PER COMMON SHARE
The calculation of earnings per common share (EPS) is as follows:
For the three months ended June 30, 	For the six months ended June 30,
In millions, except per share data 	2023 	2022 	2023 	2022
Net income attributable to Invesco Ltd. 	132.2 	121.0 	277.2 	318.7
Invesco Ltd:
Weighted average common shares outstanding - basic 	457.9 	456.5 	458.0 	458.0
Dilutive effect of non-participating common share-based awards 	0.9 	3.0 	0.9 	2.7
Weighted average common shares outstanding - diluted 	458.8 	459.5 	458.9 	460.7
Earnings per common share:
-basic 	$0.29 	$0.27 	$0.61 	$0.70
-diluted 	$0.29 	$0.26 	$0.60 	$0.69
See Note 8, "Common Share-Based Compensation," for a summary of common share awards outstanding under the company’s common share-based payment
programs. These programs could result in the issuance of common shares that would affect the measurement of basic and diluted EPS.
10. COMMITMENTS AND CONTINGENCIES
Commitments and contingencies may arise in the ordinary course of business.
The company has committed to co-invest in certain investment products, which may be called in future periods. At June 30, 2023, the company’s undrawn
co-invest capital commitments were $453.1 million (December 31, 2022: $336.1 million).
Certain of our managed investment products have entered into revolving credit facilities with financial institutions. Pursuant to these arrangements, the
company provided equity commitments and guarantees to certain of these investment products that are temporary in nature. The revolving credit facilities look
first to the respective investment products for repayment and servicing. The company’s equity commitment or guarantee would only be called in the event a
particular investment product is unable to meet its obligation. The company believes the likelihood of being required to fund its equity commitments or
guarantees under these arrangements to be remote. To date, the company has not been required to fund any equity commitments or guarantees under these
arrangements. The maximum amount of future payments under the commitments is $274.9 million and under the guarantees is $30.0 million. The fair value of
the guarantee liability is not significant to the consolidated financial statements.
The company and some of its subsidiaries have entered into agreements with financial institutions to guarantee certain obligations of other company
subsidiaries. The company would be required to perform under these guarantees in the event of certain defaults. The company has not had prior claims or losses
pursuant to these contracts and expects the risk of loss to be remote.
Legal Contingencies
The company is from time to time involved in pending or threatened litigation relating to claims arising in the ordinary course of its business. The nature and
progression of litigation can make it difficult to predict the impact a particular lawsuit or claim will have on the company. There are many reasons that the
company cannot make these assessments, including, among others, one or more of the following: the proceeding is in its early stages (or merely threatened); the
damages sought are unspecified, unsupportable, unexplained or uncertain; the claimant is seeking relief other than compensatory damages; the matter presents
novel legal claims or other meaningful legal uncertainties; discovery has not started or is not complete; there are significant facts in dispute; and there are other
parties who may share in any ultimate liability.
13

-- 16 of 111 --

Table of Contents
The company and certain related entities have in recent years been subject to various regulatory inquiries, reviews and investigations and legal proceedings,
including civil litigation and governmental investigations and enforcement actions. These actions can arise from normal business operations and/or matters that
have been the subject of previous regulatory reviews. As a global company with investment products registered in numerous countries and subject to the
jurisdiction of one or more regulators in each country, at any given time, our business operations may be subject to review, investigation, or disciplinary action.
For example, the company is cooperating with requests from the SEC in connection with their investigation of investment advisers’ compliance with record
retention requirements relating to certain types of electronic business communications.
In assessing the impact that a legal or regulatory matter will have on the company, management evaluates the need for an accrual on a case-by-case basis. If
the likelihood of a loss is deemed probable and is reasonably estimable, the estimated loss is accrued. If the likelihood of a loss is assessed as less than probable,
or an amount or range of loss cannot be reasonably estimated, a loss is not accrued. In management’s opinion, adequate accrual has been made as of June 30,
2023 to provide for any such losses that may arise from matters for which the company could reasonably estimate an amount and are deemed probable.
Management is of the opinion that the ultimate resolution of claims will not materially affect the company’s business, revenue, net income or liquidity.
11. CONSOLIDATED INVESTMENT PRODUCTS
The balances related to CIP are identified on the Consolidated Balance Sheets. At June 30, 2023, the company’s net investment in and net receivables from
CIP were $465.4 million (December 31, 2022: $386.6 million). The consolidation of investment products had no impact on net income attributable to the
company during the three months and six months ended June 30, 2023.
The following tables present the fair value hierarchy levels of certain CIP balances which are measured at fair value as of June 30, 2023 and December 31,
2022:
As of June 30, 2023
$ in millions
Fair Value
Measurements
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable Inputs
(Level 3)
Investments
Measured at NAV as
a practical expedient
Assets:
Bank loans 	6,571.1 	— 	6,187.2 	383.9 	—
Bonds 	727.3 	14.0 	713.3 	— 	—
Equity securities 	226.4 	88.3 	38.8 	99.3 	—
Equity and fixed income mutual funds 	171.4 	25.8 	145.6 	— 	—
Investments in other private equity funds 	412.5 	— 	— 	7.6 	404.9
Real estate investments 	502.6 	— 	— 	— 	502.6
Total assets at fair value 	8,611.3 	128.1 	7,084.9 	490.8 	907.5
As of December 31, 2022
$ in millions
Fair Value
Measurements
Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable Inputs
(Level 3)
Investments
Measured at NAV as
a practical expedient
Assets:
Bank loans 	6,315.1 	— 	6,069.8 	245.3 	—
Bonds 	697.5 	8.8 	688.2 	0.5 	—
Equity securities 	274.9 	129.9 	29.8 	115.2 	—
Equity and fixed income mutual funds 	230.7 	38.8 	191.9 	— 	—
Investments in other private equity funds 	461.2 	— 	— 	7.6 	453.6
Real estate investments 	552.0 	— 	— 	— 	552.0
Total assets at fair value 	8,531.4 	177.5 	6,979.7 	368.6 	1,005.6
14

-- 17 of 111 --

Table of Contents
The following table shows a reconciliation of the beginning and ending fair value measurements for level 3 assets using significant unobservable inputs:
For the three months ended June 30,
2023 	2022
$ in millions 	Level 3 Assets 	Level 3 Assets
Beginning Balance as of April 1 	351.3 	255.3
Purchases 	210.4 	0.1
Sales 	(28.7) 	(2.0)
Deconsolidation of CIP 	— 	—
Gains and losses included in the Consolidated Statements of Income 	6.4 	(1.5)
Transfers from Level 3 into Levels 1 or 2 	(112.3) 	(61.6)
Transfers into Level 3 from Levels 1 or 2 	63.7 	138.3
Foreign exchange 	— 	(0.3)
Ending Balance as of June 30 	490.8 	328.3
For the six months ended June 30,
2023 	2022
$ in millions 	Level 3 Assets 	Level 3 Assets
Beginning Balance as of January 1 	368.6 	239.5
Purchases 	210.5 	0.1
Sales 	(42.1) 	(8.5)
Deconsolidation of CIP 	(0.6) 	—
Gains and losses included in the Consolidated Statements of Income 	(1.3) 	(2.2)
Transfers from Level 3 into Levels 1 or 2 	(242.5) 	(93.4)
Transfers into Level 3 from Levels 1 or 2 	195.9 	193.4
Foreign exchange 	2.3 	(0.6)
Ending Balance as of June 30 	490.8 	328.3
Non-consolidated Variable interest entities (VIEs)
At June 30, 2023, the company's risk of loss with respect to VIEs in which the company is not the primary beneficiary included our investment carrying value
of $129.7 million (December 31, 2022: $111.5 million) and unfunded capital commitments of $92.3 million (December 31, 2022: $99.0 million).
See the company’s most recently filed Form 10-K for additional disclosures on valuation methodology and fair value.
12. RELATED PARTIES
MassMutual owns approximately 18.1% in common stock of the company and owns all of the outstanding $4.0 billion in perpetual, non-cumulative preferred
shares as of June 30, 2023. Based on the level of shares owned by MassMutual and the corresponding customary minority shareholder rights, which includes
representation on Invesco’s board of directors, the company considers MassMutual a related party.
Additionally, certain managed funds are deemed to be affiliated entities under the related party definition in ASC 850, “Related Party Disclosures.” The
majority of the company's operating revenues and receivables are from Invesco's managed funds. Related parties also include those defined in the company’s
proxy statement.
Refer to Note 2, "Fair Value of Assets and Liabilities" and Note 3, "Investments" for more information on balances invested in Invesco affiliated funds.
15

-- 18 of 111 --

Table of Contents
13. SUBSEQUENT EVENTS
On July 25, 2023, the company declared a second quarter 2023 dividend of $0.20 per common share, payable on September 5, 2023, to common shareholders
of record at the close of business on August 11, 2023 with an ex-dividend date of August 10, 2023.
On July 25, 2023, the company declared a preferred dividend of $14.75 per preferred share to the holders of preferred shares representing the period from
June 1, 2023 through August 31, 2023. The preferred dividend is payable on September 1, 2023 to preferred shareholders of record at the close of business on
August 15, 2023.
16

-- 19 of 111 --

Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Condensed
Consolidated Financial Statements and related Notes thereto, which appear elsewhere in this Report. Except for the historical financial information, this Report
may include statements that constitute “forward-looking statements” under the United States securities laws. Forward-looking statements include information
concerning future results of our operations, expenses, earnings, liquidity, cash flow, capital expenditures, and assets under management (AUM) which could
differ materially from actual results due to known and unknown risks and other important factors, including, but not limited to, industry or market conditions,
geopolitical events and pandemics or health crises and their respective potential impact on the company, acquisitions and divestitures, debt and our ability to
obtain additional financing or make payments, regulatory developments, demand for and pricing of our products, the prospects for certain legal contingencies,
and other aspects of our business or general economic conditions. In addition, words such as “believes,” “expects,” “anticipates,” “intends,” “plans,”
“estimates,” “projects,” “forecasts,” and future or conditional verbs such as “will,” “may,” “could,” “should,” and “would” as well as any other statement that
necessarily depends on future events, are intended to identify forward-looking statements. None of this information should be considered in isolation from, or as
a substitute for, historical financial statements.
Forward-looking statements are not guarantees, and they involve risks, uncertainties and assumptions. There can be no assurance that actual results will not
differ materially from our expectations. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks
described in this Report and our most recent Form 10-K and Forms 10-Q filed with the SEC.
You may obtain these reports from the SEC’s website at www.sec.gov. We expressly disclaim any obligation to update the information in any public
disclosure if any forward-looking statement later turns out to be inaccurate.
References
In this Report, unless otherwise specified, the terms “we,” “our,” “us,” “company,” “firm,” and “Invesco” refer to Invesco Ltd., a company incorporated in
Bermuda, and its subsidiaries.
Executive Overview
The following executive overview summarizes the significant trends affecting our results of operations and financial condition for the periods presented. This
overview and the remainder of this management’s discussion and analysis and supplements should be read in conjunction with the Condensed Consolidated
Financial Statements of Invesco Ltd. and the notes thereto contained elsewhere in this Report.
The company is an independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. Our
comprehensive range of active, passive and alternative investment capabilities has been constructed over many years to help clients achieve their investment
objectives. We draw on this comprehensive range of capabilities to provide customized solutions designed to deliver key outcomes aligned to client needs.
Invesco benefits from our long-term efforts to ensure a diversified base of AUM. One of Invesco's core strengths, and a key differentiator for the company
within the industry, is our broad diversification across client domiciles, asset classes and distribution channels. Our geographic diversification recognizes
growth opportunities in different parts of the world. This broad diversification helps to mitigate the impact on Invesco of different market cycles and enables the
company to take advantage of growth opportunities in various markets and channels.
In the second quarter, financial markets showed signs of recovery even as investors continued to grapple with significant uncertainty. Recovery was uneven
across sectors and geographies, and market gains were narrowly distributed. U.S. equity market increases were concentrated in large cap technology stocks,
while non-U.S. equity markets, most notably emerging, international, China, and most long-dated bond index returns, were flat or negative.
Client actions remained cautious for much of the quarter, resulting in slower industry growth in long-term assets, while cash strategies continued to account
for a historically high percentage of client investments. There was an uptick in investor appetite for risk assets late in the quarter, due to cooling inflation
measures and hopes for avoiding a global recession, providing optimism that a broader recovery could be on the horizon.
17

-- 20 of 111 --

Table of Contents
The table below summarizes returns based on price appreciation/(depreciation) of several major market indices for the three and six months ended June 30,
2023 and 2022:
Index expressed in currency
Three months ended June 30, 	Six months ended June 30,
Equity Index 	2023 	2022 	2023 	2022
S&P 500 	U.S. Dollar 	8.3 % 	(16.5)% 	15.9 % 	(20.6)%
FTSE 100 	British Pound 	(1.3)% 	(4.6)% 	1.1 % 	(2.9)%
FTSE 100 	U.S. Dollar 	1.6 % 	(11.6)% 	6.2 % 	(12.7)%
S&P/TSX 60 Index 	Canadian Dollar 	0.7 % 	(13.3)% 	3.9 % 	(10.9)%
S&P/TSX 60 Index 	U.S. Dollar 	2.9 % 	(16.0)% 	6.3 % 	(12.5)%
MSCI Emerging Markets 	U.S. Dollar 	(0.1)% 	(12.4)% 	3.5 % 	(18.8)%
Bond Index
Barclays U.S. Aggregate Bond 	U.S. Dollar 	(0.8)% 	(4.7)% 	2.1 % 	(10.4)%
Despite the $2.0 billion of net long-term outflows for the quarter, our diversified product line showed resilience in key capability areas with net long-term
inflows of $5.7 billion from ETFs, $1.6 billion from greater China and $1.0 billion from Fixed Income.
We remain highly focused on our capital priorities, investing in our key capabilities, and efficiently allocating our resources. Consistent with our commitment
to improve our leverage profile, we continue to maintain our debt at lower levels. We ended the quarter with no balance on our credit facility and continued to
maintain debt below $1.5 billion. We remain committed to a sustainable dividend and to returning capital to shareholders through a combination of modestly
increasing dividends and share repurchases. During the second quarter of 2023, the company repurchased 9.6 million common shares for $150.0 million in the
open market.
As previously disclosed, Martin L. Flanagan retired as President and Chief Executive Officer (CEO) of the company and as a member of the Board of
Directors effective June 30, 2023. Andrew R. Schlossberg succeeded Mr. Flanagan as President and CEO and as a member of the Board of Directors effective
June 30, 2023.
Presentation of Management’s Discussion and Analysis of Financial Condition and Results of Operations - Impact of Consolidated Investment
Products
The company provides investment management services to, and has transactions with, various retail mutual funds and similar entities, private equity, real
estate, fund-of-funds, collateralized loan obligations (CLOs) and other investment entities sponsored by the company for the investment of client assets in the
normal course of business. The company serves as the investment manager, making day-to-day investment decisions concerning the assets of the products.
Investment products that are consolidated are referred to in this Report as CIP. The company’s economic risk with respect to each investment in CIP is limited
to its equity ownership and any uncollected management and performance fees. See also Note 11, "Consolidated Investment Products," for additional
information regarding the impact of the consolidation of managed funds.
The majority of the company’s CIP balances are CLO-related. The collateral assets of the CLOs are held solely to satisfy the obligations of the CLOs. The
company has no right to the benefits from, nor does it bear the risks associated with, the collateral assets held by the CLOs, beyond the company’s direct
investments in, and management and performance fees generated from, the CLOs. If the company were to liquidate, the collateral assets would not be available
to the general creditors of the company, and as a result, the company does not consider them to be company assets. Likewise, the investors in the CLOs have no
recourse to the general credit of the company for the notes issued by the CLOs. The company therefore does not consider this debt to be a company liability.
18

-- 21 of 111 --

Table of Contents
Due to the significant impact that CIP has on the presentation of the company’s Consolidated Financial Statements, the company has elected to deconsolidate
these products in its non-GAAP disclosures (among other adjustments). See "Schedule of Non-GAAP Information" for additional information regarding these
adjustments. The following discussion therefore combines the results presented under U.S. GAAP with the company’s non-GAAP presentation.
This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains four distinct sections, which follow the AUM
discussion:
• Results of Operations (three and six months ended June 30, 2023 compared to three and six months ended June 30, 2022);
• Schedule of Non-GAAP Information;
• Balance Sheet Discussion; and
• Liquidity and Capital Resources.
Summary Operating Information
Wherever a non-GAAP measure is referenced, a disclosure will follow in the narrative or in the note referring the reader to the Schedule of Non-GAAP
Information, where additional details regarding the use of the non-GAAP measure by the company are disclosed, along with reconciliations of the most directly
comparable U.S. GAAP measures to the non-GAAP measures. To further enhance the readability of the Results of Operations section, separate tables for each
of the revenue, expense and other income and expenses (non-operating income/expense) sections of the income statement introduce the narrative that follows,
providing a section-by-section review of the company’s income statements for the periods presented.
Summary operating information is presented in the table below:
U.S. GAAP Financial Measures Summary 	Three months ended June 30, 	Six months ended June 30,
2023 	2022 	2023 	2022
Operating revenues 	1,442.8 	1,530.4 	2,861.0 	3,159.8
Operating income 	203.8 	344.7 	413.3 	722.4
Operating margin 	14.1 % 	22.5 % 	14.4 % 	22.9 %
Net income attributable to Invesco Ltd. 	132.2 	121.0 	277.2 	318.7
Diluted EPS 	0.29 	0.26 	0.60 	0.69
Non-GAAP Financial Measures Summary
Net revenues 	1,090.7 	1,173.9 	2,166.6 	2,426.3
Adjusted operating income 	302.0 	411.9 	628.9 	906.5
Adjusted operating margin 	27.7 % 	35.1 % 	29.0 % 	37.4 %
Adjusted net income attributable to Invesco Ltd. 	144.4 	180.3 	317.8 	439.6
Adjusted diluted EPS 	0.31 	0.39 	0.69 	0.95
Assets Under Management
Ending AUM (billions) 	1,538.2 	1,390.4 	1,538.2 	1,390.4
Average AUM (billions) 	1,494.9 	1,457.2 	1,478.9 	1,501.2
_________
(1) Net revenues, Adjusted operating income (and by calculation, Adjusted operating margin), and Adjusted net income attributable to Invesco Ltd. (and by calculation,
Adjusted diluted EPS) are non-GAAP financial measures, based on methodologies other than U.S. GAAP. See “Schedule of Non-GAAP Information” for a reconciliation of
the most directly comparable U.S. GAAP measures to the non-GAAP measures.
(1)
19

-- 22 of 111 --

Table of Contents
Investment Capabilities Performance Overview
Invesco's first strategic objective is to achieve strong investment performance over the long-term for our clients. The table below presents the one-, three-,
five-, and ten-year performance of our actively managed investment products measured by the percentage of AUM in the top half of benchmark and in the top
half of peer group.
Benchmark Comparison 	Peer Group Comparison
% of AUM In Top Half of Benchmark 	% of AUM in Top Half of Peer Group
1yr 	3yr 	5yr 	10yr 	1yr 	3yr 	5yr 	10yr
Equities
U.S. Core (4%) 	99 % 	41 % 	31 % 	15 % 	100 % 	28 % 	15 % 	11 %
U.S. Growth (6%) 	11 % 	11 % 	43 % 	43 % 	11 % 	— % 	42 % 	72 %
U.S. Value (6%) 	62 % 	61 % 	100 % 	55 % 	61 % 	61 % 	48 % 	47 %
Sector (1%) 	50 % 	6 % 	25 % 	25 % 	46 % 	24 % 	46 % 	55 %
U.K. (1%) 	46 % 	46 % 	47 % 	46 % 	55 % 	62 % 	46 % 	46 %
Canadian (<1%) 	88 % 	100 % 	100 % 	45 % 	76 % 	79 % 	67 % 	— %
Asian (4%) 	66 % 	55 % 	83 % 	91 % 	43 % 	33 % 	34 % 	83 %
Continental European (2%) 	70 % 	76 % 	20 % 	94 % 	79 % 	81 % 	21 % 	73 %
Global (6%) 	75 % 	29 % 	7 % 	85 % 	84 % 	69 % 	4 % 	15 %
Global Ex U.S. and Emerging Markets (7%) 	99 % 	19 % 	99 % 	99 % 	98 % 	31 % 	26 % 	10 %
Fixed Income
Money Market (30%) 	95 % 	92 % 	98 % 	100 % 	87 % 	88 % 	87 % 	99 %
U.S. Fixed Income (10%) 	80 % 	87 % 	84 % 	97 % 	48 % 	77 % 	72 % 	92 %
Global Fixed Income (6%) 	74 % 	86 % 	92 % 	95 % 	79 % 	67 % 	68 % 	92 %
Stable Value (5%) 	— % 	100 % 	100 % 	100 % 	97 % 	97 % 	97 % 	100 %
Other
Alternatives (5%) 	55 % 	49 % 	66 % 	72 % 	37 % 	52 % 	41 % 	50 %
Balanced (7%) 	44 % 	66 % 	65 % 	60 % 	47 % 	73 % 	88 % 	62 %
_________
(1) Excludes passive products, closed-end funds, private equity limited partnerships, non-discretionary funds, unit investment trusts (UITs), fund of funds with component
funds managed by Invesco, stable value building block funds and collateralized debt obligations. Certain funds and products were excluded from the analysis because of
limited benchmark or peer group data. Had these been available, results may have been different. These results are preliminary and subject to revision.
Data as of June 30, 2023. AUM measured versus peer group in the one, three, five and ten year quartile rankings represents 46%, 46%, 45% and 41% of total Invesco AUM,
respectively, and AUM measured versus benchmark on a one, three, five and ten year basis represents 59%, 58%, 55% and 50% of total Invesco AUM. Peer group rankings
are sourced from a widely-used third party ranking agency in each fund’s market (e.g., Morningstar, IA, Lipper, eVestment, Mercer, Galaxy, SITCA, Value Research) and
asset-weighted in USD. Rankings are as of prior quarter-end for most institutional products and prior month-end for Australian retail funds due to their late release by third
parties. Rankings are calculated against all funds in each peer group. Rankings for the primary share class of the most representative fund in each composite are applied to
all products within each composite. Performance assumes the reinvestment of dividends. Past performance is not indicative of future results and may not reflect an investor’s
experience.
(2) Numbers in parenthesis reflect AUM for each investment product (see Note above for exclusions) as a percentage of the total AUM for the five-year peer group ($698.4
billion).
(1)
(2)
(2)
(2)
20

-- 23 of 111 --

Table of Contents
Assets Under Management
The following presentation and discussion of AUM includes Passive and Active AUM. Passive AUM includes index-based ETFs, UITs, non-management fee
earning AUM and other passive mandates. Active AUM is total AUM less Passive AUM.
Non-management fee earning AUM includes non-management fee earning ETFs, UITs and product leverage. The net flows in non-management fee earning
AUM can be relatively short-term in nature and, due to the relatively low revenue yield, can have a significant impact on overall net revenue yield.
The AUM tables and the discussion below refer to certain AUM as long-term. Long-term inflows and the underlying reasons for the movements in this line
item include investments from new clients, existing clients adding new accounts/funds or contributions/subscriptions into existing accounts/funds. Long-term
outflows reflect client redemptions from accounts/funds and include the return of invested capital upon the maturity. We present net flows into money market
funds separately because shareholders of those funds typically use them as short-term funding vehicles and the flows are particularly sensitive to short-term
interest rate movements
Changes in AUM by Investment style were as follows:
Three months ended June 30,
2023 	2022
$ in billions 	Total AUM 	Active 	Passive 	Total AUM 	Active 	Passive
Beginning Assets (March 31) 	1,483.0 	1,005.2 	477.8 	1,555.9 	1,042.7 	513.2
Long-term inflows 	71.3 	40.1 	31.2 	81.4 	48.8 	32.6
Long-term outflows 	(73.3) 	(48.5) 	(24.8) 	(88.2) 	(60.1) 	(28.1)
Net long-term flows 	(2.0) 	(8.4) 	6.4 	(6.8) 	(11.3) 	4.5
Net flows in non-management fee earning AUM 	1.1 	— 	1.1 	(2.0) 	— 	(2.0)
Net flows in money market funds 	15.4 	15.4 	— 	3.5 	3.5 	—
Total net flows 	14.5 	7.0 	7.5 	(5.3) 	(7.8) 	2.5
Reinvested distributions 	1.0 	1.0 	— 	1.8 	1.8 	—
Market gains and losses 	46.5 	9.9 	36.6 	(142.3) 	(61.6) 	(80.7)
Foreign currency translation 	(6.8) 	(6.5) 	(0.3) 	(19.7) 	(17.2) 	(2.5)
Ending Assets (June 30) 	1,538.2 	1,016.6 	521.6 	1,390.4 	957.9 	432.5
Average AUM
Average long-term AUM 	1,085.9 	788.2 	297.7 	1,117.2 	829.7 	287.5
Average AUM 	1,494.9 	1,006.1 	488.8 	1,457.2 	989.2 	468.0
Average QQQ AUM 	180.9 	N/A 	180.9 	169.0 	N/A 	169.0
21

-- 24 of 111 --

Table of Contents
Six months ended June 30,
2023 	2022
$ in billions 	Total AUM 	Active 	Passive 	Total AUM 	Active 	Passive
Beginning Assets (December 31) 	1,409.2 	976.2 	433.0 	1,610.9 	1,082.5 	528.4
Long-term inflows 	150.7 	87.0 	63.7 	187.7 	110.5 	77.2
Long-term outflows 	(149.8) 	(97.9) 	(51.9) 	(177.3) 	(121.0) 	(56.3)
Net long-term flows 	0.9 	(10.9) 	11.8 	10.4 	(10.5) 	20.9
Net flows in non-management fee earning AUM 	(0.5) 	— 	(0.5) 	(3.0) 	— 	(3.0)
Net flows in money market funds 	23.1 	23.1 	— 	16.3 	16.3 	—
Total net flows 	23.5 	12.2 	11.3 	23.7 	5.8 	17.9
Reinvested distributions 	2.0 	2.0 	— 	2.6 	2.6 	—
Market gains and losses 	108.4 	30.8 	77.6 	(223.2) 	(111.6) 	(111.6)
Foreign currency translation 	(4.9) 	(4.6) 	(0.3) 	(23.6) 	(21.4) 	(2.2)
Ending Assets (June 30) 	1,538.2 	1,016.6 	521.6 	1,390.4 	957.9 	432.5
Average AUM
Average long-term AUM 	1,084.5 	788.3 	296.2 	1,152.4 	862.6 	289.8
Average AUM 	1,478.9 	1,004.0 	474.9 	1,501.2 	1,019.6 	481.6
Average QQQ AUM 	168.5 	N/A 	168.5 	179.0 	N/A 	179.0
Three months ended June 30, 	Six months ended June 30,
2023 	2022 	2023 	2022
Revenue yield (bps)
U.S. GAAP Gross revenue yield 	41.1 	44.9 	41.2 	45.0
Net revenue yield ex performance fees ex QQQ 	32.5 	36.0 	32.6 	36.3
Active net revenue yield ex performance fees 	37.6 	41.4 	37.6 	41.7
Passive net revenue yield ex QQQ 	15.9 	18.3 	16.3 	18.3
________
(1) U.S. GAAP Gross revenue yield is not considered a meaningful effective fee rate measure. Gross revenue yield on AUM is equal to U.S. GAAP annualized total Operating
revenues divided by average AUM, excluding Invesco Great Wall (IGW) AUM. The average AUM for IGW in the three and six months ended June 30, 2023 was $89.4
billion and $90.2 billion (three and six months ended June 30, 2022: $94.0 billion and $96.6 billion). It is appropriate to exclude the average AUM of IGW as the revenues
resulting from these AUM are not presented in our operating revenues. This ratio is not a good measure because the numerator of the U.S. GAAP Gross revenue yield
excludes the management fees earned from CIP; however, the denominator of the measure includes the AUM of these investment products. Net revenue yield metrics
include the Net revenues and Average AUM of IGW and CIP. See “Schedule of Non-GAAP Information” for a reconciliation of Operating revenues to Net revenues.
(2) Performance fees are earned when certain performance metrics are achieved and QQQ ETFs do not earn net revenues. Therefore, net revenue yield is calculated excluding
performance fees and QQQ AUM. Passive net revenue yield is calculated excluding QQQ AUM.
(1)
(2)
(2)
22

-- 25 of 111 --

Table of Contents
Flows
There are numerous drivers of AUM inflows and outflows, including individual investor decisions to change investments, fiduciaries and other gatekeepers
making broad asset allocation decisions on behalf of their clients, and reallocation of investments within portfolios. We are not a party to these asset allocation
decisions, as the company does not generally have access to the underlying investor’s decision-making process, including their risk appetite or liquidity needs.
Therefore, the company is not in a position to provide meaningful information regarding the drivers of inflows and outflows.
Market Returns
Market gains and losses include the net change in AUM resulting from changes in market values of the underlying securities from period to period. The table
in the “Executive Overview” section of this Management’s Discussion and Analysis summarizes returns based on price appreciation/(depreciation) of several
major market indices for the three and six months ended June 30, 2023 and 2022.
Foreign Exchange Rates
During the three and six months ended June 30, 2023, we experienced a decrease in AUM of $6.8 billion and $4.9 billion respectively due to changes in
foreign exchange rates. In the three and six months ended June 30, 2022, AUM decreased by $19.7 billion and $23.6 billion respectively due to foreign
exchange rate changes.
Total AUM by Channel
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Retail 	Institutional 	Total 	Retail 	Institutional
Beginning Assets (March 31) 	1,483.0 	924.9 	558.1 	1,555.9 	1,044.7 	511.2
Long-term inflows 	71.3 	54.4 	16.9 	81.4 	62.4 	19.0
Long-term outflows 	(73.3) 	(54.2) 	(19.1) 	(88.2) 	(70.7) 	(17.5)
Net long-term flows 	(2.0) 	0.2 	(2.2) 	(6.8) 	(8.3) 	1.5
Net flows in non-management fee earning AUM 	1.1 	1.1 	— 	(2.0) 	0.2 	(2.2)
Net flows in money market funds 	15.4 	(0.1) 	15.5 	3.5 	0.4 	3.1
Total net flows 	14.5 	1.2 	13.3 	(5.3) 	(7.7) 	2.4
Reinvested distributions 	1.0 	0.9 	0.1 	1.8 	1.7 	0.1
Market gains and losses 	46.5 	43.6 	2.9 	(142.3) 	(132.6) 	(9.7)
Foreign currency translation 	(6.8) 	(2.1) 	(4.7) 	(19.7) 	(7.3) 	(12.4)
Ending Assets (June 30) 	1,538.2 	968.5 	569.7 	1,390.4 	898.8 	491.6
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Retail 	Institutional 	Total 	Retail 	Institutional
Beginning Assets (December 31) 	1,409.2 	872.3 	536.9 	1,610.9 	1,106.5 	504.4
Long-term inflows 	150.7 	109.2 	41.5 	187.7 	143.5 	44.2
Long-term outflows 	(149.8) 	(112.7) 	(37.1) 	(177.3) 	(141.4) 	(35.9)
Net long-term flows 	0.9 	(3.5) 	4.4 	10.4 	2.1 	8.3
Net flows in non-management fee earning AUM 	(0.5) 	(1.6) 	1.1 	(3.0) 	0.6 	(3.6)
Net flows in money market funds 	23.1 	1.1 	22.0 	16.3 	2.5 	13.8
Total net flows 	23.5 	(4.0) 	27.5 	23.7 	5.2 	18.5
Reinvested distributions 	2.0 	1.8 	0.2 	2.6 	2.4 	0.2
Market gains and losses 	108.4 	99.3 	9.1 	(223.2) 	(206.9) 	(16.3)
Foreign currency translation 	(4.9) 	(0.9) 	(4.0) 	(23.6) 	(8.4) 	(15.2)
Ending Assets (June 30) 	1,538.2 	968.5 	569.7 	1,390.4 	898.8 	491.6
________
See accompanying notes immediately following these AUM tables.
(1)
23

-- 26 of 111 --

Table of Contents
Total AUM by Client Domicile
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Americas 	APAC 	EMEA 	Total 	Americas 	APAC 	EMEA
Beginning Assets (March 31) 	1,483.0 	1,055.7 	228.6 	198.7 	1,555.9 	1,091.5 	239.8 	224.6
Long-term inflows 	71.3 	35.9 	19.1 	16.3 	81.4 	49.0 	15.4 	17.0
Long-term outflows 	(73.3) 	(38.9) 	(17.6) 	(16.8) 	(88.2) 	(52.9) 	(15.3) 	(20.0)
Net long-term flows 	(2.0) 	(3.0) 	1.5 	(0.5) 	(6.8) 	(3.9) 	0.1 	(3.0)
Net flows in non-management fee earning AUM 	1.1 	0.4 	0.3 	0.4 	(2.0) 	(2.5) 	0.9 	(0.4)
Net flows in money market funds 	15.4 	14.5 	0.6 	0.3 	3.5 	4.0 	(0.4) 	(0.1)
Total net flows 	14.5 	11.9 	2.4 	0.2 	(5.3) 	(2.4) 	0.6 	(3.5)
Reinvested distributions 	1.0 	1.0 	— 	— 	1.8 	1.7 	— 	0.1
Market gains and losses 	46.5 	43.7 	(0.1) 	2.9 	(142.3) 	(116.3) 	(3.5) 	(22.5)
Foreign currency translation 	(6.8) 	0.5 	(9.0) 	1.7 	(19.7) 	(1.0) 	(12.5) 	(6.2)
Ending Assets (June 30) 	1,538.2 	1,112.8 	221.9 	203.5 	1,390.4 	973.5 	224.4 	192.5
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Americas 	APAC 	EMEA 	Total 	Americas 	APAC 	EMEA
Beginning Assets (December 31) 	1,409.2 	999.4 	223.5 	186.3 	1,610.9 	1,132.5 	247.3 	231.1
Long-term inflows 	150.7 	78.0 	38.2 	34.5 	187.7 	110.5 	36.8 	40.4
Long-term outflows 	(149.8) 	(80.3) 	(36.7) 	(32.8) 	(177.3) 	(106.5) 	(31.1) 	(39.7)
Net long-term flows 	0.9 	(2.3) 	1.5 	1.7 	10.4 	4.0 	5.7 	0.7
Net flows in non-management fee earning AUM 	(0.5) 	0.9 	(1.0) 	(0.4) 	(3.0) 	(4.7) 	0.8 	0.9
Net flows in money market funds 	23.1 	20.9 	1.9 	0.3 	16.3 	16.4 	0.8 	(0.9)
Total net flows 	23.5 	19.5 	2.4 	1.6 	23.7 	15.7 	7.3 	0.7
Reinvested distributions 	2.0 	2.0 	— 	— 	2.6 	2.5 	— 	0.1
Market gains and losses 	108.4 	91.3 	5.2 	11.9 	(223.2) 	(176.3) 	(15.9) 	(31.0)
Foreign currency translation 	(4.9) 	0.6 	(9.2) 	3.7 	(23.6) 	(0.9) 	(14.3) 	(8.4)
Ending Assets (June 30) 	1,538.2 	1,112.8 	221.9 	203.5 	1,390.4 	973.5 	224.4 	192.5
________
See accompanying notes immediately following these AUM tables.
(2)
24

-- 27 of 111 --

Table of Contents
Total AUM by Asset Class
Three Months Ended June 30,
2023 	2022
$ in billions 	Total 	Equity Fixed
Income Balanced Money
Market Alternatives 	Total 	Equity Fixed
Income Balanced Money
Market Alternatives
Beginning Assets (March 31) 1,483.0 	695.7 	321.8 	67.9 	211.5 	186.1 	1,555.9 	780.0 	323.9 	79.5 	162.0 	210.5
Long-term inflows 	71.3 	36.2 	25.3 	3.9 	— 	5.9 	81.4 	35.9 	29.1 	3.1 	— 	13.3
Long-term outflows 	(73.3) 	(34.3) 	(24.3) 	(5.4) 	— 	(9.3) 	(88.2) 	(43.6) 	(24.3) 	(5.4) 	— 	(14.9)
Net long-term flows 	(2.0) 	1.9 	1.0 	(1.5) 	— 	(3.4) 	(6.8) 	(7.7) 	4.8 	(2.3) 	— 	(1.6)
Net flows in non-
management fee earning
AUM 	1.1 	1.2 	(0.1) 	— 	— 	— 	(2.0) 	0.2 	(2.2) 	— 	— 	—
Net flows in money market
funds 	15.4 	— 	— 	— 	15.4 	— 	3.5 	— 	— 	— 	3.5 	—
Total net flows 	14.5 	3.1 	0.9 	(1.5) 	15.4 	(3.4) 	(5.3) 	(7.5) 	2.6 	(2.3) 	3.5 	(1.6)
Reinvested distributions 	1.0 	0.2 	0.4 	0.1 	0.1 	0.2 	1.8 	1.0 	0.4 	0.1 	— 	0.3
Market gains and losses 	46.5 	48.5 	(0.2) 	(1.1) 	— 	(0.7) 	(142.3) (121.9) 	(11.6) 	(1.8) 	0.6 	(7.6)
Foreign currency translation 	(6.8) 	(0.4) 	(3.9) 	(1.2) 	(1.3) 	— 	(19.7) 	(6.8) 	(6.2) 	(2.6) 	(2.1) 	(2.0)
Ending Assets (June 30) 	1,538.2 	747.1 	319.0 	64.2 	225.7 	182.2 	1,390.4 	644.8 	309.1 	72.9 	164.0 	199.6
Average AUM 	1,494.9 	706.9 	321.0 	65.7 	217.9 	183.4 	1,457.2 	701.9 	313.4 	74.0 	159.7 	208.2
% of total average AUM 	100.0 % 	47.3 % 21.5 % 	4.4 % 14.5 % 	12.3 % 	100.0 % 	48.2 % 21.5 % 	5.0 % 	11.0 % 	14.3 %
Six Months Ended June 30,
2023 	2022
$ in billions 	Total 	Equity
Fixed
Income Balanced
Money
Market Alternatives 	Total 	Equity
Fixed
Income Balanced
Money
Market Alternatives
Beginning Assets (December
31) 	1,409.2 	637.0 	313.7 	67.1 	203.5 	187.9 	1,610.9 	841.6 	334.8 	88.6 	148.8 	197.1
Long-term inflows 	150.7 	75.6 	53.9 	7.2 	— 	14.0 	187.7 	86.5 	58.5 	8.6 	— 	34.1
Long-term outflows 	(149.8) 	(68.9) 	(50.4) 	(10.1) 	— 	(20.4) 	(177.3) 	(88.6) 	(48.9) 	(11.7) 	— 	(28.1)
Net long-term flows 	0.9 	6.7 	3.5 	(2.9) 	— 	(6.4) 	10.4 	(2.1) 	9.6 	(3.1) 	— 	6.0
Net flows in non-
management fee earning
AUM 	(0.5) 	(1.5) 	1.0 	— 	— 	— 	(3.0) 	0.6 	(3.6) 	— 	— 	—
Net flows in money market
funds 	23.1 	— 	— 	— 	23.1 	— 	16.3 	— 	— 	— 	16.3 	—
Total net flows 	23.5 	5.2 	4.5 	(2.9) 	23.1 	(6.4) 	23.7 	(1.5) 	6.0 	(3.1) 	16.3 	6.0
Reinvested distributions 	2.0 	0.4 	0.8 	0.3 	0.1 	0.4 	2.6 	1.2 	0.7 	0.2 	— 	0.5
Market gains and losses 	108.4 	104.1 	3.7 	0.6 	0.1 	(0.1) 	(223.2) 	(188.4) 	(24.3) 	(10.1) 	1.0 	(1.4)
Foreign currency translation 	(4.9) 	0.4 	(3.7) 	(0.9) 	(1.1) 	0.4 	(23.6) 	(8.1) 	(8.1) 	(2.7) 	(2.1) 	(2.6)
Ending Assets (June 30) 	1,538.2 	747.1 	319.0 	64.2 	225.7 	182.2 	1,390.4 	644.8 	309.1 	72.9 	164.0 	199.6
Average AUM 	1,478.9 	690.4 	319.5 	67.2 	215.8 	186.0 	1,501.2 	739.3 	320.6 	78.8 	157.1 	205.4
% of total average AUM 	100.0 % 	46.7 % 	21.6 % 	4.5 % 14.6 % 	12.6 % 100.0 % 	49.2 % 21.4 % 	5.2 % 10.5 % 	13.7 %
________
See accompanying notes immediately following these AUM tables.
(3)
25

-- 28 of 111 --

Table of Contents
Active AUM by Channel
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Retail 	Institutional 	Total 	Retail 	Institutional
Beginning Assets (March 31) 	1,005.2 	495.6 	509.6 	1,042.7 	581.9 	460.8
Long-term inflows 	40.1 	25.0 	15.1 	48.8 	30.9 	17.9
Long-term outflows 	(48.5) 	(30.9) 	(17.6) 	(60.1) 	(43.8) 	(16.3)
Net long-term flows 	(8.4) 	(5.9) 	(2.5) 	(11.3) 	(12.9) 	1.6
Net flows in money market funds 	15.4 	(0.1) 	15.5 	3.5 	0.4 	3.1
Total net flows 	7.0 	(6.0) 	13.0 	(7.8) 	(12.5) 	4.7
Reinvested distributions 	1.0 	0.9 	0.1 	1.8 	1.7 	0.1
Market gains and losses 	9.9 	9.8 	0.1 	(61.6) 	(55.5) 	(6.1)
Foreign currency translation 	(6.5) 	(2.0) 	(4.5) 	(17.2) 	(6.6) 	(10.6)
Ending Assets (June 30) 	1,016.6 	498.3 	518.3 	957.9 	509.0 	448.9
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Retail 	Institutional 	Total 	Retail 	Institutional
Beginning Assets (December 31) 	976.2 	482.1 	494.1 	1,082.5 	631.7 	450.8
Long-term inflows 	87.0 	51.3 	35.7 	110.5 	68.0 	42.5
Long-term outflows 	(97.9) 	(63.9) 	(34.0) 	(121.0) 	(87.2) 	(33.8)
Net long-term flows 	(10.9) 	(12.6) 	1.7 	(10.5) 	(19.2) 	8.7
Net flows in money market funds 	23.1 	1.1 	22.0 	16.3 	2.5 	13.8
Total net flows 	12.2 	(11.5) 	23.7 	5.8 	(16.7) 	22.5
Reinvested distributions 	2.0 	1.8 	0.2 	2.6 	2.4 	0.2
Market gains and losses 	30.8 	26.9 	3.9 	(111.6) 	(100.9) 	(10.7)
Foreign currency translation 	(4.6) 	(1.0) 	(3.6) 	(21.4) 	(7.5) 	(13.9)
Ending Assets (June 30) 	1,016.6 	498.3 	518.3 	957.9 	509.0 	448.9
________
See accompanying notes immediately following these AUM tables.
(1)
26

-- 29 of 111 --

Table of Contents
Active AUM by Client Domicile
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Americas 	APAC 	EMEA 	Total 	Americas 	APAC 	EMEA
Beginning Assets (March 31) 	1,005.2 	688.7 	195.1 	121.4 	1,042.7 	703.2 	202.3 	137.2
Long-term inflows 	40.1 	17.7 	16.0 	6.4 	48.8 	28.7 	13.8 	6.3
Long-term outflows 	(48.5) 	(26.7) 	(15.0) 	(6.8) 	(60.1) 	(36.3) 	(13.2) 	(10.6)
Net long-term flows 	(8.4) 	(9.0) 	1.0 	(0.4) 	(11.3) 	(7.6) 	0.6 	(4.3)
Net flows in non-management fee earning AUM 	— 	— 	— 	— 	— 	— 	0.1 	(0.1)
Net flows in money market funds 	15.4 	14.5 	0.6 	0.3 	3.5 	4.0 	(0.4) 	(0.1)
Total net flows 	7.0 	5.5 	1.6 	(0.1) 	(7.8) 	(3.6) 	0.3 	(4.5)
Reinvested distributions 	1.0 	1.0 	— 	— 	1.8 	1.7 	— 	0.1
Market gains and losses 	9.9 	10.9 	(1.0) 	— 	(61.6) 	(51.2) 	(0.9) 	(9.5)
Foreign currency translation 	(6.5) 	0.5 	(8.6) 	1.6 	(17.2) 	(1.0) 	(10.4) 	(5.8)
Ending Assets (June 30) 	1,016.6 	706.6 	187.1 	122.9 	957.9 	649.1 	191.3 	117.5
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Americas 	APAC 	EMEA 	Total 	Americas 	APAC 	EMEA
Beginning Assets (December 31) 	976.2 	670.8 	191.0 	114.4 	1,082.5 	724.5 	208.8 	149.2
Long-term inflows 	87.0 	39.4 	32.8 	14.8 	110.5 	63.2 	33.6 	13.7
Long-term outflows 	(97.9) 	(53.9) 	(30.8) 	(13.2) 	(121.0) 	(71.8) 	(27.9) 	(21.3)
Net long-term flows 	(10.9) 	(14.5) 	2.0 	1.6 	(10.5) 	(8.6) 	5.7 	(7.6)
Net flows in non-management fee earning AUM 	— 	— 	— 	— 	— 	— 	0.1 	(0.1)
Net flows in money market funds 	23.1 	20.9 	1.9 	0.3 	16.3 	16.4 	0.8 	(0.9)
Total net flows 	12.2 	6.4 	3.9 	1.9 	5.8 	7.8 	6.6 	(8.6)
Reinvested distributions 	2.0 	2.0 	— 	— 	2.6 	2.5 	— 	0.1
Market gains and losses 	30.8 	26.8 	0.7 	3.3 	(111.6) 	(84.8) 	(11.4) 	(15.4)
Foreign currency translation 	(4.6) 	0.6 	(8.5) 	3.3 	(21.4) 	(0.9) 	(12.7) 	(7.8)
Ending Assets (June 30) 	1,016.6 	706.6 	187.1 	122.9 	957.9 	649.1 	191.3 	117.5
________
See accompanying notes immediately following these AUM tables.
(2)
27

-- 30 of 111 --

Table of Contents
Active AUM by Asset Class
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Equity Fixed
Income Balanced Money
Market Alternatives 	Total 	Equity Fixed
Income Balanced Money
Market Alternatives
Beginning Assets (March 31) 1,005.2 	294.3 	276.7 	67.1 	211.5 	155.6 	1,042.7 	347.9 	283.3 	78.5 	162.0 	171.0
Long-term inflows 	40.1 	12.4 	20.6 	3.9 	— 	3.2 	48.8 	13.7 	23.8 	3.1 	— 	8.2
Long-term outflows 	(48.5) 	(16.9) 	(20.0) 	(5.4) 	— 	(6.2) 	(60.1) 	(24.5) 	(21.6) 	(5.4) 	— 	(8.6)
Net long-term flows 	(8.4) 	(4.5) 	0.6 	(1.5) 	— 	(3.0) 	(11.3) 	(10.8) 	2.2 	(2.3) 	— 	(0.4)
Net flows in non-management
fee earning AUM 	— 	(0.1) 	0.1 	— 	— 	— 	— 	— 	— 	— 	— 	—
Net flows in money market
funds 	15.4 	— 	— 	— 	15.4 	— 	3.5 	— 	— 	— 	3.5 	—
Total net flows 	7.0 	(4.6) 	0.7 	(1.5) 	15.4 	(3.0) 	(7.8) 	(10.8) 	2.2 	(2.3) 	3.5 	(0.4)
Reinvested distributions 	1.0 	0.2 	0.4 	0.1 	0.1 	0.2 	1.8 	1.0 	0.4 	0.1 	— 	0.3
Market gains and losses 	9.9 	10.9 	0.1 	(1.1) 	— 	— 	(61.6) 	(45.5) 	(9.6) 	(1.7) 	0.6 	(5.4)
Foreign currency translation 	(6.5) 	(0.2) 	(3.9) 	(1.2) 	(1.3) 	0.1 	(17.2) 	(5.1) 	(5.7) 	(2.6) 	(2.1) 	(1.7)
Ending Assets (June 30) 	1,016.6 	300.6 	274.0 	63.4 	225.7 	152.9 	957.9 	287.5 	270.6 	72.0 	164.0 	163.8
Average AUM 	1,006.1 	294.6 	275.9 	64.9 	217.9 	152.8 	989.2 	313.1 	274.4 	73.1 	159.7 	168.9
% of total average AUM 	100.0 % 29.3 % 27.4 % 	6.4 % 21.7 % 	15.2 % 	100.0 % 	31.7 % 27.7 % 	7.4 % 16.1 % 	17.1 %
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Equity
Fixed
Income Balanced
Money
Market Alternatives 	Total 	Equity
Fixed
Income Balanced
Money
Market Alternatives
Beginning Assets (December
31) 	976.2 	277.5 	273.0 	66.3 	203.5 	155.9 	1,082.5 	389.6 	293.1 	87.4 	148.8 	163.6
Long-term inflows 	87.0 	27.4 	43.8 	7.2 	— 	8.6 	110.5 	32.8 	48.3 	8.6 	— 	20.8
Long-term outflows 	(97.9) 	(32.3) 	(43.5) 	(10.1) 	— 	(12.0) 	(121.0) 	(48.7) 	(43.6) 	(11.6) 	— 	(17.1)
Net long-term flows 	(10.9) 	(4.9) 	0.3 	(2.9) 	— 	(3.4) 	(10.5) 	(15.9) 	4.7 	(3.0) 	— 	3.7
Net flows in non-management
fee earning AUM 	— 	(0.1) 	0.1 	— 	— 	— 	— 	— 	— 	— 	— 	—
Net flows in money market
funds 	23.1 	— 	— 	— 	23.1 	— 	16.3 	— 	— 	— 	16.3 	—
Total net flows 	12.2 	(5.0) 	0.4 	(2.9) 	23.1 	(3.4) 	5.8 	(15.9) 	4.7 	(3.0) 	16.3 	3.7
Reinvested distributions 	2.0 	0.4 	0.8 	0.3 	0.1 	0.4 	2.6 	1.2 	0.7 	0.2 	— 	0.5
Market gains and losses 	30.8 	27.0 	3.6 	0.6 	0.1 	(0.5) 	(111.6) 	(80.7) 	(20.3) 	(9.9) 	1.0 	(1.7)
Foreign currency translation 	(4.6) 	0.7 	(3.8) 	(0.9) 	(1.1) 	0.5 	(21.4) 	(6.7) 	(7.6) 	(2.7) 	(2.1) 	(2.3)
Ending Assets (June 30) 	1,016.6 	300.6 	274.0 	63.4 	225.7 	152.9 	957.9 	287.5 	270.6 	72.0 	164.0 	163.8
Average AUM 	1,004.0 	292.0 	275.1 	66.4 	215.8 	154.7 	1,019.6 	335.9 	280.8 	77.7 	157.1 	168.1
% of total average AUM 	100.0 % 	29.1 % 27.4 % 	6.6 % 21.5 % 	15.4 % 100.0 % 	32.9 % 27.5 % 	7.7 % 15.4 % 	16.5 %
_________
See accompanying notes immediately following these AUM tables.
(3)
28

-- 31 of 111 --

Table of Contents
Passive AUM by Channel
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Retail 	Institutional 	Total 	Retail 	Institutional
Beginning Assets (March 31) 	477.8 	429.3 	48.5 	513.2 	462.8 	50.4
Long-term inflows 	31.2 	29.4 	1.8 	32.6 	31.5 	1.1
Long-term outflows 	(24.8) 	(23.3) 	(1.5) 	(28.1) 	(26.9) 	(1.2)
Net long-term flows 	6.4 	6.1 	0.3 	4.5 	4.6 	(0.1)
Net flows in non-management fee earning AUM 	1.1 	1.1 	— 	(2.0) 	0.2 	(2.2)
Total net flows 	7.5 	7.2 	0.3 	2.5 	4.8 	(2.3)
Market gains and losses 	36.6 	33.8 	2.8 	(80.7) 	(77.1) 	(3.6)
Foreign currency translation 	(0.3) 	(0.1) 	(0.2) 	(2.5) 	(0.7) 	(1.8)
Ending Assets (June 30) 	521.6 	470.2 	51.4 	432.5 	389.8 	42.7
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Retail 	Institutional 	Total 	Retail 	Institutional
Beginning Assets (December 31) 	433.0 	390.2 	42.8 	528.4 	474.8 	53.6
Long-term inflows 	63.7 	57.9 	5.8 	77.2 	75.5 	1.7
Long-term outflows 	(51.9) 	(48.8) 	(3.1) 	(56.3) 	(54.2) 	(2.1)
Net long-term flows 	11.8 	9.1 	2.7 	20.9 	21.3 	(0.4)
Net flows in non-management fee earning AUM 	(0.5) 	(1.6) 	1.1 	(3.0) 	0.6 	(3.6)
Total net flows 	11.3 	7.5 	3.8 	17.9 	21.9 	(4.0)
Market gains and losses 	77.6 	72.4 	5.2 	(111.6) 	(106.0) 	(5.6)
Foreign currency translation 	(0.3) 	0.1 	(0.4) 	(2.2) 	(0.9) 	(1.3)
Ending Assets (June 30) 	521.6 	470.2 	51.4 	432.5 	389.8 	42.7
(1)
29

-- 32 of 111 --

Table of Contents
Passive AUM by Client Domicile
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Americas 	APAC 	EMEA 	Total 	Americas 	APAC 	EMEA
Beginning Assets (March 31) 	477.8 	367.0 	33.5 	77.3 	513.2 	388.3 	37.5 	87.4
Long-term inflows 	31.2 	18.2 	3.1 	9.9 	32.6 	20.3 	1.6 	10.7
Long-term outflows 	(24.8) 	(12.2) 	(2.6) 	(10.0) 	(28.1) 	(16.6) 	(2.1) 	(9.4)
Net long-term flows 	6.4 	6.0 	0.5 	(0.1) 	4.5 	3.7 	(0.5) 	1.3
Net flows in non-management fee earning AUM 	1.1 	0.4 	0.3 	0.4 	(2.0) 	(2.5) 	0.8 	(0.3)
Total net flows 	7.5 	6.4 	0.8 	0.3 	2.5 	1.2 	0.3 	1.0
Market gains and losses 	36.6 	32.8 	0.9 	2.9 	(80.7) 	(65.1) 	(2.6) 	(13.0)
Foreign currency translation 	(0.3) 	— 	(0.4) 	0.1 	(2.5) 	— 	(2.1) 	(0.4)
Ending Assets (June 30) 	521.6 	406.2 	34.8 	80.6 	432.5 	324.4 	33.1 	75.0
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Americas 	APAC 	EMEA 	Total 	Americas 	APAC 	EMEA
Beginning Assets (December 31) 	433.0 	328.6 	32.5 	71.9 	528.4 	408.0 	38.5 	81.9
Long-term inflows 	63.7 	38.6 	5.4 	19.7 	77.2 	47.3 	3.2 	26.7
Long-term outflows 	(51.9) 	(26.4) 	(5.9) 	(19.6) 	(56.3) 	(34.7) 	(3.2) 	(18.4)
Net long-term flows 	11.8 	12.2 	(0.5) 	0.1 	20.9 	12.6 	— 	8.3
Net flows in non-management fee earning AUM 	(0.5) 	0.9 	(1.0) 	(0.4) 	(3.0) 	(4.7) 	0.7 	1.0
Total net flows 	11.3 	13.1 	(1.5) 	(0.3) 	17.9 	7.9 	0.7 	9.3
Market gains and losses 	77.6 	64.5 	4.5 	8.6 	(111.6) 	(91.5) 	(4.5) 	(15.6)
Foreign currency translation 	(0.3) 	— 	(0.7) 	0.4 	(2.2) 	— 	(1.6) 	(0.6)
Ending Assets (June 30) 	521.6 	406.2 	34.8 	80.6 	432.5 	324.4 	33.1 	75.0
_________
See accompanying notes immediately following these AUM tables.
(2)
30

-- 33 of 111 --

Table of Contents
Passive AUM by Asset Class
Three months ended June 30,
2023 	2022
$ in billions 	Total 	Equity Fixed
Income Balanced Money
Market Alternatives 	Total 	Equity Fixed
Income Balanced Money
Market Alternatives
Beginning Assets (March 31) 	477.8 	401.4 	45.1 	0.8 	— 	30.5 	513.2 	432.1 	40.6 	1.0 	— 	39.5
Long-term inflows 	31.2 	23.8 	4.7 	— 	— 	2.7 	32.6 	22.2 	5.3 	— 	— 	5.1
Long-term outflows 	(24.8) 	(17.4) 	(4.3) 	— 	— 	(3.1) 	(28.1) 	(19.1) 	(2.7) 	— 	— 	(6.3)
Net long-term flows 	6.4 	6.4 	0.4 	— 	— 	(0.4) 	4.5 	3.1 	2.6 	— 	— 	(1.2)
Net flows in non-management
fee earning AUM 	1.1 	1.3 	(0.2) 	— 	— 	— 	(2.0) 	0.2 	(2.2) 	— 	— 	—
Total net flows 	7.5 	7.7 	0.2 	— 	— 	(0.4) 	2.5 	3.3 	0.4 	— 	— 	(1.2)
Market gains and losses 	36.6 	37.6 	(0.3) 	— 	— 	(0.7) 	(80.7) 	(76.4) 	(2.0) 	(0.1) 	— 	(2.2)
Foreign currency translation 	(0.3) 	(0.2) 	— 	— 	— 	(0.1) 	(2.5) 	(1.7) 	(0.5) 	— 	— 	(0.3)
Ending Assets (June 30) 	521.6 	446.5 	45.0 	0.8 	— 	29.3 	432.5 	357.3 	38.5 	0.9 	— 	35.8
Average AUM 	488.8 	412.3 	45.1 	0.8 	— 	30.6 	468.0 	388.8 	39.0 	0.9 	— 	39.3
% of total average AUM 	100.0 % 	84.3 % 	9.2 % 	0.2 % 	— % 	6.3 % 100.0 % 83.1 % 	8.3 % 	0.2 % 	— % 	8.4 %
Six months ended June 30,
2023 	2022
$ in billions 	Total 	Equity
Fixed
Income Balanced
Money
Market Alternatives 	Total 	Equity
Fixed
Income Balanced
Money
Market Alternatives
Beginning Assets (December
31) 	433.0 	359.5 	40.7 	0.8 	— 	32.0 	528.4 	452.0 	41.7 	1.2 	— 	33.5
Long-term inflows 	63.7 	48.2 	10.1 	— 	— 	5.4 	77.2 	53.7 	10.2 	— 	— 	13.3
Long-term outflows 	(51.9) 	(36.6) 	(6.9) 	— 	— 	(8.4) 	(56.3) 	(39.9) 	(5.3) 	(0.1) 	— 	(11.0)
Net long-term flows 	11.8 	11.6 	3.2 	— 	— 	(3.0) 	20.9 	13.8 	4.9 	(0.1) 	— 	2.3
Net flows in non-management
fee earning AUM 	(0.5) 	(1.4) 	0.9 	— 	— 	— 	(3.0) 	0.6 	(3.6) 	— 	— 	—
Total net flows 	11.3 	10.2 	4.1 	— 	— 	(3.0) 	17.9 	14.4 	1.3 	(0.1) 	— 	2.3
Market gains and losses 	77.6 	77.1 	0.1 	— 	— 	0.4 	(111.6) 	(107.7) 	(4.0) 	(0.2) 	— 	0.3
Foreign currency translation 	(0.3) 	(0.3) 	0.1 	— 	— 	(0.1) 	(2.2) 	(1.4) 	(0.5) 	— 	— 	(0.3)
Ending Assets (June 30) 	521.6 	446.5 	45.0 	0.8 	— 	29.3 	432.5 	357.3 	38.5 	0.9 	— 	35.8
Average AUM 	474.9 	398.4 	44.4 	0.8 	— 	31.3 	481.6 	403.4 	39.8 	1.0 	— 	37.4
% of total average AUM 	100.0 % 	83.9 % 	9.3 % 	0.2 % 	— % 	6.6 % 100.0 % 	83.8 % 	8.3 % 	0.1 % 	— % 	7.8 %
___________
(1) Channel refers to the internal distribution channel from which the AUM originated. Retail AUM represents AUM distributed by the company’s retail sales team. Institutional
AUM represents AUM distributed by our institutional sales team. This aggregation is viewed as a proxy for presenting AUM in the retail and institutional markets in which the
company operates.
(2) Client domicile disclosure groups AUM by the domicile of the underlying clients.
(3) Asset classes are descriptive groupings of AUM by common type of underlying investments.
(3)
31

-- 34 of 111 --

Table of Contents
Results of Operations for the three and six months ended June 30, 2023 compared to the three and six months ended June 30, 2022
The discussion below includes the use of non-GAAP financial measures. See “Schedule of Non-GAAP Information” for additional details and reconciliations
of the most directly comparable U.S. GAAP measures to the non-GAAP measures.
Operating Revenues and Net Revenues
The main categories of revenues, and the dollar and percentage change between the periods, are as follows:
Three months ended 	Six months ended
June 30, 	Variance 	June 30, 	Variance
$ in millions 	2023 	2022 	$ Change 	% Change 	2023 	2022 	$ Change 	% Change
Investment management fees 	1,033.5 	1,113.5 	(80.0) 	(7.2)% 	2,061.4 	2,294.0 	(232.6) 	(10.1)%
Service and distribution fees 	342.3 	353.8 	(11.5) 	(3.3)% 	676.5 	732.8 	(56.3) 	(7.7)%
Performance fees 	19.6 	9.2 	10.4 	113.0 % 	25.2 	10.2 	15.0 	147.1 %
Other 	47.4 	53.9 	(6.5) 	(12.1)% 	97.9 	122.8 	(24.9) 	(20.3)%
Total operating revenues 	1,442.8 	1,530.4 	(87.6) 	(5.7)% 	2,861.0 	3,159.8 	(298.8) 	(9.5)%
Revenue Adjustments:
Investment management fees 	(195.4) 	(193.1) 	(2.3) 	1.2 % 	(385.2) 	(399.0) 	13.8 	(3.5)%
Service and distribution fees 	(230.9) 	(240.3) 	9.4 	(3.9)% 	(456.2) 	(498.0) 	41.8 	(8.4)%
Other 	(36.2) 	(41.6) 	5.4 	(13.0)% 	(76.2) 	(90.6) 	14.4 	(15.9)%
Total Revenue Adjustments 	(462.5) 	(475.0) 	12.5 	(2.6)% 	(917.6) 	(987.6) 	70.0 	(7.1)%
Invesco Great Wall 	97.6 	106.1 	(8.5) 	(8.0)% 	198.1 	230.2 	(32.1) 	(13.9)%
CIP 	12.8 	12.4 	0.4 	3.2 % 	25.1 	23.9 	1.2 	5.0 %
Net revenues 	1,090.7 	1,173.9 	(83.2) 	(7.1)% 	2,166.6 	2,426.3 	(259.7) 	(10.7)%
____________
(1) Total revenue adjustments remove pass through investment management, service and distribution, and other revenues and equal the same amount as the Third-party
distribution, service and advisory expenses.
(2) See “Schedule of Non-GAAP Information” for additional important disclosures regarding the use of net revenues.
Our revenues are directly influenced by the level and composition of our AUM. Therefore, movements in global capital market levels, net business inflows
(or outflows), changes in the mix of investment products between asset classes and geographies may materially affect our revenues from period to period. See
the company’s disclosures regarding the changes in AUM during the three and six months ended June 30, 2023 and June 30, 2022 in the “Assets Under
Management” section above for additional information.
Passive AUM generally earn a lower effective fee rate than active asset classes, and therefore, changes in the mix of AUM have an impact on revenues and
net revenue yield. In addition, as fee rates differ across geographic locations, changes to exchange rates have an impact on revenues and net revenue yields.
Average AUM was $1,494.9 billion in the three months ended June 30, 2023 as compared to $1,457.2 billion in the three months ended June 30, 2022. The
impact of the increase in AUM on our revenues was offset by changes in the mix of the AUM between the periods as Investors continued to shift AUM toward
lower yield products during three months ended June 30, 2023. The impact of foreign exchange rate movements decreased Operating revenues by $1.9 million
during the three months ended June 30, 2023 when compared to the three months ended June 30, 2022.
Average AUM was $1,478.9 billion in the six months ended June 30, 2023 as compared to $1,501.2 billion in the six months ended June 30, 2022. In addition
to the impact of the decrease in AUM on our revenues, changes in the mix of the AUM between the periods also impact our revenues as investors continued to
shift AUM toward lower yield products during six months ended June 30, 2023. The impact of foreign exchange rate movements decreased Operating revenues
by $29.3 million during the six months ended June 30, 2023 when compared to the six months ended June 30, 2022.
(1)
(2)
32

-- 35 of 111 --

Table of Contents
Investment Management Fees
Investment management fees were $1,033.5 million for three months ended June 30, 2023 as compared to $1,113.5 million for three months ended June 30,
2022. The impact of foreign exchange rate movements decreased Investment management fees by $2.2 million during the three months ended June 30, 2023 as
compared to the three months ended June 30, 2022. After allowing for foreign exchange movements, Investment management fees decreased by $77.8 million.
See discussion above on how AUM changes impact our Investment management fees.
Investment management fees were $2,061.4 million for six months ended June 30, 2023 as compared to $2,294.0 million for six months ended June 30, 2022.
The impact of foreign exchange rate movements decreased Investment management fees by $26.2 million during the six months ended June 30, 2023 as
compared to the six months ended June 30, 2022. After allowing for foreign exchange movements, Investment management fees decreased by $206.4 million.
See discussion above on how AUM changes impact our Investment management fees.
Service and Distribution Fees
In the three months ended June 30, 2023, Service and distribution fees were $342.3 million as compared to $353.8 million for the three months ended
June 30, 2022. After allowing for foreign exchange movements, Service and distribution fees decreased by $11.8 million. The decrease was a result of lower
AUM to which these fees apply.
In the six months ended June 30, 2023, Service and distribution fees were $676.5 million as compared to $732.8 million for the six months ended June 30,
2022. The impact of foreign exchange rate movements decreased Service and distribution fees by $2.8 million during the six months ended June 30, 2023 as
compared to the six months ended June 30, 2022. After allowing for foreign exchange movements, Service and distribution fees decreased by $53.5 million.
The decrease was a result of lower AUM to which these fees apply.
Performance Fees
Performance fees were $19.6 million and $25.2 million for the three and six months ended June 30, 2023, respectively, and were primarily generated from
real estate products.
Other Revenues
In the three months ended June 30, 2023, Other revenues were $47.4 million as compared to $53.9 million for the three months ended June 30, 2022. The
decrease in Other revenues was primarily driven by lower front end fees and real estate transaction fees of $5.4 million and $1.3 million, respectively.
In the six months ended June 30, 2023, Other revenues were $97.9 million as compared to $122.8 million for the six months ended June 30, 2022. The
decrease in Other revenues was primarily driven by lower real estate transaction fees and front end fees of $17.1 million and $13.9 million, respectively,
partially offset by a $6.2 million increase in other transaction fees.
Invesco Great Wall
The company’s most significant joint venture is our 49% investment in IGW. Management reflects 100% of IGW's results in its net revenues and adjusted
operating expenses because it is important to evaluate the contribution that IGW is making to the business. The company’s non-GAAP operating results reflect
the economics of these holdings on a basis consistent with the underlying AUM and flows. Adjusted net income is reduced by the amount of earnings
attributable to the 51% noncontrolling interests. See “Schedule of Non-GAAP Information” for additional disclosures regarding the use of net revenues.
Net revenues from IGW were $97.6 million and average AUM was $89.4 billion for the three months ended June 30, 2023 (net revenues were $106.1 million
and average AUM was $94.0 billion for the three months ended June 30, 2022). The impact of foreign exchange rate movements during the three months ended
June 30, 2023 decreased Net revenues by $5.9 million as compared to the three months ended June 30, 2022. After allowing for foreign exchange movements,
Net revenues from IGW were $103.5 million. The decrease in revenue is a result of lower average AUM and changes in the mix of AUM.
33

-- 36 of 111 --

Table of Contents
Net revenues from IGW were $198.1 million and average AUM was $90.2 billion for the six months ended June 30, 2023 (net revenues were $230.2 million
and average AUM was $96.6 billion for the six months ended June 30, 2022). The impact of foreign exchange rate movements during the six months ended
June 30, 2023 decreased Net revenues by $13.7 million as compared to the six months ended June 30, 2022. After allowing for foreign exchange movements,
Net revenues from IGW were $211.8 million. The decrease in revenue is a result of lower average AUM and changes in the mix of AUM.
Management, performance and other fees earned from CIP
Management believes that the consolidation of investment products may impact a reader's analysis of our underlying results of operations and could result in
investor confusion or the production of information about the company by analysts or external credit rating agencies that is not reflective of the underlying
results of operations and financial condition of the company. Accordingly, management believes that it is appropriate to adjust operating revenues for the impact
of CIP in calculating net revenues. As Management and Performance fees earned by Invesco from the consolidated products are eliminated upon consolidation
of the investment products, management believes that it is appropriate to add these operating revenues back in the calculation of net revenues. See “Schedule of
Non-GAAP Information” for additional disclosures regarding the use of net revenues.
Management and Performance fees earned from CIP were $12.8 million for the three months ended June 30, 2023 (three months ended June 30, 2022: $12.4
million).
Management and Performance fees earned from CIP were $25.1 million for the six months ended June 30, 2023 (six months ended June 30, 2022: $23.9
million).
34

-- 37 of 111 --

Table of Contents
Operating Expenses
The main categories of Operating expenses, and the dollar and percentage changes between periods, are as follows:
Three months ended 	Six months ended
June 30, 	Variance 	June 30, 	Variance
$ in millions 	2023 	2022 	$ Change 	% Change 	2023 	2022 	$ Change 	% Change
Third-party distribution, service and
advisory 	462.5 	475.0 	(12.5) 	(2.6)% 	917.6 	987.6 	(70.0) 	(7.1)%
Employee compensation 	475.7 	407.2 	68.5 	16.8 % 	938.5 	840.1 	98.4 	11.7 %
Marketing 	29.0 	33.8 	(4.8) 	(14.2)% 	54.0 	55.5 	(1.5) 	(2.7)%
Property, office and technology 	137.1 	135.0 	2.1 	1.6 % 	271.5 	267.0 	4.5 	1.7 %
General and administrative 	121.6 	119.7 	1.9 	1.6 % 	197.3 	221.9 	(24.6) 	(11.1)%
Transaction, integration and restructuring 	— 	0.2 	(0.2) 	N/A 	41.6 	35.4 	6.2 	17.5 %
Amortization of intangibles 	13.1 	14.8 	(1.7) 	(11.5)% 	27.2 	29.9 	(2.7) 	(9.0)%
Total operating expenses 	1,239.0 	1,185.7 	53.3 	4.5 % 	2,447.7 	2,437.4 	10.3 	0.4 %
The table below sets forth these expense categories as a percentage of total Operating expenses and Operating revenues, which we believe provides useful
information as to the relative significance of each type of expense.
$ in millions
Three months ended
June 30, 2023
% of Total
Operating
Expenses
% of Operating
Revenues
Three months ended
June 30, 2022
% of Total
Operating
Expenses
% of Operating
Revenues
Third-party distribution, service and
advisory 	462.5 	37.3 % 	32.1 % 	475.0 	40.1 % 	31.0 %
Employee compensation 	475.7 	38.4 % 	33.0 % 	407.2 	34.3 % 	26.6 %
Marketing 	29.0 	2.3 % 	2.0 % 	33.8 	2.9 % 	2.2 %
Property, office and technology 	137.1 	11.1 % 	9.5 % 	135.0 	11.4 % 	8.8 %
General and administrative 	121.6 	9.8 % 	8.4 % 	119.7 	10.1 % 	7.8 %
Transaction, integration and
restructuring 	— 	— % 	— % 	0.2 	— % 	— %
Amortization of intangibles 	13.1 	1.1 % 	0.9 % 	14.8 	1.2 % 	1.0 %
Total operating expenses 	1,239.0 	100.0 % 	85.9 % 	1,185.7 	100.0 % 	77.4 %
$ in millions
Six months ended
June 30, 2023
% of Total
Operating
Expenses % of Operating
Revenues Six months ended
June 30, 2022
% of Total
Operating
Expenses % of Operating
Revenues
Third-party distribution, service and
advisory 	917.6 	37.5 % 	32.1 % 	987.6 	40.5 % 	31.3 %
Employee compensation 	938.5 	38.3 % 	32.7 % 	840.1 	34.5 % 	26.6 %
Marketing 	54.0 	2.2 % 	1.9 % 	55.5 	2.3 % 	1.8 %
Property, office and technology 	271.5 	11.1 % 	9.5 % 	267.0 	11.0 % 	8.4 %
General and administrative 	197.3 	8.1 % 	6.9 % 	221.9 	9.1 % 	7.0 %
Transaction, integration and
restructuring 	41.6 	1.7 % 	1.5 % 	35.4 	1.5 % 	1.1 %
Amortization of intangibles 	27.2 	1.1 % 	1.0 % 	29.9 	1.1 % 	0.9 %
Total operating expenses 	2,447.7 	100.0 % 	85.6 % 	2,437.4 	100.0 % 	77.1 %
During the three months ended June 30, 2023, Operating expenses increased by $53.3 million as compared to the three months ended June 30, 2022. The
impact of foreign exchange rate movements decreased Operating expenses by $2.5 million during the three months ended June 30, 2023 as compared to the
three months ended June 30, 2022.
35

-- 38 of 111 --

Table of Contents
During the six months ended June 30, 2023, Operating expenses increased by $10.3 million as compared to the six months ended June 30, 2022. The impact
of foreign exchange rate movements decreased Operating expenses by $28.0 million during the six months ended June 30, 2023 as compared to the six months
ended June 30, 2022.
Third-Party Distribution, Service and Advisory
Third-party distribution, service and advisory expenses were $462.5 million for the three months ended June 30, 2023 as compared to $475.0 million for the
three months ended June 30, 2022. After allowing for foreign exchange rate changes, the decrease in expenses was $12.8 million. The decrease is primarily due
to decreases of $9.3 million in service fees resulting from changes in the mix of the AUM, $14.1 million in renewal commissions, transaction and other third-
party management fees, partially offset by $10.5 million of higher asset-based fees.
Third-party distribution, service and advisory expenses were $917.6 million for the six months ended June 30, 2023 as compared to $987.6 million for the six
months ended June 30, 2022. The impact of foreign exchange rate movements decreased third-party expenses by $5.8 million during the six months ended
June 30, 2023 as compared to the six months ended June 30, 2022. After allowing for foreign exchange rate changes, the decrease in costs was $64.2 million.
The decrease is primarily due to decreases of $39.2 million in service fees resulting from lower average AUM and changes in the mix of the AUM, $37.0
million in renewal commissions and transaction fees, partially offset by $17.0 million of higher asset-based fees.
Employee Compensation
Employee compensation was $475.7 million for the three months ended June 30, 2023 as compared to $407.2 million for the three months ended June 30,
2022. The impact of foreign exchange rate movements decreased Employee compensation by $2.2 million during the three months ended June 30, 2023 as
compared to the three months ended June 30, 2022. After allowing for foreign exchange rate changes, there was an increase in Employee compensation of $70.7
million. This increase was primarily driven by $35.7 million in higher mark-to-market gains on deferred compensation liabilities, costs related to executive
retirements and organizational changes of $27.0 million, and higher staff costs.
Employee compensation was $938.5 million for the six months ended June 30, 2023 as compared to $840.1 million for the six months ended June 30, 2022.
The impact of foreign exchange rate movements decreased Employee compensation by $15.2 million during the six months ended June 30, 2023 as compared
to the six months ended June 30, 2022. After allowing for foreign exchange rate changes, there was an increase in Employee compensation of $113.6 million.
This increase was primarily driven by $69.4 million in higher mark-to-market gains on deferred compensation liabilities, costs related to executive retirements
and organizational changes of $40.3 million, and higher staff costs.
Headcount at June 30, 2023 was 8,621 (June 30, 2022: 8,506).
Marketing
Marketing expenses were $29.0 million for the three months ended June 30, 2023 as compared to $33.8 million for the three months ended June 30, 2022.
After allowing for foreign exchange rate changes, the decrease in Marketing expenses was $4.8 million driven by lower advertising spend.
Marketing expenses were $54.0 million for the six months ended June 30, 2023 as compared to $55.5 million for the six months ended June 30, 2022. After
allowing for foreign exchange rate changes, the decrease in Marketing expenses was $0.7 million.
Property, Office and Technology
Property, office and technology costs were $137.1 million for the three months ended June 30, 2023 as compared to $135.0 million for the three months
ended June 30, 2022. After allowing for foreign exchange rate movements, the increase in costs was $2.7 million. The increase was primarily driven by higher
outsourced administration costs of $3.1 million.
Property, office and technology costs were $271.5 million for the six months ended June 30, 2023 as compared to $267.0 million for the six months ended
June 30, 2022. The impact of foreign exchange rate movements decreased Property, office and technology expenses by $4.3 million during the six months
ended June 30, 2023 as compared to the six months ended June 30, 2022. After allowing for foreign exchange rate movements, the increase in costs was $8.8
million. The increase was driven by $4.3 million in property and office costs including overlapping rent in the first quarter associated with the move to our new
Atlanta headquarters and $3.1 million in outsourced administration costs and technology costs including software maintenance.
36

-- 39 of 111 --

Table of Contents
General and Administrative
General and administrative expenses were $121.6 million for the three months ended June 30, 2023 as compared to $119.7 million for the three months ended
June 30, 2022. After allowing for foreign exchange rate movements, the increase in costs was $1.8 million.
General and administrative expenses were $197.3 million for the six months ended June 30, 2023 as compared to $221.9 million for the six months ended
June 30, 2022. The impact of foreign exchange rate movements decreased General and administrative expenses by $1.8 million during the six months ended
June 30, 2023 as compared to the six months ended June 30, 2022. After allowing for foreign exchange rate movements, the decrease in costs was $22.8
million. The decrease was primarily due to $20.0 million of insurance recoveries and $14.8 million of indirect tax refunds received during the six months ended
June 30, 2023 which were partially offset by increases in consulting and professional fees primarily related to the Alpha NextGen program and costs associated
with the move to the new Atlanta headquarters.
Transaction, Integration and Restructuring
For the three months ended June 30, 2023, Transaction, integration and restructuring costs were zero due to the completion of strategic initiatives. Any costs
related to on-going projects are classified in the income statement based on the nature of the expense.
For the six months ended June 30, 2023, Transaction, integration and restructuring charges were $41.6 million as compared to $35.4 million for the six
months ended June 30, 2022. These costs are primarily comprised of compensation-related restructuring costs in connection with our strategic evaluation which
we completed during the first quarter of 2023.
Other Income and Expenses
The main categories of Other income and expenses, and the dollar and percentage changes between periods, are as follows:
Variance 	Variance
Three months ended June
30, 	2023 vs 2022 Six months ended June
30, 	2023 vs 2022
$ in millions 	2023 	2022 	$ Change 	% Change 	2023 	2022 	$ Change 	% Change
Equity in earnings of unconsolidated affiliates 	19.2 	24.7 	(5.5) 	(22.3)% 	45.3 	58.1 	(12.8) 	(22.0)%
Interest and dividend income 	7.1 	2.1 	5.0 	238.1 % 	15.7 	3.3 	12.4 	375.8 %
Interest expense 	(18.4) 	(25.8) 	7.4 	(28.7)% 	(36.4) 	(49.0) 	12.6 	(25.7)%
Other gains/(losses), net 	20.9 	(90.0) 	110.9 	N/A 	48.3 	(135.5) 	183.8 	N/A
Other income/(expense) of CIP, net 	(2.7) 	26.2 	(28.9) 	N/A 	(20.6) 	2.9 	(23.5) 	N/A
Total other income and expenses 	26.1 	(62.8) 	88.9 	N/A 	52.3 	(120.2) 	172.5 	N/A
Equity in earnings of unconsolidated affiliates
Equity in earnings of unconsolidated affiliates decreased $5.5 million to $19.2 million for the three months ended June 30, 2023 as compared to $24.7 million
for the three months ended June 30, 2022. The decrease was primarily driven by lower income from our joint venture investment in IGW of 3.7 million.
Equity in earnings of unconsolidated affiliates decreased $12.8 million to $45.3 million for the six months ended June 30, 2023 as compared to $58.1 million
for the six months ended June 30, 2022. The decrease was primarily driven by decreases of $16.3 million in our income from our real estate investments and
$9.7 million from our joint venture investment in IGW which were partially offset by increases in income from private equity and other investments.
37

-- 40 of 111 --

Table of Contents
Interest expense
Interest expense was $18.4 million for the three months ended June 30, 2023 as compared to $25.8 million for the three months ended June 30, 2022 as a
result of a decrease in debt.
Interest expense was $36.4 million for the six months ended June 30, 2023 as compared to $49.0 million for the six months ended June 30, 2022 as a result of
a decrease in debt.
Other gains/(losses), net
Other gains/(losses), net was a gain of $20.9 million for the three months ended June 30, 2023 as compared to a $90.0 million loss for the three months ended
June 30, 2022. Included in the net gain for the second quarter of 2023 were $14.9 million of net gains on investments and instruments held for our deferred
compensation plans and $3.6 million related to the mark-to-market on seed capital investments. Included in the net loss for the three months ended June 30,
2022 were $79.2 million of net losses on investments and instruments held for our deferred compensation plans and $16.2 million of net losses related to the
mark-to-market on seed money investments.
Other gains/(losses), net was a gain of $48.3 million for the six months ended June 30, 2023 as compared to a $135.5 million loss for the six months ended
June 30, 2022. Included in the net gain for the six months ended June 30, 2023 were $37.0 million of net gains on investments and instruments held for our
deferred compensation plans and $8.8 million of net gains related to the mark-to-market on seed capital investments. Included in the net loss for the six months
ended June 30, 2022 were $122.1 million of net losses on investments and instruments held for our deferred compensation plans and $22.1 million of net losses
related to the mark-to-market on seed money investments, partially offset by $3.7 million of net foreign exchange gains on intercompany loans.
Other income/(expense) of CIP, net
For the three months ended June 30, 2023, Other income/(expense) of CIP, net was a net expense of $2.7 million for the three months ended June 30, 2023
(three months ended June 30, 2022: net income of $26.2 million). Interest and dividend income of CIP increased $81.1 million to $163.7 million (three months
ended June 30, 2022: $82.6 million). Interest expense of CIP increased $64.7 million to $109.7 million (three months ended June 30, 2022: $45.0 million).
Unrealized gains/(losses) of CIP were net losses of $56.7 million (three months ended June 30, 2022: net losses of $11.4 million).
For the six months ended June 30, 2023, Other income/(expense) of CIP, net was a net expense of $20.6 million for the six months ended June 30, 2023 (six
months ended June 30, 2022: net income of $2.9 million). Interest and dividend income of CIP increased $146.2 million to $303.3 million (six months ended
June 30, 2022: $157.1 million). Interest expense of CIP increased $116.5 million to $204.0 million (six months ended June 30, 2022: $87.5 million). Unrealized
gains/(losses) of CIP were net losses of $119.9 million (six months ended June 30, 2022: net losses of $66.7 million). The net losses during the months ended
June 30, 2023 and 2022 were attributable to market-driven losses on investments held by consolidated funds.
Net impact of CIP and related noncontrolling interests in consolidated entities
The consolidation of investment products did not have an impact on Net income attributable to Invesco for the three and six months ended June 30, 2023 and
June 30, 2022. The adjustment to net income for the Net income/(loss) attributable to noncontrolling interests in consolidated entities represents the profit or
loss attributable to third-party investors. The impact of any realized or unrealized gains or losses attributable to the interests of third-parties, which is reflected
in Other income/(expense) of CIP, net, is offset by this adjustment to arrive at Net income attributable to Invesco. Also, the net income or loss of CIP is taxed at
the investor level, not at the product level; therefore, a tax provision is not reflected in the net impact of CIP.
Additionally, CIP represent less than 1% of the company's AUM. Therefore, the net gains or losses of CIP are not indicative of the performance of the
company's aggregate AUM.
Income Tax Expense
The company’s subsidiaries operate in numerous taxing jurisdictions around the world, each with its own statutory tax rate. As a result, the blended statutory
tax rate will vary from year to year depending on the mix of the profits and losses from each jurisdiction.
38

-- 41 of 111 --

Table of Contents
Our effective tax rate increased to 28.5% for the three months ended June 30, 2023 (three months ended June 30, 2022: 22.3%). The increase was primarily
due to the unfavorable impact that the Net loss attributable to noncontrolling interests in consolidated entities had on the effective tax rate in the second quarter
of 2023 compared to the favorable impact that the Net income attributable to noncontrolling interests in consolidated entities had on the effective tax rate in the
second quarter of 2022.
Our effective tax rate increased to 29.1% for the six months ended June 30, 2023 (six months ended June 30, 2022: 24.2%). The increase was primarily due to
the unfavorable impact that the Net loss attributable to non-controlling interests in consolidated entities had on the effective tax rate for the six months ended
June 30, 2023 compared to the favorable impact that the Net income attributable to non-controlling interests in consolidated entities had on the effective tax rate
for the six months ended June 30, 2022.
39

-- 42 of 111 --

Table of Contents
Schedule of Non-GAAP Information
We utilize the following non-GAAP performance measures: Net revenue (and by calculation, Net revenue yield on AUM), Adjusted operating income,
Adjusted operating margin, Adjusted net income attributable to Invesco and Adjusted diluted EPS. The company believes the adjusted measures provide
valuable insight into the company’s ongoing operational performance and assist in comparisons to its competitors. These measures also assist the company’s
management with the establishment of operational budgets and forecasts. The most directly comparable U.S. GAAP measures are Operating revenues (and by
calculation, Gross revenue yield on AUM), Operating income, Operating margin, Net income attributable to Invesco and diluted EPS. Each of these measures is
discussed more fully below.
The following are reconciliations of Operating revenues, Operating income (and by calculation, operating margin) and Net income attributable to Invesco
(and by calculation, Diluted EPS) on a U.S. GAAP basis to a non-GAAP basis of Net revenues, Adjusted operating income (and by calculation, Adjusted
operating margin) and Adjusted net income attributable to Invesco (and by calculation, Adjusted diluted EPS). These non-GAAP measures should not be
considered as substitutes for any U.S. GAAP measures and may not be comparable to other similarly titled measures of other companies. Additional reconciling
items may be added in the future to these non-GAAP measures if deemed appropriate. The tax effects related to the reconciling items have been calculated
based on the tax rate attributable to the jurisdiction to which the transaction relates. Notes to the reconciliations follow the tables.
Reconciliation of Operating revenues to Net revenues:
Three months ended June 30, 	Six months ended June 30,
$ in millions 	2023 	2022 	2023 	2022
Operating revenues, U.S. GAAP basis 	1,442.8 	1,530.4 	2,861.0 	3,159.8
Revenue Adjustments
Investment management fees 	(195.4) 	(193.1) 	(385.2) 	(399.0)
Service and distribution fees 	(230.9) 	(240.3) 	(456.2) 	(498.0)
Other 	(36.2) 	(41.6) 	(76.2) 	(90.6)
Total Revenue Adjustments 	(462.5) 	(475.0) 	(917.6) 	(987.6)
Invesco Great Wall 	97.6 	106.1 	198.1 	230.2
CIP 	12.8 	12.4 	25.1 	23.9
Net revenues 	1,090.7 	1,173.9 	2,166.6 	2,426.3
Reconciliation of Operating income to Adjusted operating income:
Three months ended June 30, 	Six months ended June 30,
$ in millions 	2023 	2022 	2023 	2022
Operating income, U.S. GAAP basis 	203.8 	344.7 	413.3 	722.4
Invesco Great Wall 	53.6 	62.2 	108.2 	135.9
CIP 	21.7 	16.1 	36.4 	30.9
Transaction, integration and restructuring 	— 	0.2 	41.6 	35.4
Amortization of intangible assets 	13.1 	14.8 	27.2 	29.9
Compensation expense related to market valuation changes in
deferred compensation plans 	9.8 	(26.1) 	22.2 	(48.0)
General and administrative 	— 	— 	(20.0) 	—
Adjusted operating income 	302.0 	411.9 	628.9 	906.5
Operating margin 	14.1 % 	22.5 % 	14.4 % 	22.9 %
Adjusted operating margin 	27.7 % 	35.1 % 	29.0 % 	37.4 %
(2)
(1)
(3)
(1)
(3)
(4)
(8)
(10)
(7)
(5)
(6)
40

-- 43 of 111 --

Table of Contents
Reconciliation of net income attributable to Invesco to Adjusted net income attributable to Invesco:
Three months ended June 30, 	Six months ended June 30,
$ in millions, except per common share data 	2023 	2022 	2023 	2022
Net income attributable to Invesco Ltd., U.S. GAAP basis 	132.2 	121.0 	277.2 	318.7
Adjustments (excluding tax):
Transaction, integration and restructuring 	— 	0.2 	41.6 	35.4
Amortization of intangible assets 	13.1 	14.8 	27.2 	29.9
Deferred compensation plan market valuation changes and dividend
income less compensation expense 	(6.1) 	52.5 	(16.5) 	73.0
General and administrative 	— 	— 	(20.0) 	—
Total adjustments excluding tax 	7.0 	67.5 	32.3 	138.3
Tax adjustment for amortization of intangible assets and goodwill 3.6 	3.8 	7.8 	7.5
Other tax effects of adjustments above 	1.6 	(12.0) 	0.5 	(24.9)
Adjusted net income attributable to Invesco Ltd. 	144.4 	180.3 	317.8 	439.6
Average common shares outstanding - diluted 	458.8 	459.5 	458.9 	460.7
Diluted EPS 	$0.29 	$0.26 	$0.60 	$0.69
Adjusted diluted EPS 	$0.31 	$0.39 	$0.69 	$0.95
____________
(1) Invesco Great Wall: The company reflects 100% of IGW in its Net revenues and Adjusted operating income (and by calculation, Adjusted operating margin). The company’s non-GAAP operating
results reflect the economics of these holdings on a basis consistent with the underlying AUM and flows. Adjusted net income is reduced by the amount of earnings attributable to the 51%
noncontrolling interests.
(2) Revenue adjustments: The company calculates Net revenues by reducing Operating revenues to exclude fees that are passed through to external parties who perform functions on behalf of, and
distribute, the company’s managed funds. The Net revenue presentation assists in identifying the revenue contribution generated by the company, removing distortions caused by the differing
distribution channel fees and allowing for a fair comparison with U.S. peer investment managers and within Invesco’s own investment units. Additionally, management evaluates Net revenue yield on
AUM, which is equal to Net revenues divided by Average AUM during the reporting period, as an indicator of the basis point Net revenues we receive for each dollar of AUM we manage.
Investment management fees are adjusted by renewal commissions and certain administrative fees. Service and distribution fees are primarily adjusted by distribution fees passed through to broker
dealers for certain share classes and pass through fund-related costs. Other revenues are primarily adjusted by transaction fees passed through to third parties.
(3) CIP: See note 11, “Consolidated Investment Products,” for a detailed analysis of the impact to the company’s Condensed Consolidated Financial Statements from the consolidation of CIP. The
company believes that the CIP may impact a reader’s analysis of our underlying results of operations and could result in investor confusion or the production of information about the company by
analysts or external credit rating agencies that is not reflective of the underlying results of operations and financial condition of the company. Accordingly, the company believes that it is appropriate to
adjust Operating revenues and Operating income for the impact of CIP in calculating the respective Net revenues and Adjusted operating income (and by calculation, Adjusted operating margin).
(4) Transaction, integration and restructuring: The company believes it is useful to adjust for the Transaction, integration and restructuring charges in arriving at Adjusted operating income, Adjusted
operating margin, Adjusted net income, and Adjusted diluted EPS, as this will aid comparability of our results period to period, and aid comparability with peer companies that may not have similar
acquisition and restructuring related charges. Transaction, integration and restructuring costs were zero for the second quarter 2023 due to the completion of strategic initiatives.
(5) Operating margin is equal to Operating income divided by Operating revenues.
(6) Adjusted operating margin is equal to Adjusted operating income divided by Net revenues.
(7) General and administrative: The adjustment removes insurance recoveries related to fund-related losses incurred in prior periods.
(8) Amortization of intangible assets: The company removes amortization expense related to acquired assets in arriving at Adjusted operating income, Adjusted operating margin and Adjusted diluted
EPS, as this will aid comparability of our results period to period, and aid comparability with peer companies that may not have similar acquisition-related charges.
(9) Tax adjustment for amortization of intangible assets and goodwill: The company reflects the tax benefit realized on the tax amortization of goodwill and intangibles in Adjusted net income. The
company believes it is useful to include this tax benefit in arriving at the Adjusted diluted EPS measure.
(10) Market movement on deferred compensation plan liabilities: Certain deferred compensation plan awards involve a return to the employee linked to the appreciation (depreciation) of specified
investments. The company hedges economically the exposure to market movements for these investments. Since these plans are hedged economically, the company believes it is useful to reflect the
offset ultimately achieved from hedging the market exposure in the calculation of Adjusted operating income (and by calculation, Adjusted operating margin) and Adjusted net income (and by
calculation, Adjusted diluted EPS) to produce results that will be more comparable period to period.
(11) The effective tax rate on Adjusted net income attributable to Invesco Ltd. for the three months and six months ended June 30, 2023 is 24.7% and 24.4%, respectively (for the three months and six
months ended June 30, 2022, it was 24.8% and 24.5%, respectively).
(12) Adjusted diluted EPS is equal to Adjusted net income attributable to Invesco Ltd. divided by the weighted average number of common and restricted common shares outstanding.
(4)
(8)
(10)
(7)
(9)
(11)
(12)
41

-- 44 of 111 --

Table of Contents
Balance Sheet Discussion
The following table represents a reconciliation of the balance sheet information presented on a U.S. GAAP basis to the balance sheet information excluding
the impact of CIP and policyholder balances for the reasons outlined in footnote 1 to the table:
As of June 30, 2023 	As of December 31, 2022
Balance sheet information
$ in millions 	U.S. GAAP
Impact of
CIP
Impact of
Policyholders 	As Adjusted 	U.S. GAAP
Impact of
CIP
Impact of
Policyholders 	As Adjusted
ASSETS
Cash and cash equivalents 	1,009.9 	— 	— 	1,009.9 	1,234.7 	— 	— 	1,234.7
Investments 	992.1 	(452.6) 	— 	1,444.7 	996.6 	(376.8) 	— 	1,373.4
Assets of CIP:
Investments and other assets of CIP 	8,808.9 	8,808.9 	— 	— 	8,735.1 	8,735.1 	— 	—
Cash and cash equivalents of CIP 	277.2 	277.2 	— 	— 	199.4 	199.4 	— 	—
Assets held for policyholders 	444.0 	— 	444.0 	— 	668.7 	— 	668.7 	—
Goodwill and intangible assets, net 	15,793.0 	— 	— 	15,793.0 	15,698.9 	— 	— 	15,698.9
Other assets 	2,132.7 	(12.8) 	— 	2,145.5 	2,223.4 	(9.8) 	— 	2,233.2
Total assets 	29,457.8 	8,620.7 	444.0 	20,393.1 	29,756.8 	8,547.9 	668.7 	20,540.2
LIABILITIES
Liabilities of CIP:
Debt of CIP 	6,884.5 	6,884.5 	— 	— 	6,590.4 	6,590.4 	— 	—
Other liabilities of CIP 	357.3 	357.3 	— 	— 	329.6 	329.6 	— 	—
Policyholder payables 	444.0 	— 	444.0 	— 	668.7 	— 	668.7 	—
Debt 	1,488.6 	— 	— 	1,488.6 	1,487.6 	— 	— 	1,487.6
Other liabilities 	3,574.8 	— 	— 	3,574.8 	3,838.3 	— 	— 	3,838.3
Total liabilities 	12,749.2 	7,241.8 	444.0 	5,063.4 	12,914.6 	6,920.0 	668.7 	5,325.9
EQUITY
Total equity attributable to Invesco
Ltd. 	15,328.9 	(0.1) 	— 	15,329.0 	15,213.6 	(0.1) 	— 	15,213.7
Noncontrolling interests 	1,379.7 	1,379.0 	— 	0.7 	1,628.6 	1,628.0 	— 	0.6
Total equity 	16,708.6 	1,378.9 	— 	15,329.7 	16,842.2 	1,627.9 	— 	15,214.3
Total liabilities and equity 	29,457.8 	8,620.7 	444.0 	20,393.1 	29,756.8 	8,547.9 	668.7 	20,540.2
____________
(1) This table includes non-GAAP presentations. Assets of CIP are not available for use by Invesco. Additionally, there is no recourse to Invesco for CIP debt. Policyholder
assets and liabilities are equal and offsetting and have no impact on Invesco’s shareholder’s equity.
(2) Amounts include Accounts receivable, prepaid assets, Property, equipment and software, right-of-use assets and Other assets.
(3) Amounts include Accrued compensation and benefits, Accounts payable and accrued expenses, lease liability and Deferred tax liabilities.
(4) Amounts include Redeemable noncontrolling interests in consolidated entities and Equity attributable to nonredeemable noncontrolling interests in consolidated entities.
Cash and cash equivalents
Cash and cash equivalents decreased by $224.8 million from $1,234.7 million at December 31, 2022 to $1,009.9 million at June 30, 2023. See “Cash Flows
Discussion” in the following section within this Management’s Discussion and Analysis for additional discussion regarding the movements in cash flows during
the period.
Investments
Investments are comprised primarily of the equity method investment in IGW, seed capital and co-investments in affiliated funds, and investments related to
the company’s deferred compensation plans.
(1)
(2)
(3)
(4)
42

-- 45 of 111 --

Table of Contents
As of June 30, 2023, the company had $920.0 million in seed capital and co-investments (December 31, 2022: $909.2 million), including direct investments
in CIP. Total seed capital and co-investments is presented as a helpful measure for investors and represents our total net investment interest including our
investment in CIP. The following table reconciles the investments balance to the total seed capital and co-investment balance.
As of
$ in millions 	June 30, 2023 	December 31, 2022
Investments 	992.1 	996.6
Net investment in CIP 	452.6 	376.8
Less: Investments related to deferred compensation plans, joint ventures, and other investments 	(524.7) 	(464.2)
Total seed capital and co-investments 	920.0 	909.2
____________
(1) Included in the total seed capital and co-investments balance as of June 30, 2023 is $281.2 million of seed capital and $638.8 million of co-investments (December 31,
2022: $305.4 million of seed capital and $603.8 million of co-investments).
Liquidity and Capital Resources
Our capital structure, together with available cash balances, cash flows generated from operations, existing capacity under our credit facility and further
capital market activities, if necessary, should provide us with sufficient resources to meet present and future cash needs, including operating expenses, debt and
other obligations as they come due and anticipated future capital requirements.
Sources of Liquidity by Type
As of
$ in millions 	June 30, 2023 	December 31, 2022
Cash and cash equivalents 	1,009.9 	1,234.7
Available revolver 	2,000.0 	1,500.0
Total sources of liquidity by type 	3,009.9 	2,734.7
On April 26, 2023, Invesco Ltd. and its indirect subsidiary, Invesco Finance PLC, amended and restated the $1.5 billion floating rate credit facility, increasing
facility capacity to $2.0 billion and extending the expiration date from April 26, 2026 to April 26, 2028. As of June 30, 2023, the balance on the $2.0 billion
capacity credit facility was zero.
Capital Management
Our capital management priorities have evolved with the growth and success of our business and include, in no particular order of priority: reinvestment in
the business, maintaining a strong balance sheet and returning capital to shareholders longer term through a combination of modestly increasing dividends and
share repurchases.
During the second quarter ended June 30, 2023, the company repurchased 9.6 million common shares in open market transactions utilizing $150.0 million in
cash. As of June 30, 2023, approximately $382.2 million remained authorized under the company’s common share repurchase authorization approved by the
Board on July 22, 2016.
Our capital process is executed in a manner consistent with our desire to maintain strong, investment grade credit ratings. As of the date of our filing, Invesco
held credit ratings of BBB+/Stable, A3/Stable and A/Stable from Standard & Poor’s Ratings Service (S&P), Moody’s Investor Services and Fitch Ratings,
respectively.
Other Items
Certain of our subsidiaries are required to maintain minimum levels of regulatory capital, liquidity, and working capital. Such requirements may change from
time-to-time as additional guidance is released based on a variety of factors, including balance sheet composition, assessment of risk exposures and governance,
and review from regulators. These and other similar provisions of applicable laws and regulations may have the effect of limiting withdrawals of capital,
repayment of
(1)
43

-- 46 of 111 --

Table of Contents
intercompany loans and payment of dividends by such entities. Our financial condition or liquidity could be adversely affected if certain of our subsidiaries are
unable to distribute funds to us.
We are in compliance with all regulatory minimum net capital requirements. As of June 30, 2023, the company’s minimum regulatory capital requirement
was $430.0 million (December 31, 2022: $639.8 million). The decrease was driven by a reduction in regulatory capital requirements as part of a transition into a
new regulatory regime in the UK (Investment Firm Prudential Regime). However, there has been no change to the related regulatory liquidity and working
capital requirements, and as such, there has not been a material reduction in the level of cash and cash equivalents required outside of the US.
We meet the regulatory liquidity and working capital requirements by holding cash and cash equivalents in the European sub-group. This retained cash can be
used for general business purposes in the European sub-group in the countries where it is located. Due to the liquidity and working capital requirements, the
ability to transfer cash between certain jurisdictions may be limited. In addition, transfers of cash between international jurisdictions may have adverse tax
consequences.
The consolidation of $9,086.1 million and $6,884.5 million of assets and debt of CIP as of June 30, 2023, respectively, did not impact the company’s liquidity
and capital resources. See Part I, Item 1, Financial Statements - Note 11, “Consolidated Investment Products,” for additional details.
Cash Flows Discussion
The ability to consistently generate cash flows from operations in excess of dividend payments, common share repurchases, capital expenditures and ongoing
operating expenses is one of our company’s fundamental financial strengths. Operations continue to be financed from current earnings and borrowings.
The following table represents a reconciliation of the cash flow information presented on a U.S. GAAP basis to the cash flows information excluding the
impact of the cash flows of CIP for the reasons outlined in footnote 1 to the table:
Cash flows information 	Six months ended June 30, 2023 	Six months ended June 30, 2022
$ in millions 	U.S. GAAP
Impact of
CIP 	Excluding CIP U.S. GAAP
Impact of
CIP 	Excluding CIP
Cash and cash equivalents, beginning of the period 	1,434.1 	199.4 	1,234.7 	2,147.1 	250.7 	1,896.4
Cash flows from operating activities 	232.4 	(124.7) 	357.1 	(252.3) 	(407.2) 	154.9
Cash flows from investing activities 	(49.2) 	75.7 	(124.9) 	(155.8) 	(38.3) 	(117.5)
Cash flows from financing activities 	(349.6) 	125.6 	(475.2) 	(533.0) 	398.6 	(931.6)
Increase/(decrease) in cash and cash equivalents 	(166.4) 	76.6 	(243.0) 	(941.1) 	(46.9) 	(894.2)
Foreign exchange movement on cash and cash equivalents 	19.4 	1.2 	18.2 	(73.2) 	(7.8) 	(65.4)
Cash and cash equivalents, end of the period 	1,287.1 	277.2 	1,009.9 	1,132.8 	196.0 	936.8
Cash and cash equivalents 	1,009.9 	— 	1,009.9 	936.8 	— 	936.8
Cash and cash equivalents of CIP 	277.2 	277.2 	— 	196.0 	196.0 	—
Total cash and cash equivalents per condensed consolidated statement of cash
flows 	1,287.1 	277.2 	1,009.9 	1,132.8 	196.0 	936.8
____________
(1) These tables include non-GAAP presentations. Cash held by CIP is not available for use by Invesco. Additionally, there is no recourse to Invesco for CIP debt. The cash
flows of CIP do not form part of the company’s cash flow management processes, nor do they form part of the company’s significant liquidity evaluations and decisions.
Operating Activities
Operating cash flows include the receipt of Investment management and Other fees generated from AUM, offset by Operating expenses and Changes in
operating assets and liabilities. After allowing for the change in cash held by CIP, investment activities, and seasonal payments such as bonus payments in the
first quarter, our operating cash flows generally move in the same direction as our Operating income.
Cash inflows for the six months ended June 30, 2023, excluding the impact of the consolidation of CIP, was primarily driven by lower net outflows from
changes in payables and receivables due to timing of payments and receipts as compared to the six
(1)
44

-- 47 of 111 --

Table of Contents
months ended June 30, 2022 which were partially offset by a decrease of $309.1 million in Operating Income. Also, included in cash inflows were net
investment sales of $12.6 million related to seed capital and deferred compensation investments (six months ended June 30, 2022: net investment purchases of
$59.7 million).
Investing Activities
Investing cash outflows for the six months ended June 30, 2023, excluding the impact of the consolidation of CIP, included Purchases of investments of $87.9
million (six months ended June 30, 2022: $133.8 million purchases), partially offset by proceeds of $47.8 million from sales and returns of capital of
investments (six months ended June 30, 2022: $73.4 million proceeds). In addition, the company had capital expenditures of $84.8 million for the six months
ended June 30, 2023 (six months ended June 30, 2022: $57.1 million). Our capital expenditures related principally to technology initiatives related to
investments in foundational technology projects as well as facilities costs related to our move to our new Atlanta headquarters.
Financing Activities
Financing cash outflows during the six months ended June 30, 2023, excluding the impact of the consolidation of CIP, included $177.6 million of common
dividend payments for the dividends declared in January and April (six months ended June 30, 2022: common dividends paid of $163.4 million), $118.4 million
of preferred dividend payments for dividends declared in January and April (six months ended June 30, 2022: $118.4 million) and the payment of $29.2 million
to meet employees’ withholding tax obligations on common share vestings (six months ended June 30, 2022: $34.4 million). The six months ended June 30,
2023 also included purchases of common shares through the open market of $150.0 million ( six months ended June 30, 2022 purchases of common shares
through the open market of $200.0 million). Financing cash outflows for the six months ended June 30, 2022 also included the $600.0 million redemption of
senior notes due in November 2022 which was partially offset by a net borrowing on the credit facility of $184.6 million.
Dividends
When declared, Invesco pays dividends on a quarterly basis in arrears. Holders of our preferred shares are eligible to receive dividends at an annual rate of
5.9% of the liquidation preference of $1,000 per share, or $59 per share per annum. The preferred stock dividend is payable quarterly on a non-cumulative basis
when, if and as declared by our board of directors. However, if we have not declared and paid or set aside for payment full quarterly dividends on the preferred
stock for a particular dividend period, we may not declare or pay dividends on, redeem, purchase or acquire, our common stock or other junior securities in the
next succeeding dividend period. In addition, if we have not declared and paid or set aside for payment quarterly dividends on the preferred stock for six
quarterly periods, whether or not consecutive, the number of directors of the company will be increased by two and the holders of the preferred shares shall
have the right to elect such two additional members of the Board of Directors.
On July 25, 2023, the company announced a second quarter 2023 cash dividend of $0.20 per share, payable on September 5, 2023, to shareholders of record
at the close of business on August 11, 2023 with an ex-dividend date of August 10, 2023.
On July 25, 2023, the company announced a preferred dividend of $14.75 per share to the holders of preferred shares, representing the period from June 1,
2023 through August 31, 2023 The preferred dividend is payable on September 1, 2023 to shareholders of record at close of business on August 15, 2023.
The declaration, payment and amount of any future dividends will depend upon, among other factors, our earnings, financial condition and capital
requirements at the time such declaration and payment are considered. The company has a policy of managing dividends in a prudent fashion, with due
consideration given to profit levels, overall debt levels and historical dividend payouts.
Debt
The carrying value of our debt at June 30, 2023 was $1,488.6 million (December 31, 2022: $1,487.6 million). See Part I, Item 1, Financial Statements - Note
4, “Debt,” for additional disclosures.
For the six months ended June 30, 2023, the company’s weighted average cost of debt was 4.28% (six months ended June 30, 2022: 4.02%).
Financial covenants under the credit facility agreement include: (i) the quarterly maintenance of an Adjusted debt/Earnings before income tax, depreciation,
amortization, interest expense, common share-based compensation expense, unrealized (gains)/
45

-- 48 of 111 --

Table of Contents
losses from investments, net, and unusual or otherwise non-recurring gains and losses (Covenant Adjusted EBITDA) leverage ratio, as defined in the credit
facility agreement, of not greater than 3.25:1.00, (ii) an interest coverage ratio (Covenant Adjusted EBITDA/interest payable for the four consecutive fiscal
quarters ended before the date of determination) of not less than 4.00:1.00. As of June 30, 2023, we were in compliance with our financial covenants. At
June 30, 2023, our leverage ratio was 0.66:1.00 (December 31, 2022: 0.78:1.00), and our interest coverage ratio was 20.66:1.00 (December 31, 2022:
19.51:1.00).
The June 30, 2023 coverage ratio calculations are as follows:
$ in millions 	Total 	Q2 2023 	Q1 2023 	Q4 2022 	Q3 2022
Net income attributable to Invesco Ltd. 	642.4 	132.2 	145.0 	187.8 	177.4
Dividends on preferred shares 	236.8 	59.2 	59.2 	59.2 	59.2
Tax expense 	311.8 	65.5 	69.9 	89.6 	86.8
Amortization/depreciation 	190.7 	47.4 	46.8 	48.6 	47.9
Interest expense 	72.6 	18.4 	18.0 	17.6 	18.6
Common share-based compensation expense 	118.9 	32.0 	37.8 	23.1 	26.0
Unrealized (gains)/losses from investments, net 	(33.2) 	(8.6) 	(17.1) 	(32.1) 	24.6
OppenheimerFunds acquisition-related matter recoveries 	(40.0) 	— 	— 	(25.0) 	(15.0)
Covenant Adjusted EBITDA 	1,500.0 	346.1 	359.6 	368.8 	425.5
Adjusted debt 	$991.3
Leverage ratio (Adjusted debt/Covenant Adjusted EBITDA - maximum 3.25:1.00) 	0.66
Interest coverage (Covenant Adjusted EBITDA/Interest expense - minimum
4.00:1.00) 	20.66
(1) Adjustments for unrealized gains and losses from investments, as defined in our credit facility, may also include non-cash gains and losses on investments to the extent that
they do not represent anticipated future cash receipts or expenditures.
(2) Unusual or otherwise non-recurring gains and losses, as defined in our credit facility, are adjusted for in the determination of Covenant Adjusted EBITDA. The insurance
recoveries related to the OppenheimerFunds acquisition-related matter are considered unusual and have been removed from the determination of Covenant Adjusted
EBITDA.
(3) Covenant Adjusted EBITDA and Adjusted debt are non-GAAP financial measures that are used by management in connection with certain debt covenant calculations under
our credit agreement. The calculation of Covenant Adjusted EBITDA above (a reconciliation from Net income attributable to Invesco Ltd.) is defined by our credit facility
agreement, and therefore Net income attributable to Invesco Ltd. is the most appropriate GAAP measure from which to reconcile to Covenant Adjusted EBITDA. The
calculation of Adjusted debt is defined in our credit facility and equals debt of $1,488.6 million plus $2.7 million in letters of credit less $500.0 million of excess unrestricted
cash (cash and cash equivalents less the minimum regulatory capital requirement, not to exceed $500 million).
Credit and Liquidity Risk
The company manages its capital by reviewing annual and projected cash flow forecasts and by monitoring credit, liquidity and market risks, such as interest
rate and foreign currency risks (as discussed in Part I, Item 3, Quantitative and Qualitative Disclosures About Market Risk), through measurement and analysis.
The company is primarily exposed to credit risk through its cash and cash equivalent deposits, which are held by external firms. The company invests its cash
balances in its own institutional money market products, as well as with external high credit-quality financial institutions. These arrangements create exposure
to concentrations of credit risk.
Credit Risk
Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to meet an obligation. All cash and cash
equivalent balances are subject to credit risk, as they represent deposits made by the company with external banks and other institutions. As of June 30, 2023,
our maximum exposure to credit risk related to our cash and cash equivalent balances is $1,009.9 million, of which $565.4 million is invested in affiliated
money market funds. No more than 10% of our cash and cash equivalent balances is held with any one third-party financial institution. See Part I, Item 1,
Financial Statements - Note 2, "Fair Value of Assets and Liabilities," for information regarding cash and cash equivalents invested in affiliated money market
funds.
(1)
(2)
(3)
(3)
46

-- 49 of 111 --

Table of Contents
Liquidity Risk
Liquidity risk is the risk that the company will encounter difficulty in meeting obligations associated with its financial liabilities as they become due. The
company is exposed to liquidity risk through its $1,488.6 million in total debt. The company actively manages liquidity risk by preparing cash flow forecasts for
future periods, reviewing them regularly with senior management, maintaining a committed credit facility, scheduling significant gaps between major debt
maturities and engaging external financing sources in regular dialogue.
Effects of Inflation
Inflation can impact our organization primarily in two ways. First, inflationary pressures can result in increases in our cost structure, especially to the extent
that large expense components such as compensation are impacted. To the degree that these expense increases are not recoverable or cannot be counterbalanced
through pricing increases due to the competitive environment, our profitability could be negatively impacted. Secondly, the value of the assets that we manage
may be negatively impacted when inflationary expectations result in a rising interest rate environment. A decline in the values of AUM could lead to reduced
revenues as management fees are generally calculated based upon the size of AUM.
Common Share Repurchase Plan
During the three months ended June 30, 2023, the company repurchased 9.6 million common shares for $150.0 million in the open market (three months
ended June 30, 2022: none; six months ended June 30, 2022: 8.9 million common shares for $200.0 million). At June 30, 2023, approximately $382.2 million
remains available under the share repurchase authorizations approved by the Board on July 22, 2016.
Off Balance Sheet Commitments
See Part I, Item 1, Financial Statements - Note 10, “Commitments and Contingencies - Legal Contingencies”, for more information regarding undrawn
capital commitments.
Critical Accounting Policies and Estimates
There have been no changes to the critical accounting policies disclosed in our most recent Forms 10-K and 10-Q for the year ended December 31, 2022 and
the three months ended March 31, 2023, respectively. Critical accounting policies are those that require management’s most difficult, subjective or complex
judgments and would therefore be deemed the most critical to an understanding of our results of operations and financial condition.
Recent Accounting Standards
See Part I, Item 1, Financial Statements - Note 1, "Accounting Policies - Accounting Pronouncements Recently Adopted.”
47

-- 50 of 111 --

Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of its business, the company is primarily exposed to market risk in the form of AUM market price risk, securities market risk, interest
rate risk and foreign exchange rate risk. There have not been any material changes to the company’s exposures to market risks during the period ended June 30,
2023 that would require an update to the disclosures provided in the most recent Form 10-K.
AUM Market Price Risk
The company’s investment management revenues are comprised of fees based on the value of AUM. Declines in the market prices of equity and fixed income
securities, commodities and derivatives, or other similar financial instruments held in client portfolios could cause revenues to decline because of lower
investment management fees by:
• Causing the value of AUM to decrease.
• Causing the returns realized on AUM to decrease (impacting performance fees).
• Causing clients to withdraw funds in favor of investments in markets that they perceive to offer greater opportunity and that the company does not
serve.
• Causing clients to rebalance assets away from investments that the company manages into investments that the company does not manage.
• Causing clients to reallocate assets away from products that earn higher revenues into products that earn lower revenues.
Underperformance of client accounts relative to competing products could exacerbate these factors.
Securities Market Risk
The company has investments in managed investment products that invest in a variety of asset classes. Investments are generally made to establish a track
record for a new fund or investment vehicle or to hedge economically exposure to certain deferred compensation plans. The company’s exposure to market risk
from financial instruments measured at fair value arises from its investments.
Interest Rate Risk
Interest rate risk relates to the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates.
The company is exposed to interest rate risk primarily through its external debt and cash and cash equivalent investments. See Part I, Item 1, Financial
Statements - Note 4, “Debt,” for details of the company’s debt arrangements. As of June 30, 2023, the interest rates on 100.0% of the company’s borrowings
were fixed for a weighted average period of 6.46 years, and the company had a zero balance on its floating rate credit facility.
Foreign Exchange Rate Risk
The company has certain investments in foreign operations, whose net assets and results of operations are exposed to foreign currency translation risk when
translated into U.S. Dollars upon consolidation into Invesco.
The company is also exposed to foreign translation risk on monetary assets and liabilities that are held by subsidiaries in different functional currencies than
the subsidiaries’ functional currencies. Net foreign exchange revaluation gains were $1.2 million during the six months ended June 30, 2023 (six months ended
June 30, 2022: $2.1 million gains) and are included in general and administrative expenses and other gains/(losses), net on the Condensed Consolidated
Statements of Income.
48

-- 51 of 111 --

Table of Contents
Item 4. Controls and Procedures
Our management is responsible for establishing and maintaining disclosure controls and procedures that are designed to ensure that information the company
is required to disclose in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the SEC’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be
disclosed in the reports that the company files or submits under the Exchange Act is accumulated and communicated to the company’s management, including
its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure.
We have evaluated, with the participation of our chief executive officer and chief financial officer, the effectiveness of our disclosure controls and procedures
as of June 30, 2023. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human
error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide
reasonable assurance of achieving their control objectives. Based upon our evaluation, our chief executive officer and chief financial officer concluded that our
disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or
submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the applicable rules and forms, and that it
is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions
regarding required disclosure.
We have evaluated any change in our internal control over financial reporting that occurred during the six months ended June 30, 2023 and have concluded
that there was no change that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
49

-- 52 of 111 --

Table of Contents
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
See Part I, Item 1, Financial Statements - Note 10, “Commitments and Contingencies - Legal Contingencies,” for information regarding legal proceedings.
Item 1A. Risk Factors
The company has had no significant changes in its risk factors from those previously disclosed in its Annual Report on Form 10-K for the year ended
December 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Repurchases of Equity Securities
The following table sets forth information regarding purchases of our common shares by us and any affiliated purchases during the three months ended
June 30, 2023:
Month
Total Number of Shares
Purchased
Average Price Paid
Per Share
Total Number of Shares
Purchased as Part of
Publicly Announced Plans or
Programs
Maximum Number at end of period
(or Approximate
Dollar Value) of Shares
that May Yet Be Purchased
Under the Plans
or Programs (millions)
April 1-30, 2023 	41,502 $ 	16.47 	— 	$532.2
May 1-31, 2023 	44,827 $ 	15.76 	— 	$532.2
June 1-30, 2023 	9,604,409 $ 	15.65 	9,587,105 	$382.2
Total 	9,690,738 	9,587,105
____________
(1) An aggregate of 103,633 shares were surrendered to us by Invesco employees to satisfy tax withholding obligations in connection with the vesting of equity awards.
(2) At June 30, 2023, a balance of $382.2 million remains available under the share repurchase authorization approved by the Board on July 22, 2016.
Item 5. Other Information
None.
(1) 	(2) 	(2)
50

-- 53 of 111 --

Table of Contents
Item 6. Exhibits
Exhibit Index
3.1 	Memorandum of Association of Invesco Ltd., incorporating amendments up to and including December 4, 2007, incorporated by reference to
exhibit 3.1 to Invesco’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 12, 2007
3.2 	Fourth Amended and Restated Bye-Laws of Invesco Ltd.
3.3 	Certificate of Designation for the 5.900% fixed rate non-cumulative perpetual series A preference shares, par value $0.20 per share, of Invesco
Ltd. incorporated by reference to Exhibit 3.1 to Invesco’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on
May 24, 2019
10.1 	Form of Restricted Stock Award Agreement for Executive Officers-Time Vesting-under the Invesco Ltd. 2016 Global Equity Incentive Plan
(2023)
22 	Subsidiary Guarantors and Issuers of Guaranteed Securities, incorporated by reference to Exhibit 22 to Invesco’s Quarterly Report on Form 10-Q
for the period ended March 31, 2021, filed with the Securities and Exchange Commission on April 30, 2021
31.1 	Certification of Andrew R. Schlossberg pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 	Certification of L. Allison Dukes pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 	Certification of Andrew R. Schlossberg pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
32.2 	Certification of L. Allison Dukes pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002
101 	The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline
XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated
Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of
Changes in Equity, and (vi) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
104 	The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL
51

-- 54 of 111 --

Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf
by the undersigned, thereunto duly authorized.
INVESCO LTD.
August 2, 2023 	/s/ ANDREW R. SCHLOSSBERG
Andrew Schlossberg
President and Chief Executive Officer
August 2, 2023 	/s/ L. ALLISON DUKES
L. Allison Dukes
Senior Managing Director and Chief Financial Officer
52

-- 55 of 111 --

Exhibit 3.2
FOURTH AMENDED AND RESTATED
B Y E - L A W S
OF
INVESCO LTD.
(effective as of May 25, 2023)

-- 56 of 111 --

TABLE OF CONTENTS
Page
INTERPRETATION
1. Interpretation 	1
BOARD OF DIRECTORS
2. Board of Directors 	3
3. Powers of the Board 	4
4. Power to Delegate to a Committee 	4
5. Power to Appoint and Dismiss Employees 	4
6. Power to Borrow and Charge Property 	4
7. Exercise of Power to Purchase Shares of or Discontinue the Company 	4
8. Board Size; Term of Directors 	5
9. Defects in Appointment of Directors 	6
10. Shareholder Proposals and Nominations; Proxy Access 	6
11. Removal of Directors 	18
12. Vacancies on the Board 	18
13. Notice of Meetings of the Board 	19
14. Quorum at Meetings of the Board 	19
15. Meetings of the Board 	20
16. Unanimous Written Resolutions 	20
17. Contracts and Disclosure of Directors’ Interests 	20
18. Remuneration of Directors 	20
OFFICERS
19. Officers of the Company 	20
20. Remuneration of Officers 	21
21. Duties of Officers 	21
22. Chairperson and Secretary of Meetings 	21
23. Register of Directors and Officers 	21
MINUTES
24. Obligations of Board to Keep Minutes 	21
INDEMNITY
25. Indemnification and Exculpation of Directors of the Company and Others 	22
26. Waiver of Certain Claims 	23
MEETINGS
-i-

-- 57 of 111 --

27. Notice of Annual General Meeting of Shareholders 	23
28. Notice of Special General Meeting 	23
29. Accidental Omission of Notice of General Meeting 	23
30. Short Notice 	24
31. Postponement of Meetings 	24
32. Quorum for General Meeting 	24
33. Adjournment of Meetings 	24
34. Attendance at Meetings 	25
35. Written Resolutions 	25
36. Attendance of Directors 	25
37. Voting at Meetings 	25
38. Voting by Hand or by Poll 	26
39. Decision of Chairperson 	27
40. Instrument of Proxy 	27
41. Representation of Corporations at Meetings 	28
VOTES OF SHAREHOLDERS
42. General 	28
SHARE CAPITAL AND SHARES
43. Share Capital 	29
44. Rights of Shares 	29
45. Modification of Rights 	30
46. Shares 	31
47. Registered Holder of Shares 	31
48. Death of a Joint Holder 	32
49. Share Certificates 	32
50. Calls on Shares 	32
51. Forfeiture of Shares 	32
INTERESTED SHAREHOLDERS
52. Limitations on Business Combinations 	33
53. Certain Definitions 	33
REGISTER OF SHAREHOLDERS
54. Contents of Register of Shareholders 	35
55. Inspection of Register of Shareholders 	35
56. Determination of Record Dates 	36
TRANSFER OF SHARES
-ii-

-- 58 of 111 --

57. Instrument of Transfer 	36
58. Restrictions on Transfer 	36
TRANSMISSION OF SHARES
59. Representative of Deceased Shareholder 	36
60. Registration on Death or Bankruptcy 	37
DIVIDENDS AND OTHER DISTRIBUTIONS
61. Declaration of Dividends by the Board 	37
62. Other Distributions 	37
63. Reserve Fund 	37
64. Deduction of Amounts Due to the Company 	37
CAPITALIZATION
65. Issue of Bonus Shares: Capitalization of Profits 	38
ACCOUNTS AND FINANCIAL STATEMENTS
66. Records of Account 	38
67. Financial Year End 	38
68. Financial Statements 	39
AUDIT
69. Appointment of Auditor 	39
70. Remuneration of Auditor 	39
71. Report of the Auditor 	39
NOTICES
72. Notices to Shareholders of the Company 	39
73. Notices to Joint Shareholders 	39
74. Service and Delivery of Notice 	39
SEAL OF THE COMPANY
75. The Seal 	40
76. Manner in which Seal is to be Affixed 	40
WINDING-UP
77. Winding-Up/Distribution by Liquidator 	40
ALTERATION OF BYE-LAWS
78. Alteration of Bye-Laws 	40
-iii-

-- 59 of 111 --

INTERPRETATION
1. Interpretation
(1) In these Bye-Laws the following words and expressions shall have the following meanings, respectively:
(a) “Act” means the Companies Act 1981 of Bermuda as amended from time to time;
(b) “Affiliate” means, with respect to any Person, any other Person that directly, or indirectly through one or more
intermediaries, controls, or is controlled by, or is under common control with such Person. For the purposes of this definition,
“control”, with respect to any Person, means the possession, direct or indirect, of the power to direct or cause the direction of the
management and policies of such Person, whether through the ownership of voting securities, by contract, or otherwise;
(c) “Associate” has the meaning set forth in Bye-Law 53(1);
(d) “Audit Committee” means the committee appointed by the Board in accordance with these Bye-Laws;
(e) “Auditor” includes any individual, partnership or other entity appointed in accordance with the Act to audit the
accounts of the Company;
(f) “beneficially own” has the meaning set forth in Bye-Law 53(2);
(g) “beneficially owned” has the meaning set forth in Bye-Law 10(4);
(h) “Beneficial Owner” has the meaning set forth in Bye-Law 53(2);
(i) “Board” means the Board of Directors appointed or elected pursuant to these Bye-Laws and acting pursuant to
the Act and these Bye-Laws;
(j) “Business Combination” has the meaning set forth in Bye-Law 53(3);
(k) “Business Day” means any day other than a Saturday, a Sunday, any day on which commercial banking
institutions in Hamilton, Bermuda or Atlanta, Georgia are authorized or obligated by law to close or any day on which the New York
Stock Exchange is not open for trading;
(l) “Cause” means (1) willful misconduct or gross negligence which is materially injurious to the Company, (2)
fraud or embezzlement or (3) a conviction of, or a plea of “guilty” or “no contest” to, a felony;
(m) “Chairperson” means the person designated by the Board as the chairperson of the Board;
(n) “Common Shares” has the meaning set forth in Bye-Law 43;
(o) “Company” means the company for which these Bye-Laws are approved and confirmed;
(p) “Constituent Holder” has the meaning set forth in Bye-Law 10(3).
1

-- 60 of 111 --

(q) “Director” means a director of the Company;
(r) “Eligible Shareholder” has the meaning set forth in Bye-Law 10(3).
(s) “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended;
(t) “Interested Shareholder” has the meaning set forth in Bye-Law 53(4);
(u) “legal proceeding” has the meaning set forth in Bye-Law 59;
(v) “legal representative” has the meaning set forth in Bye-Law 59.
(w) “Nomination and Corporate Governance Committee” means the committee appointed by the Board in
accordance with these Bye-Laws as such;
(x) “notice” means written notice as further defined in these Bye-Laws unless otherwise specifically stated;
(y) “Officer” means any person appointed by the Board to hold an office in the Company;
(z) “own” has the meaning set forth in Bye-Law 10(3).
(aa) “Person” means an individual, corporation, partnership, association, joint-stock company, trust, unincorporated
organization or government or political subdivision thereof;
(bb) “Preference Shares” has the meaning set forth in Bye-Law 44(3);
(cc) “proceeding” has the meaning set forth in Bye-Law 25(1);
(dd) “Proxy Access Request Required Shares” has the meaning set forth in Bye-Law 10(3).
(ee) “public announcement” has the meaning set forth in Bye-Law 10(3);
(ff) “Qualifying Fund” has the meaning set forth in Bye-Law 10(3).
(gg) “Register of Directors and Officers” means the Register of Directors and Officers referred to in these Bye-Laws
and shall be the same “register of directors and officers” required to be kept by the Company under the Act;
(hh) “Register of Shareholders” means the Register of Shareholders referred to in these Bye-Laws and shall be the
same “register of members” required to be kept by the Company under the Act;
(ii) “Resident Representative” means any Person appointed to act as resident representative of the Company in
accordance with the Act;
(jj) “Secretary” means the person appointed to perform any or all of the duties of secretary of the Company and
includes any deputy or assistant or acting secretary;
(kk) “Securities Act” means the U.S. Securities Act of 1933, as amended;
2

-- 61 of 111 --

(ll) “Shareholder” shall have the same meaning as the term “Member” in the Act and means the Person registered in
the Register of Shareholders as the holder of shares (sometimes referred to in these Bye-Laws as the direct holder) of the Company
or, when two or more Persons are so registered as joint holders of shares, means the Person whose name stands first in the Register of
Shareholders as one of such joint holders or all of such Persons as the context so requires;
(mm) “Undesignated Shares” has the meaning set forth in Bye-Law 43;
(nn) “United States of America” or “U.S.” means the United States of America and dependent territories or any part
thereof;
(oo) “Voting Commitment” has the meaning set forth in Bye-Law 8(4).
(pp) “Voting Stock” has the meaning set forth in Bye-Law 10(3).
(2) In these Bye-Laws, where not inconsistent with the context:
(a) words denoting the plural number include the singular number and vice versa;
(b) words denoting the masculine gender include the feminine and neuter gender;
(c) the words:
(i) “may” shall be construed as permissive;
(ii) “shall” shall be construed as imperative;
(d) references to particular laws, rules and regulations (including references to particular Sections of, Rules under
and filings pursuant to the Exchange Act), shall be deemed to refer to any applicable successor laws, rules, regulations or filings as
may be enacted or promulgated from time to time; and
(e) unless otherwise provided herein, words or expressions defined in the Act shall bear the same meaning in these
Bye-Laws.
(3) Expressions referring to writing or its cognates shall, unless the contrary intention appears, include facsimile, printing,
lithography, photography, electronic mail and other modes of representing words in a visible form.
(4) Headings used in these Bye-Laws are for convenience only and are not to be used or relied upon in the construction
hereof.
BOARD OF DIRECTORS
2. Board of Directors
The Board shall have the full power and authority provided to it by the Act and these Bye-Laws.
3

-- 62 of 111 --

3. Powers of the Board
(1) In exercising such power and authority, the Board may exercise all such powers of the Company as are not, by statute or
by these Bye-Laws, required to be exercised by the Company in a general meeting subject, nevertheless, to these Bye-Laws and the
provisions of any statute.
(2) No regulation or alteration to these Bye-Laws made by the Company in a general meeting shall invalidate any prior act
of the Board that would have been valid if such regulation or alteration had not been made.
(3) The Board may procure that the Company pays all expenses incurred in promoting and incorporating the Company.
(4) The Board may from time to time and at any time by power of attorney appoint any company, firm, person or body of
persons, whether nominated directly or indirectly by the Board, to be an attorney of the Company for such purposes and with such
powers, authorities and discretions (not exceeding those vested in or exercisable by the Board) and for such period and subject to
such conditions as it may think fit and any such power of attorney may contain such provisions for the protection and convenience of
Persons dealing with any such attorney as the Board may think fit and may also authorize any such attorney to sub-delegate all or any
of the powers, authorities and discretions so vested in the attorney. Such attorney may, if so authorized by the power of attorney,
execute any deed or instrument or other document on behalf of the Company under hand or under its common seal.
4. Power to Delegate to a Committee
The Board may delegate any of its powers to a committee appointed by the Board (including the power to sub-delegate) and
every such committee shall conform to such directions as the Board shall impose on them. Committees may consist of one or more
Directors.
The meetings and proceedings of any such committee shall be governed by the provisions of these Bye-Laws regulating the
meetings and proceedings of the Board, so far as the same are applicable and are not superseded by directions imposed by the Board,
and in that connection the Board may authorize a committee to adopt such rules for its meetings.
5. Power to Appoint and Dismiss Employees
The Board may appoint, suspend or remove any Officer, employee, agent or representative of the Company and may
determine their duties.
6. Power to Borrow and Charge Property
The Board may exercise all of the powers of the Company to borrow money and to mortgage or charge its undertaking,
property and uncalled capital, or any part thereof, and may issue debentures, debenture stock and other securities whether outright or
as security for any debt, liability or obligation of the Company or any third party.
7. Exercise of Power to Purchase Shares of or Discontinue the Company
(1) The Board may exercise all of the powers of the Company to purchase (sometimes referred to in these Bye-Laws as
“repurchase”) all or any part of its own shares pursuant to the Act.
4

-- 63 of 111 --

(2) The Board may exercise all of the powers of the Company to discontinue or redomesticate the Company to a named
country or jurisdiction outside Bermuda pursuant to the Act.
8. Board Size; Term of Directors
(1) Subject to the rights of the holders of any class or series of preference shares, the Board shall consist of such number of
Directors (not less than 3) as the Board may determine from time to time by resolution adopted by the affirmative vote of at least a
majority of the Board then in office. Any increase in the number of Directors on the Board pursuant to this Bye-Law 8 shall be
deemed to be a vacancy and may be filled in accordance with Bye-Law 12 hereof. A decrease in the number of Directors shall not
shorten the term of any Director then in office.
(2) Subject to the rights of the holders of any class or series of preference shares, Directors shall be elected, except in the
case of a vacancy (as provided for in Bye-Law 11 or 12, as the case may be), by the Shareholders in the manner set forth in these
Bye-Laws at an annual general meeting of Shareholders or any special general meeting called for such purpose and shall hold office
for the term set forth in paragraph (3) of this Bye-Law 8.
(3) Directors shall be elected annually for a one-year term expiring at the next annual general meeting of Shareholders. A
Director shall hold office until such Director’s successor shall have been duly elected and qualified or until such Director is removed
from office pursuant to Bye-Law 11 or such Director’s office is otherwise earlier vacated.
(4) No person may be appointed, nominated or elected a Director unless such person, at the time such person is nominated
and appointed or elected, would then be able to serve as a Director without conflicting in any material respect with any law or
regulation applicable to the Company, as determined in good faith by the Board of Directors. In addition, to be eligible to be a
nominee for election or reelection as a Director pursuant to any provision of these Bye-Laws, a person must deliver (in accordance
with the time periods prescribed for delivery of notice under Bye-Law 10) to the Secretary at the principal executive offices of the
Company a written questionnaire with respect to the background and qualification of such person and the background of any other
person or entity on whose behalf the nomination is being made (which questionnaire shall be provided by the Secretary upon written
request) and a written representation and agreement (in the form provided by the Secretary upon written request) that such person (i)
will abide by the requirements of these Bye-Laws, (ii) is not and will not become a party to (a) any agreement, arrangement or
understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a
Director, will act or vote on any issue or question (a “Voting Commitment”) that has not been disclosed to the Company or (b) any
Voting Commitment that could limit or interfere with such person’s ability to comply, if elected as a Director, with such person’s
fiduciary duties under applicable law, (iii) is not and will not become a party to any agreement, arrangement or understanding with
any person or entity other than the Company with respect to any direct or indirect compensation, reimbursement or indemnification
in connection with service or action as a Director that has not been disclosed therein, and (iv) in such person’s individual capacity
and on behalf of any person or entity on whose behalf the nomination is being made, would be in compliance, if elected as a Director,
and will comply with all applicable publicly disclosed corporate governance, conflict of interest, confidentiality and stock ownership
and trading policies and guidelines of the Company.
(5) Subject to the rights of the holders of any class or series of preference shares, at any meeting for the election of
Directors at which a quorum is present, each nominee shall be elected by the vote of the majority of the votes cast with respect to the
Director, provided that if the number of nominees exceeds the number of positions available for the election of Directors, the
Directors shall be elected by a plurality of the votes cast in person or by proxy at any such
5

-- 64 of 111 --

meeting. For purposes of this Bye-Law 8(5), a majority of the votes cast means that the number of shares voted “for” a Director must
exceed 50% of the votes cast with respect to that Director. Votes cast with respect to the election of a Director shall include only
votes cast with respect to stock present in person or represented by proxy at the meeting and entitled to vote and shall exclude
abstentions.
(6) If a nominee for Director who is an incumbent Director is not elected and no successor has been elected at such meeting,
the Director will promptly tender his or her resignation to the Board. The Nomination and Corporate Governance Committee shall
make a recommendation to the Board as to whether to accept or reject the tendered resignation, or whether other actions should be
taken. The Board shall act on the tendered resignation, taking into account the Nomination and Corporate Governance Committee’s
recommendation, and publicly disclose (by a press release, a filing with the U.S. Securities and Exchange Commission or other
broadly disseminated means of communication) its decision regarding the tendered resignation and the rationale behind the decision
within 90 days from the date of the certification of the election results. The Nomination and Corporate Governance Committee in
making its recommendation, and the Board in making its decision, may each consider any factors or other information that it
considers appropriate and relevant. The Director who tenders his or her resignation shall not participate in the recommendation of the
Nomination and Corporate Governance Committee or the decision of the Board with respect to his or her resignation. If such
incumbent Director’s resignation is not accepted by the Board, such Director shall continue to serve until the next annual meeting
and until his or her successor is duly elected, or his or her earlier resignation or removal. If a Director’s resignation is accepted by the
Board pursuant to these Bye-Laws, or if a nominee for Director is not elected and the nominee is not an incumbent Director, then the
Board, in its sole discretion, may fill any resulting vacancy pursuant to Bye-Law 12 or may decrease the size of the Board pursuant
to this Bye-Law 8.
9. Defects in Appointment of Directors
All acts done by any meeting of the Board or by a committee of the Board shall, notwithstanding that it be afterwards
discovered that there was some defect in the appointment of any person as a Director, or that they or any of them were disqualified,
be as valid as if every such person had been duly appointed and was qualified to be a Director.
10. Shareholder Proposals and Nominations; Proxy Access
(1) Annual General Meeting
(a) At any annual general meeting of Shareholders, nominations of persons for election to the Board of Directors of
the Company may be made only (i) pursuant to the Company’s notice of meeting, (ii) by or at the direction of a majority of the
Board, (iii) by any Shareholder who (A) is a Shareholder of record at the time of giving of notice provided for in these Bye-Laws,
(B) is entitled to vote at the meeting and (C) complies with the notice and other procedures set forth in paragraph (1) of this Bye-Law
10 as to such nomination or (iv) by any Eligible Shareholder (as defined in paragraph (3) of this Bye-Law 10) who (A) is entitled to
vote at the meeting and (B) complies with the notice and other procedures set forth in paragraph (3) of this Bye-Law 10; the
preceding clauses (iii) and (iv) shall be the exclusive means for a Shareholder to make nominations before an annual general meeting
of Shareholders. At any annual general meeting of Shareholders, proposals of any other business to be considered by the
Shareholders may be made only (i) pursuant to the Company’s notice of meeting, (ii) by or at the direction of a majority of the Board
or (iii) by any Shareholder who (A) is a Shareholder of record at the time of giving of notice provided for in these Bye-Laws, (B) is
entitled to vote at the meeting and (C) complies with the procedures set forth in these Bye-Laws; the preceding clause (iii) shall be
the exclusive means for a Shareholder to submit other business (other than
6

-- 65 of 111 --

matters properly brought under Rule 14a-8 under the Exchange Act and included in the Corporation’s notice of meeting) before an
annual general meeting of Shareholders. To be properly brought before a meeting of Shareholders, business must be of a proper
subject for action by Shareholders under applicable law and must not, if implemented, cause the Company to violate any applicable
law or regulation, each as determined in good faith by the Board.
(b) For nominations or other business to be properly brought before an annual general meeting by a Shareholder
pursuant to these Bye-Laws, the Shareholder must have given timely notice thereof in writing to the Secretary and such other
business must otherwise be a proper matter for Shareholder action. Notice shall be considered timely only if given to the Secretary of
the Company not less than 90 nor more than 120 days prior to the first anniversary of the date of the preceding year’s annual general
meeting of Shareholders; provided, however, that if the date of the annual general meeting is more than 30 days before or more than
60 days after such anniversary date, any notice by the Shareholder of business or the nomination of Directors for election or
reelection to be brought before the annual general meeting to be timely must be so delivered not earlier than the close of business on
the 120th day prior to such annual general meeting and not later than the close of business on the later of the 90th day prior to such
annual general meeting and the 10th day following the day on which public announcement of the date of such meeting is first made.
Notwithstanding the foregoing, in the event that the number of Directors to be elected to the Board at the applicable annual general
meeting is increased and there is no public announcement by the Company naming all of the nominees for Director or specifying the
size of the increased Board of Directors at least 100 days prior to the first anniversary of the preceding year’s annual general meeting,
a Shareholder’s notice required by this Bye-Law 10 shall also be considered timely, but only with respect to nominees for any new
positions created by such increase, if it shall be delivered to the Secretary at the principal executive offices of the Company not later
than the close of business on the 10th day following the day on which such public announcement is first made by the Company.
(c) Any Shareholder who gives notice of any such proposal shall deliver therewith, in writing: the text of the
proposal to be presented and a brief statement of the reasons why such Shareholder and the beneficial owner, if any, on whose behalf
the proposal is made favors the proposal; the name and address, as they appear on the Company’s books, of any such Shareholder
and the name and address of any such beneficial owner; the number and class of all shares of each class of stock of the Company
beneficially owned by such Shareholder and any such beneficial owner and evidence thereof reasonably satisfactory to the Secretary
of the Company; a description of any material interest in the proposal of such Shareholder and any such beneficial owner (other than
any interest as a Shareholder) and of all arrangements or understandings between such Shareholder and any such beneficial owner
and any other Person or Persons in connection with the proposal of such business; and a representation that such Shareholder intends
to appear in person or by proxy at the annual general meeting to bring such business before the meeting.
(d) Any Shareholder desiring to nominate any person for election as a Director, whether pursuant to paragraph (1),
(2) or (3) of this Bye-Law 10, shall deliver with such notice a statement in writing setting forth: the name of the person to be
nominated; the number and class of all shares of each class of stock of the Company beneficially owned by such person; the
information regarding such person required by paragraphs (d), (e) and (f) of Item 401 of Regulation S-K adopted by the U.S.
Securities and Exchange Commission; all other information relating to such person that is required to be disclosed in solicitations of
proxies for Directors pursuant to Regulation 14A under the Exchange Act (including such person’s signed consent to serve as a
Director if elected); a certification by each Shareholder nominee that such nominee is as of the time of nomination and will be as of
the time of the applicable meeting eligible to serves as a Director in accordance with this Bye-Law 10 and (in both such person’s
individual capacity and on behalf of any Person for whom such person may be a representative),
7

-- 66 of 111 --

has complied with Bye-Law 8 and has complied and will comply with all applicable corporate governance, conflicts, confidentiality
and stock ownership and trading policies of the Company; the name and address, as they appear on the Company’s books, of such
Shareholder and the name and address of any such beneficial owner, if any, on whose behalf the nomination is made; the number and
class of all shares of each class of stock of the Company beneficially owned by such Shareholder or any such beneficial owner; and a
description of all arrangements or understandings between such Shareholder or any such beneficial owner and each nominee and any
other Person or Persons (including their names) pursuant to which the nomination or nominations are to be made. The Company may
require any proposed nominee, whether pursuant to paragraph (1), (2) or (3) of this Bye-Law 10, to furnish such other information as
may be reasonably required by the Company to determine the qualifications of such proposed nominee to serve as a Director or to
determine whether any of the matters contemplated by clause (I) of paragraph (3) of this Bylaw 10 apply to such proposed nominee.
(2) Special General Meeting
(a) The Chairperson, the Chief Executive Officer or the Board acting by vote of a majority of the Board may
convene a special general meeting of the Company whenever in its judgment such a meeting is necessary or desirable. Subject to the
next sentence and subject to the rights of the holders of any class or series of preference shares, special general meetings of the
Company may only be called as provided in the preceding sentence. In addition, the Board shall, (i) on the requisition of the holders
of any class or series of preference shares as may have express rights to requisition special general meetings, and (ii) on the
requisition of Shareholders holding at the date of the deposit of the requisition not less than one-tenth of such of the paid-up capital
of the Company as at the date of the deposit carries the right to vote in general meetings of the Company, forthwith proceed to
convene a special general meeting of the Company (or the applicable class(es) of shares) and the provisions of Section 74 of the Act
shall apply. Special general meetings may be held at such place as may from time to time be designated by the Board and stated in
the notice of the meeting. In any special general meeting of the Company only such business shall be conducted as is set forth in the
notice thereof.
(b) Nominations of persons for election to the Board may be made at a special general meeting at which Directors
are to be elected pursuant to the Company’s notice of meeting (i) by or at the direction of the Board or (ii) provided that the Board
has determined that Directors shall be elected at such meeting, by any Shareholder who is a Shareholder of record at the time of
giving of notice provided for in this Bye-Law, who shall be entitled to vote at the meeting and who complies with the notice
procedures set forth in these Bye-Laws; the preceding clause (ii) shall be the exclusive means for a Shareholders to make
nominations before any special general meeting of Shareholders. In the event the Company calls a special general meeting for the
purpose of electing one or more Directors to the Board, any such Shareholder may nominate a person or persons (as the case may be)
for election to such position(s) as specified in the Company’s notice of meeting, if the Shareholder’s notice containing the
information specified in Bye-Laws 10(1)(d) and 8(4) shall be delivered to the Secretary at the principal executive offices of the
Company not earlier than the close of business on the 120th day prior to such special general meeting and not later than the close of
business on the later of the 90th day prior to such special general meeting and the 10th day following the day on which public
announcement of the date of such meeting is first made and of the nominees proposed by the Board to be elected at such meeting.
(3) Inclusion of Shareholder Director Nominations in the Company’s Proxy Materials
Subject to the terms and conditions set forth in these Bye-Laws, the Company shall include in its proxy materials for an
annual general meeting of Shareholders the name, together
8

-- 67 of 111 --

with the Required Information (as defined below), of any person nominated for election (the “Shareholder Nominee”) to the Board of
Directors by a Shareholder or group of Shareholders that satisfy the requirements of this Bye-Law 10(3) and that expressly elects at
the time of providing the written notice required by this Bye-Law 10(3) (a “Proxy Access Notice”) to have its nominee included in
the Company’s proxy material pursuant to this Bye-Law 10(3). For the purposes of this Bye-Law 10(3):
(1) “Voting Stock” shall mean outstanding shares of capital stock of the Company entitled to vote generally for the
election of Directors;
(2) “Constituent Holder” shall mean any Shareholder, collective investment fund included within a Qualifying Fund
(as defined in paragraph (D) below) or beneficial holder whose stock ownership is counted for the purposes of qualifying as
an Eligible Shareholder (as defined in paragraph (D) below);
(3) “affiliate” and “associate” shall have the meanings ascribed thereto in Rule 405 under the Securities Act;
provided, however, that the term “partner” as used in the definition of “associate” shall not include any limited partner that is
not involved in the management of the relevant partnership; and
(4) a Shareholder (including any Constituent Holder) shall be deemed to “own” only those outstanding shares of
Voting Stock as to which the Shareholder (or such Constituent Holder) possesses both (a) the full voting and investment
rights pertaining to the shares and (b) the full economic interest in (including the opportunity for profit and risk of loss on)
such shares. The number of shares calculated in accordance with the foregoing clauses (a) and (b) shall be deemed not to
include (and, to the extent any of the following arrangements have been entered into by affiliates of the Shareholder (or of
any Constituent Holder), shall be reduced by) any shares (x) sold by such Shareholder or Constituent Holder (or any of
either’s affiliates) in any transaction that has not been settled or closed, including any short sale, (y) borrowed by such
Shareholder or Constituent Holder (or any of either’s affiliates) for any purposes or purchased by such Shareholder or
Constituent Holder (or any of either’s affiliates) pursuant to an agreement to resell, or (z) subject to any option, warrant,
forward contract, swap, contract of sale, other derivative or similar agreement entered into by or effecting such Shareholder or
Constituent Holder (or any of either’s affiliates), whether any such instrument or agreement is to be settled with shares, cash
or other consideration, in any such case which instrument or agreement has, or is intended to have, or if exercised by either
party thereto would have, the purpose or effect of (i) reducing in any manner, presently or in the future, the full voting and
investment rights pertaining to such shares, and/or (ii) hedging, offsetting or altering to any degree the full economic interest
in (including the opportunity for profit and risk of loss on) such shares. A Shareholder (including any Constituent Holder)
shall “own” shares held in the name of a nominee or other intermediary so long as the Shareholder (or such Constituent
Holder) retains the right to instruct how the shares are voted with respect to the election of Directors and the right to direct the
disposition thereof and possesses the full economic interest in the shares. A Shareholder’s (including any Constituent
Holder’s) ownership of shares shall be deemed to continue during any period in which such person has (i) loaned such shares,
provided that such Shareholder has the power to recall such loaned shares on not more than five (5) business days’ notice and
includes in its Proxy Access Notice an agreement that it (A) will promptly recall such loaned shares upon being notified that
any of its Shareholder Nominees will be included in the Company’s proxy materials and (B) will continue to hold such
recalled shares through the date of the annual meeting or (ii) delegated any voting power over such shares by means of a
proxy, power of attorney or other instrument or arrangement which in all such cases is revocable at any time by the
9

-- 68 of 111 --

Shareholder. The terms “owned,” “owning” and other variations of the word “own” shall have correlative meanings.
(A) For purposes of this Bye-Law 10(3), the “Required Information” that the Company will include in its
proxy statement is (1) the information concerning the Shareholder Nominee and the Eligible Shareholder that the
Company determines is required to be disclosed in the Company’s proxy statement by the regulations promulgated
under the Exchange Act; and (2) if the Eligible Shareholder so elects, a Statement (as defined in paragraph (F) below).
The Company shall also include the name of the Shareholder Nominee in its proxy card. For the avoidance of doubt,
and any other provision of these Bye-Laws notwithstanding, the Company may in its sole discretion solicit against,
and include in the proxy statement its own statements or other information relating to, any Eligible Shareholder and/or
Shareholder Nominee.
(B) To be timely, a Shareholder’s Proxy Access Notice, together with all related materials provided for
herein, must be delivered to the principal executive offices of the Company within the time periods applicable to
Shareholder notices of nominations pursuant to paragraph (1)(b) of Bye-Law 10. In no event shall any adjournment or
postponement of an annual general meeting, the date of which has been announced by the Company, commence a new
time period for the giving of a Proxy Access Notice.
(C) The number of Shareholder Nominees (which shall include Shareholder Nominees that were submitted
by all Eligible Shareholders for inclusion in the Company’s proxy materials pursuant to this Bye-Law 10(3) but either
(x) are subsequently withdrawn (or withdraw) or (y) the Board of Directors decides to nominate as Board of Directors’
nominees) appearing in the Company’s proxy materials with respect to an annual general meeting of Shareholders
shall not exceed the greater of (x) two (2) and (y) the largest whole number that does not exceed 20% of the number of
directors in office as of the last day on which a Proxy Access Notice may be delivered in accordance with the
procedures set forth in this Bye-Law 10(3) (such greater number, the “Permitted Number”); provided, however, that
the Permitted Number shall be reduced by:
(1) the number of directors in office that will be included in the Company’s proxy materials with
respect to such annual general meeting for whom access to the Company’s proxy materials was previously
provided pursuant to this Bye-Law 10(3), other than any such director who at the time of such annual general
meeting will have served as a director continuously, as a nominee of the Board of Directors, for at least two (2)
successive annual terms; and
(2) the number of directors in office or director candidates that in either case will be included in the
Company’s proxy materials with respect to such annual general meeting as an unopposed (by the Company)
nominee pursuant to an agreement, arrangement or other understanding with a Shareholder or group of
Shareholders (other than any such agreement, arrangement or understanding entered into in connection with an
acquisition of Voting Stock, by such Shareholder or group of Shareholders, directly from the Company), other
than any such director referred to in this clause (2) who at the time of such annual general meeting will have
served as a director continuously, as a nominee of the Board of Directors, for at least two (2) successive annual
terms;
10

-- 69 of 111 --

provided, further, that in the event the Board of Directors resolves to reduce the size of the Board of Directors
effective on or prior to the date of the annual general meeting, the Permitted Number shall be calculated based on the
number of directors in office as so reduced. An Eligible Shareholder submitting more than one Shareholder Nominee
for inclusion in the Company’s proxy statement pursuant to this paragraph (C) of this Bye-Law 10(3) shall rank such
Shareholder Nominees based on the order that the Eligible Shareholder desires such Shareholder Nominees to be
selected for inclusion in the Company’s proxy statement and include such specified rank in its Proxy Access Notice. If
the number of Shareholder Nominees pursuant to this paragraph (C) of this Bye-Law 10(3) for an annual general
meeting of Shareholders exceeds the Permitted Number, then the highest ranking qualifying Shareholder Nominee
from each Eligible Shareholder will be selected by the Company for inclusion in the proxy statement until the
Permitted Number is reached, going in order of the amount (largest to smallest) of the ownership position as disclosed
in each Eligible Shareholder’s Proxy Access Notice. If the Permitted Number is not reached after the highest ranking
Shareholder Nominee from each Eligible Shareholder has been selected, this selection process will continue as many
times as necessary, following the same order each time, until the Permitted Number is reached.
Notwithstanding anything to the contrary contained in this Bye-Law 10(3), the Company shall not be required to
include any Shareholder Nominees in its proxy materials pursuant to this Bye-Law 10(3) for any meeting of
Shareholders for which the Secretary of the Company receives notice (whether or not subsequently withdrawn) that a
Shareholder intends to nominate one or more persons for election to the Board of Directors pursuant to the advance
notice requirements for Shareholder nominees set forth in Bye-Law 10(1).
(D) An “Eligible Shareholder” is one or more Shareholders of record who own and have owned, or are acting
on behalf of one or more beneficial owners who own and have owned, in each case continuously for at least three (3)
years as of both the date that the Proxy Access Notice is received by the Company pursuant to this Bye-Law 10(3),
and as of the record date for determining Shareholders eligible to vote at the annual general meeting, at least three
percent (3%) of the aggregate voting power of the Voting Stock (the “Proxy Access Request Required Shares”), and
who continue to own the Proxy Access Request Required Shares at all times between the date such Proxy Access
Notice is received by the Company and the date of the applicable annual general meeting, provided that the aggregate
number of Shareholders (and, if and to the extent that a Shareholder is acting on behalf of one or more beneficial
owners, of such beneficial owners) whose stock ownership is counted for the purpose of satisfying the foregoing
ownership requirement shall not exceed twenty (20).
Two or more collective investment funds that are (I) part of the same family of funds or sponsored by the same adviser
or (II) a “group of investment companies” as such term is defined in Section 12(d)(1)(G)(ii) of the Investment
Company Act of 1940 (a “Qualifying Fund”) shall be treated as one Shareholder for the purpose of determining the
aggregate number of Shareholders in this paragraph (D). For the avoidance of doubt, each fund included within a
Qualifying Fund must meet the requirements set forth in this Bye-Law 10(3), including by providing the required
information and materials.
No share may be attributed to more than one group constituting an Eligible Shareholder under this Bye-Law 10(3).
For the avoidance of doubt, no
11

-- 70 of 111 --

Shareholder may be a member of more than one group constituting an Eligible Shareholder.
A record holder acting on behalf of one or more beneficial owners will not be counted separately as a Shareholder
with respect to the shares owned by such beneficial owner(s). Each such beneficial owner will be counted separately
as a Shareholder with respect to the shares owned by such beneficial owner, subject to the other provisions of this
paragraph (D).
For the avoidance of doubt, Proxy Access Request Required Shares will qualify as such only if the beneficial owner of
such shares as of the date of the Proxy Access Notice has individually beneficially owned such shares continuously for
the three-year (3 year) period ending on that date and through the other applicable dates referred to above (in addition
to the other applicable requirements being met).
(E) On the date on which an Eligible Shareholder delivers a nomination pursuant to this Bye-Law 10(3),
such Eligible Shareholder (including each Constituent Holder) must provide the following information in writing to
the Secretary of the Company with respect to such Eligible Shareholder (and each Constituent Holder):
(1) the name and address of, and number of shares of Voting Stock owned by, such person;
(2) one or more written statements from the record holder of the shares (and from each intermediary
through which the shares are or have been held during the requisite three-year (3 year) holding period)
verifying that, as of a date within seven (7) calendar days prior to the date the Proxy Access Notice is delivered
to the Company, such person owns, and has owned continuously for the preceding three (3) years, the Proxy
Access Request Required Shares, and such person’s agreement to provide:
(a) within ten (10) days after the record date for the annual general meeting, written
statements from the record holder and intermediaries verifying such person’s continuous ownership of
the Proxy Access Request Required Shares through the record date, together with any additional
information reasonably requested by the Company to verify such person’s ownership of the Proxy
Access Request Required Shares; and
(b) immediate notice to the Company if the Eligible Shareholder ceases to own any of the
Proxy Access Request Required Shares prior to the date of the applicable annual general meeting of
Shareholders;
(3) the information that would be required to be submitted pursuant to paragraph (1)(d) of Bye-Law
10 for Director nominations;
(4) a description of all direct and indirect compensation and other material monetary agreements,
arrangements and understandings during the past three (3) years, and any other material relationships, between
or among the Eligible Shareholder (including any Constituent Holder) and its or their respective affiliates and
associates, or others acting in concert therewith, on the one hand, and each of such Eligible
12

-- 71 of 111 --

Shareholder’s Shareholder Nominees, and his or her respective affiliates and associates, or others acting in
concert therewith, on the other hand, including without limitation all information that would be required to be
disclosed pursuant to Rule 404 promulgated under Regulation S-K of the U.S. Securities and Exchange
Commission if the Eligible Shareholder (including any Constituent Holder), or any affiliate or associate
thereof or person acting in concert therewith, were the “registrant” for purposes of such rule and the
Shareholder Nominee or any affiliate or associate thereof or person acting in concert therewith were a director
or executive officer of such registrant;
(5) a representation that the Eligible Shareholder (and each Constituent Holder):
(a) acquired the Proxy Access Request Required Shares in the ordinary course of business and
not with the intent to change or influence control of the Company, and does not presently have any
such intent;
(b) has not nominated and will not nominate for election to the Board of Directors at the
annual general meeting any person other than the Shareholder Nominees being nominated pursuant to
this Bye-Law 10(3);
(c) has not engaged and will not engage in, and has not and will not be a “participant” in
another person’s, “solicitation” within the meaning of Rule 14a-1(l) under the Exchange Act in support
of the election of any individual as a director at the annual general meeting other than its Shareholder
Nominees or a nominee of the Board of Directors;
(d) will not distribute to any Shareholder any form of proxy for the annual general meeting
other than the form distributed by the Company; and
(e) will provide facts, statements and other information in all communications with the
Company and its Shareholders that are and will be true and correct in all material respects and do not
and will not omit to state a material fact necessary in order to make the statements made, in light of the
circumstances under which they were made, not misleading, and will otherwise comply with all
applicable laws, rules and regulations in connection with any actions taken pursuant to this Bye-Law
10(3) (and the other provisions of this Bye-Law 10 to the extent related to this Bye-Law 10(3));
(6) in the case of a nomination by a group of Shareholders that together is such an Eligible
Shareholder, the designation by all group members of one group member that is authorized to act on behalf of
all members of the nominating Shareholder group with respect to the nomination and matters related thereto,
including withdrawal of the nomination; and
13

-- 72 of 111 --

(7) an undertaking that the Eligible Shareholder (and each Constituent Holder) agrees to:
(a) assume all liability stemming from, and indemnify and hold harmless the Company and
each of its directors, officers, and employees individually against any liability, loss or damages in
connection with any threatened or pending action, suit or proceeding, whether legal, administrative or
investigative, against the Company or any of its directors, officers or employees arising out of any legal
or regulatory violation arising out of the communications of the Eligible Shareholder (and any
Constituent Holder) with the Shareholders of the Company or out of the information that the Eligible
Shareholder (and any Constituent Holder) provided to the Company in connection with the nomination
of the Shareholder Nominee(s) or efforts to elect the Shareholder Nominee(s); and
(b) file with the Securities and Exchange Commission any solicitation by the Eligible
Shareholder of Shareholders of the Company relating to the annual general meeting at which the
Shareholder Nominee will be nominated.
In addition, on the date on which an Eligible Shareholder delivers a nomination pursuant to this Bye-Law 10(3), any
Qualifying Fund whose stock ownership is counted for purposes of qualifying as an Eligible Shareholder must provide
to the Secretary of the Company documentation reasonably satisfactory to the Board of Directors that demonstrates
that the funds included within the Qualifying Fund satisfy the definition thereof.
In order to be considered timely, all information required by this paragraph (E) to be provided to the Company must
be supplemented, by delivery to the Secretary of the Company, to disclose such information (1) as of the record date
for the applicable annual general meeting and (2) as of the date that is no earlier than ten (10) days prior to such
annual general meeting. Any supplemental information delivered pursuant to clause (1) of the preceding sentence
must be delivered to the Secretary of the Company no later than ten (10) days following the record date for the
applicable annual general meeting, and any supplemental information delivered pursuant to clause (2) of the preceding
sentence must be delivered to the Secretary of the Company no later than the fifth day before the applicable annual
general meeting. For the avoidance of doubt, the requirement to update and supplement such information shall not
permit any Eligible Shareholder (or any Constituent Holder) or other person to change or add any proposed
Shareholder Nominee or be deemed to cure any defects or limit the remedies (including without limitation under these
Bye-Laws) available to the Company relating to any defect.
(F) The Eligible Shareholder may provide to the Secretary of the Company, at the time the information
required by this Bye-Law 10(3) is originally provided, a written statement for inclusion in the Company’s proxy
statement for the annual general meeting, not to exceed five hundred (500) words, in support of the candidacy of each
such Eligible Shareholder’s Shareholder Nominee (the “Statement”). Notwithstanding anything to the contrary
contained in this Bye-Law 10(3), the Company may omit from its proxy materials any information or Statement that
it, in good faith, believes is materially false or
14

-- 73 of 111 --

misleading, omits to state any material fact, or would violate any applicable law or regulation.
(G) On the date on which an Eligible Shareholder delivers a nomination pursuant to this Bye-Law 10(3),
each Shareholder Nominee must:
(1) provide to the Company an executed agreement, in a form deemed satisfactory by the Board of
Directors or its designee (which form shall be provided by the Company reasonably promptly upon written
request of a Shareholder), that such Shareholder Nominee consents to being named in the Company’s proxy
statement and form of proxy card (and will not agree to be named in any other person’s proxy statement or
form of proxy card with respect to the applicable annual general meeting of the Company) as a nominee and to
serving as a director of the Company if elected;
(2) provide the information with respect to a Shareholder Nominee that would be required to be
submitted pursuant to paragraph (1)(d) of Bye-Law 10 for Director nominations;
(3) complete, sign and submit all questionnaires, representations and agreements required by these
Bye-Laws or of the Company’s directors generally, including the questionnaire, representation and agreement
required by paragraph (4) of Bye-Law 8; and
(4) provide such additional information as necessary to permit the Board of Directors to determine if
such Shareholder Nominee:
(a) is independent under the listing standards of each principal U.S. exchange upon which the
Common Shares of the Company is listed, any applicable rules of the Securities and Exchange
Commission and any publicly disclosed standards used by the Board of Directors in determining and
disclosing the independence of the Company’s directors;
(b) has any direct or indirect relationship with the Company;
(c) would, by serving on the Board of Directors, violate or cause the Company to be in
violation of these Bye-Laws, the rules and listing standards of the principal U.S. exchange upon which
the Common Shares of the Company is listed or any applicable law, rule or regulation; and
(d) is or has been subject to any event specified in Item 401(f) of Regulation S-K (or
successor rule) of the Securities and Exchange Commission.
In the event that any information or communications provided by the Eligible Shareholder (or any Constituent Holder)
or the Shareholder Nominee to the Company or its Shareholders ceases to be true and correct in all material respects
or omits a material fact necessary to make the statements made, in light of the circumstances under which they were
made, not misleading, each Eligible Shareholder (or any Constituent Holder) or Shareholder Nominee, as the case
may
15

-- 74 of 111 --

be, shall promptly notify the Secretary of the Company of any defect in such previously provided information and of
the information that is required to correct any such defect; it being understood for the avoidance of doubt that
providing any such notification shall not be deemed to cure any such defect or limit the remedies (including without
limitation under these Bye-Laws) available to the Company relating to any such defect.
(H) Any Shareholder Nominee who is included in the Company’s proxy materials for a particular annual
general meeting of Shareholders but either (1) withdraws from or becomes ineligible or unavailable for election at that
annual general meeting (other than by reason of such Shareholder Nominee’s disability or other health reason), or (2)
does not receive at least twenty-five (25)% of the votes cast in favor of his or her election, will be ineligible to be a
Shareholder Nominee pursuant to this Bye-Law 10(3) for (x) such particular annual general meeting and (y) the next
two annual general meetings.
(I) The Company shall not be required to include, pursuant to this Bye-Law 10(3), a Shareholder Nominee in
its proxy materials for any annual general meeting of Shareholders, or, if the proxy statement already has been filed, to
permit a vote with respect to the election of a Shareholder Nominee, notwithstanding that proxies in respect of such
vote may have been received by the Company:
(1) who is not independent under the listing standards of the principal U.S. exchange upon which the
Common Shares of the Company is listed, any applicable rules of the U.S. Securities and Exchange
Commission and any publicly disclosed standards used by the Board of Directors in determining and
disclosing independence of the Company’s Directors, who does not meet the audit committee independence
requirements under the rules of any stock exchange on which the Company’s Common Shares are traded and
applicable securities laws, who is not a “non-employee director” for the purposes of Rule 16b-3 under the
Exchange Act (or any successor rule), who is not an “outside director” for the purposes of Section 162(m) of
the Internal Revenue Code of 1986, as amended (or any successor provision), in each of the foregoing cases as
determined by the Board of Directors in its sole discretion;
(2) whose service as a member of the Board of Directors would violate or cause the Company to be
in violation of these Bye-Laws, the rules and listing standards of the principal U.S. exchange upon which the
Common Shares of the Company is traded, or any applicable law, rule or regulation;
(3) who is or has been, within the past three years, an employee, officer or director of, or otherwise
affiliated with, a competitor, as defined in Section 8 of the Clayton Antitrust Act of 1914;
(4) who is or has been a named subject of a pending criminal proceeding (excluding non-criminal
traffic violations) or has been convicted in such a criminal proceeding within the past ten years, or who is or
has been a named subject of any legal, regulatory or self-regulatory proceeding, action or settlement as a result
of which the service of such Shareholder Nominee on the Board of Directors would result in any
16

-- 75 of 111 --

restrictions on the ability of any of the Company or its affiliates to conduct business in any jurisdiction;
(5) who is subject to any order of the type specified in Rule 506(d) of Regulation D promulgated
under the Securities Act;
(6) who shall have provided information to the Company in respect of such nomination that was
untrue in any material respect or omitted to state a material fact necessary in order to make the statement
made, in light of the circumstances under which they were made, not misleading, as determined by the Board
of Directors or any committee thereof, in each of the foregoing cases as determined by the Board of Directors
in its sole discretion;
(7) who otherwise breaches or fails to comply in any material respect with its obligations pursuant to
this Bye-Law 10(3) or any agreement, representation or undertaking required by these Bye-Laws; or
(8) was proposed by an Eligible Shareholder who ceases to be an Eligible Shareholder for any reason,
including but not limited to not owning the Proxy Access Request Required Shares through the date of the
applicable annual general meeting.
In addition, if any Constituent Holder (i) shall have provided information to the Company in respect of a nomination
under this Bye-Law 10(3) that was untrue in any material respect or omitted to state a material fact necessary in order
to make the statement made, in light of the circumstances under which they were made, not misleading, as determined
by the Board of Directors or any committee thereof, in each of the foregoing cases as determined by the Board of
Directors in its sole discretion or (ii) otherwise breaches or fails to comply in any material respect with its obligations
pursuant to this Bye-Law 10(3) or any agreement, representation or undertaking required by these Bye-Laws, the
Voting Stock owned by such Constituent Holder shall be excluded from the Proxy Access Request Required Shares
and, if as a result the Eligible Shareholder no longer meets the requirements as such, all of the applicable Eligible
Shareholder’s Shareholder Nominees shall be excluded from the Company’s proxy statement for the applicable annual
general meeting of Shareholders, if such proxy statement has not been filed, and, in any case, all of such Shareholder’s
Shareholder Nominees shall be ineligible to be nominated at such annual general meeting.
Notwithstanding anything contained herein to the contrary, no Shareholder Nominee shall be eligible to serve as a
Shareholder Nominee in any of the next two (2) successive annual general meetings following an act or omission
specified in clause (6) or (7) of this paragraph (I) by such person, in each case as determined by the Board of Directors
or any committee thereof in its sole discretion. In addition, no Person who has submitted materials as a purported
Eligible Shareholder (or Constituent Holder) under this Bye-Law 10(3), or any of its affiliates or associates, shall be
eligible to be an Eligible Shareholder (or Constituent Holder) in any of the next two (2) successive annual general
meetings following a nomination proposed under this Bye-Law 10(3) if, in connection therewith, such purported
Eligible Shareholder (or such Constituent Holder) shall have provided information to the Company in respect of such
nomination that was untrue in any material respect or omitted to state a material fact necessary in order to make the
statement made, in light of the circumstances under which they were
17

-- 76 of 111 --

made, not misleading, or shall have otherwise materially breached or failed to comply with its obligations pursuant to
this Bye-Law 10(3) or any agreement, representation or undertaking required by these Bye-Laws, in each case as
determined by the Board of Directors or any committee thereof in its sole discretion.
(4) General. As used in this Bye-Law 10, shares “beneficially owned” shall mean all shares as to which such Person,
together with such Person’s affiliates and associates (as defined in Rule 12b-2 under the Exchange Act), may be deemed to
beneficially own pursuant to Rules 13d-3 and 13d-5 under the Exchange Act, as well as all shares as to which such Person, together
with such Person’s affiliates and associates, has the right to become the beneficial owner pursuant to any agreement or understanding,
or upon the exercise of warrants, options or rights to convert or exchange (whether such rights are exercisable immediately or only
after the passage of time or the occurrence of conditions). The person presiding at the meeting shall determine whether such notice
has been duly given and shall direct that proposals and nominees not be considered if such notice has not been so given. For purposes
of this by-law, “public announcement” shall mean disclosure in a press release reported by the Dow Jones News Service, Associated
Press or comparable national news service or in a document publicly filed by the Company with the U.S. Securities and Exchange
Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act. In no event shall the public announcement of an adjournment
or postponement of an annual meeting or a special meeting commence a new time period for the giving of a Shareholder’s notice as
described above.
(5) The chairperson of the annual general meeting of Shareholders or special general meeting shall, if the facts warrant,
refuse to acknowledge a proposal or nomination not made in compliance with the foregoing procedure and any such proposal or
nomination not properly brought before the meeting shall not be considered.
11. Removal of Directors
(1) Subject to the rights of the holders of any class or series of preference shares, the Shareholders may remove a Director
before the stated expiry of his term only for Cause, and only by the affirmative vote of at least a majority of the votes cast by the
holders of shares of the Company entitled to vote generally on the election of Directors at an annual general or special general
meeting convened and held in accordance with these Bye-Laws for the purpose of such removal.
(2) Subject to the rights of the holders of any class or series of preference shares, a vacancy on the Board created by the
removal of a Director under the provisions of paragraph (1) of this Bye-Law 11 may be filled by the Shareholders at the meeting at
which such Director is removed, acting by the affirmative vote of at least a majority of the votes cast by the holders of shares of the
Company entitled to vote generally on the election of Directors, and, in the absence of such election or appointment, the Board may
fill the vacancy. A Director so elected or appointed shall hold office until the next annual general meeting of Shareholders.
(3) Subject to the rights of the holders of any class or series of preference shares, the Board may, at any meeting of the
Board convened and held in accordance with these Bye-Laws, remove a Director before the stated expiry of his term only for Cause
by a resolution of the Board carried by the affirmative vote of at least a two-thirds majority of the Board then in office.
12. Vacancies on the Board
(1) Subject to the rights of the holders of any class or series of preference shares, the Board shall have the power from time
to time and at any time to appoint any person as a Director
18

-- 77 of 111 --

to fill a vacancy on the Board occurring as the result of any of the events listed in paragraph (3) of this Bye-Law 12 or from an
increase in the size of the Board pursuant to Bye-Law 8. The Board shall also have the power from time to time to fill any vacancy
left unfilled at a general meeting. A Director appointed by the Board to fill a vacancy shall hold office until the next annual general
meeting of Shareholders.
(2) The Board may act notwithstanding any vacancy in its number but, if and so long as its number is reduced below the
number fixed by these Bye-Laws as the quorum necessary for the transaction of business at meetings of the Board, the continuing
Directors or Director may act, notwithstanding the absence of a quorum, for the purpose of (i) summoning a general meeting of the
Company or (ii) preserving the assets of the Company.
(3) The office of a Director shall be vacated if the Director:
(a) is removed from office pursuant to these Bye-Laws or is prohibited from being a Director by law;
(b) is or becomes bankrupt or makes any arrangement or composition with his creditors generally;
(c) is or becomes disqualified, disabled, of unsound mind, or dies; or
(d) resigns his or her office by notice in writing to the Company.
(4) Notwithstanding anything contained herein to the contrary, the provisions of Bye-Law 11, this Bye-Law 12 and all other
provisions contained in these Bye-Laws related to the filling of vacancies on the Board shall be subject to any contractual or other
legally binding obligation hereafter created by the Company and approved by the Board to provide any third party with the ability to
nominate persons for election as Directors.
13. Notice of Meetings of the Board
(1) The Chairperson may, and the Chairperson on the requisition of the Chief Executive Officer or a majority of the
Directors then in office shall, at any time, upon two days’ notice (or such shorter notice as may be reasonable under the
circumstances), summon a meeting of the Board.
(2) Notice of a meeting of the Board shall be deemed to be duly given to a Director if it is sent to such Director by mail,
courier service, facsimile, email or other mode of representing words in a legible form at such Director’s last known address or any
other address given by such Director to the Company for this purpose.
14. Quorum at Meetings of the Board
The quorum necessary for the transaction of business at a meeting of the Board shall be as fixed by the Board from time to
time and, unless so fixed at any other level, shall be at least one-half of the total number of the Directors then in office, present in
person or represented by a duly authorized representative appointed in accordance with the Act. The Directors present at a duly called
meeting at which a quorum is present may continue to transact business until adjournment or termination, notwithstanding the
withdrawal of enough Directors to leave less than a quorum.
19

-- 78 of 111 --

15. Meetings of the Board
(1) The Board may meet for the transaction of business, adjourn and otherwise regulate its meetings as it sees fit.
(2) Directors may participate in any meeting of the Board by means of such telephone, electronic or other communication
facilities as permit all persons participating in the meeting to communicate with each other simultaneously and instantaneously, and
participation in such a meeting shall constitute presence in person at such meeting.
(3) Unless otherwise provided in these Bye-Laws, a resolution put to the vote at a meeting of the Board shall be carried by
the affirmative votes of a majority of the Directors present.
16. Unanimous Written Resolutions
A resolution in writing signed by all of the Directors then in office, which may be in counterparts, shall be as valid as if it had
been passed at a meeting of the Board duly called and constituted, such resolution to be effective on the date on which the last
Director signs the resolution.
17. Contracts and Disclosure of Directors’ Interests
(1) Any Director, or any Director’s firm, partner or any company with whom any Director is associated, may act in any
capacity for, be employed by or render services to the Company and such Director or such Director’s firm, partner or company shall
be entitled to remuneration as if such Director were not a Director. Nothing herein contained shall authorize a Director or Director’s
firm, partner or company to act as Auditor to the Company.
(2) A Director who is directly or indirectly interested in a contract or proposed contract or arrangement with the Company
or any of its subsidiaries shall declare the nature of such interest to the Board or any duly appointed committee thereof, whether or
not such declaration is required by law.
(3) Following a declaration being made pursuant to this Bye-Law 17, and unless disqualified by the chairperson of the
relevant Board meeting or recused, a Director may vote in respect of any contract or proposed contract or arrangement in which such
Director is interested and may be counted in the quorum for such meeting.
18. Remuneration of Directors
The remuneration and benefits (if any) of the Directors shall be determined by the Board or any duly appointed committee
thereof in accordance with applicable law and securities exchange rules. The Directors may also be paid or reimbursed for all travel,
hotel and other expenses incurred by them in attending and returning from meetings of the Board, any committee appointed by the
Board, general or special meetings of the Company or in connection with the business of the Company or their duties as Directors
generally.
OFFICERS
19. Officers of the Company
The Officers of the Company, who may or may not be Directors, may be appointed at any time by the Board or by such other
persons as may be designated by the Board. Any person
20

-- 79 of 111 --

appointed pursuant to this Bye-Law 19 shall hold office for such period and upon such terms as the Board or, in the case of Officers
other than the Chief Executive Officer, as the Chief Executive Officer may determine and the Board (or the Chief Executive Officer
unless otherwise directed by the Board) may revoke or terminate any such appointment. Any such revocation or termination shall be
without prejudice to any claim for damages that such Officer may have against the Company or the Company may have against such
Officer for any breach of any contract of service between him and the Company which may be involved in such revocation or
termination.
20. Remuneration of Officers
The Officers shall receive such remuneration and benefits as the Board or any duly appointed committee thereof (or, in the
case of Officers who are not “executive officers” as defined under applicable Rules promulgated under the Exchange Act, as
management acting under authority duly delegated by the Board) may from time to time determine in accordance with applicable law
and securities exchange rules.
21. Duties of Officers
The Officers shall have such powers and perform such duties in the management, business and affairs of the Company as may
be delegated to them from time to time by the Board or, in the case of Officers other than the Chief Executive Officer, by the Chief
Executive Officer (or by any other Officer or employee of the Company acting, directly or indirectly, under his direction).
22. Chairperson and Secretary of Meetings
(1) The Chairperson shall act as chairperson at all meetings of the Shareholders and of the Board at which he or she is
present. In the Chairperson’s absence, the Chief Executive Officer or any other Director or Officer designated in writing by the
Chairperson, the Chief Executive Officer or a majority of the Board shall act as chairperson of the applicable meeting.
(2) The Secretary shall act as secretary at all meetings of the Shareholders and of the Board and any committee thereof at
which he or she is present. In the Secretary’s absence, a secretary shall be appointed by the chairperson of such meeting.
23. Register of Directors and Officers
The Board shall cause to be kept in one or more books at the registered office of the Company a Register of Directors and
Officers and shall enter therein the particulars required by the Act.
MINUTES
24. Obligations of Board to Keep Minutes
(1) The Board shall cause minutes to be duly entered in books provided for the purpose:
(a) of all elections and appointments of Officers;
(b) of the names of the Directors present at each meeting of the Board and of any committee appointed by the
Board; and
21

-- 80 of 111 --

(c) of all resolutions and proceedings of general meetings of the Shareholders, meetings of the Board and meetings
of committees appointed by the Board.
(2) Minutes prepared in accordance with the Act and these Bye-Laws shall be kept by the Secretary at the registered office
of the Company.
INDEMNITY
25. Indemnification and Exculpation of Directors of the Company and Others
(1) The Company shall indemnify in accordance with and to the full extent now or (if greater) hereafter permitted by
Bermuda law, each person who was or is a party or is threatened to be made a party to any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative (including, without limitation, an action by or in the right
of the Company) (hereinafter, a “proceeding”), by reason of the fact that he or she is or was a Director or Officer (or is or was a
director or officer of any subsidiary or any predecessor of the Company or any subsidiary) or is or was serving at the request of the
Company (or any subsidiary of the Company or any predecessor of the Company or any subsidiary) as a director, officer, employee
or agent of another corporation, partnership, joint venture, trust or other enterprise (or any predecessor of any of such entities),
including without limitation any service with respect to employee benefit plans maintained or sponsored by the Company (or any
subsidiary of the Company or any predecessor of the Company or any subsidiary), whether the basis of such proceeding is alleged
action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer,
employee or agent, against any liability or expense actually and reasonably incurred by such person in respect thereof. For the
avoidance of doubt, the indemnity provided in this Bye-Law 25 shall extend, without limitation, to any matter in which an
indemnified party may be guilty of negligence, default, breach of duty or breach of trust in relation to the Company or any of its
subsidiaries, but shall not extend to any matter as to which such indemnified party admits that he is guilty, or is found, by a court of
competent jurisdiction in a final judgment or decree not subject to appeal, guilty, of any fraud or dishonesty in relation to the
Company or any such subsidiary. In connection with the foregoing, the Company shall advance the expenses of Directors and
Officers in defending any such act, suit or proceeding; provided that such advancement shall be subject to reimbursement to the
extent such person shall be found not to be entitled to such advancement of expenses under Bermuda law. In addition to the
foregoing, the Company shall have the power, to the extent and in the manner permitted by Bermuda law, to indemnify each of its
other employees and agents against any liability or expense (including advancement of expenses) incurred in connection with any
proceeding arising by reason of the fact that such person is or was an employee or agent of the Company (or is or was an employee
or agent of any subsidiary or any predecessor of the Company or any subsidiary) or is or was serving at the request of the Company
(or any subsidiary of the Company or any predecessor of the Company or any subsidiary) as a director, officer, employee or agent of
another corporation, partnership, joint venture, trust or other enterprise (or any predecessor of any of such entities), including without
limitation any service with respect to employee benefit plans maintained or sponsored by the Company (or any subsidiary of the
Company or any predecessor of the Company or any subsidiary).
(2) The Board may authorize the Company to purchase and maintain insurance on behalf of any person who is or was a
Director, Officer, employee or agent of the Company, or is or was serving at the request of the Company as a Director, Officer,
employee or agent of another company, partnership, joint venture, trust or other enterprise, or in a fiduciary or other capacity with
respect to any employee benefit plan maintained by the Company (or any subsidiary of the Company or any predecessor of the
Company or any subsidiary), against any liability asserted against him and incurred by him in any such capacity, or arising out of his
22

-- 81 of 111 --

status as such, whether or not the Company would have the power to indemnify him against such liability under the provisions of this
Bye-Law 25.
(3) Directors, Officers and employees of the Company shall have no personal liability to the Company or its Shareholders
for any action or failure to act to the fullest extent now or (if greater) hereafter permitted by Bermuda law.
(4) The indemnification, expense reimbursement, exculpation and other provisions provided by this Bye-Law 25 shall not
be deemed exclusive of any other rights to which the persons identified in this Bye-Law 25 may be entitled under any bye-law,
agreement, vote of Shareholders or Directors or otherwise, both as to action in his official capacity and as to action in another
capacity while holding such office; shall continue as to a person who has ceased to be a Director, Officer, employee or agent and
shall inure to the benefit of the heirs, executors and administrators of such a person; and shall be deemed to be a contractual right of
such benefited Persons.
26. Waiver of Certain Claims
(1) Each present and future Shareholder agrees to waive any claim or right of action such Shareholder might have, whether
individually or by or in the right of the Company, against any Director, Officer or employee on account of any action taken by such
Director, Officer or employee, or the failure of such Director, Officer or employee to take any action, in the performance of his duties
with or for the Company (including, for the avoidance of doubt, with respect to the approval or disapproval of any transaction
between the Company and one or more of its Affiliates or the pursuit of corporate opportunities), in each case to the fullest extent
now or (if greater) hereafter permitted by Bermuda law.
(2) The provisions of this Bye-Law 26 shall apply to, and for the benefit of, any person acting as (or with the reasonable
belief that he or she will be appointed or elected as) a Director, Officer or employee in the reasonable belief that he or she has been
so appointed or elected notwithstanding any defect in such appointment or election and to any person who is no longer, but at one
time was, a Director, Officer or employee.
MEETINGS
27. Notice of Annual General Meeting of Shareholders
The annual general meeting of Shareholders shall be held in each year other than the year of incorporation at such time and
place as the Chairperson or the Chief Executive Officer may determine. At least 20 days’ notice of such meeting shall be given to
each Shareholder, stating the date, place and time at which the meeting is to be held, that the election of Directors will take place
thereat and such additional information as may be required by the Act.
28. Notice of Special General Meeting
Special general meetings may be called as specified in Bye-Law 10 upon not less than twenty days’ notice (or as otherwise
prescribed by the Act), which notice shall state the date, time, place and such additional information as may be required by the Act or
Bye-Law 10.
29. Accidental Omission of Notice of General Meeting
The accidental omission to give notice of a general meeting to, or the non-receipt of notice of a general meeting by, any
Person entitled to receive notice shall not invalidate the proceedings at that meeting.
23

-- 82 of 111 --

30. Short Notice
Subject to any applicable requirements of the New York Stock Exchange (or any other applicable stock exchange), a general
meeting of the Company shall, notwithstanding that it is called by shorter notice than that specified in these Bye-Laws, be deemed to
have been properly called if it is so agreed by (i) all of the Shareholders entitled to attend and vote thereat, in the case of an annual
general meeting of Shareholders or (ii) by a majority in number of the Shareholders having the right to attend and vote at the
meeting, being a majority together holding not less than 95% in nominal value of the shares giving a right to attend and vote thereat,
in the case of a special general meeting.
31. Postponement of Meetings
The Chairperson or the Chief Executive Officer may, and the Secretary on instruction from the Chairperson or the Chief
Executive Officer shall, postpone any general meeting called in accordance with the provisions of these Bye-Laws, provided that
notice of postponement is given to each Shareholder before the time for such meeting. Fresh notice of the date, time and place for the
postponed meeting shall be given to each Shareholder in accordance with the provisions of these Bye-Laws.
32. Quorum for General Meeting
At the commencement of any general meeting of the Company, two or more Persons present in person and representing in
person or by proxy more than fifty percent (50%) of the issued and outstanding shares entitled to vote at the meeting shall form a
quorum for the transaction of business, provided that, if the Company shall at any time have only one Shareholder, such one
Shareholder present in person or by proxy shall form a quorum for the transaction of business at any general meeting of the Company
held during such time. If the holders of the number of shares necessary to constitute a quorum shall fail to attend in person or by
proxy at the time and place fixed in accordance with these Bye-Laws for any annual or special general meeting, the chairperson or a
majority in interest of the Shareholders present, in person or by proxy, may adjourn from time to time without notice other than
announcement at the meeting until the holders of the amount of shares requisite to constitute a quorum shall attend; provided that in
the case of any such meeting convened pursuant to requisition of Shareholders, the meeting shall be cancelled. At any such adjourned
meeting at which a quorum shall be present, any business may be transacted which might have been transacted at the meeting as
originally notified. The Shareholders present at a duly called meeting at which a quorum is present may continue to transact business
until adjournment, notwithstanding the withdrawal of enough Shareholders to leave less than a quorum.
33. Adjournment of Meetings
(1) The chairperson of a general meeting may, with the consent of the majority of the Shareholders present at any general
meeting at which a quorum is present (and shall if so directed), adjourn the meeting. In addition, the chairperson may adjourn the
meeting to another time and place without such consent or direction if it appears to him that:
(a) it is likely to be impracticable to hold or continue that meeting because of the number of Shareholders wishing to
attend who are not present;
(b) the unruly conduct of persons attending the meeting prevents, or is likely to prevent, the orderly continuation of
the business of the meeting; or
24

-- 83 of 111 --

(c) an adjournment is otherwise in the best interests of the Company or is necessary so that the business of the
meeting may be properly conducted.
(2) Unless the meeting is adjourned to a specific date, place and time announced at the meeting being adjourned, fresh
notice of the date, place and time for the resumption of the adjourned meeting shall be given to each Shareholder entitled to attend
and vote thereat in accordance with the provisions of these Bye-Laws.
34. Attendance at Meetings
(1) If a majority of the Board shall so determine, Shareholders may participate in any general meeting by means of such
telephone, electronic or other communication facilities as permit all persons participating in the meeting to communicate with each
other simultaneously and instantaneously, and participation in such a meeting shall constitute presence in person at such meeting.
(2) The Board may, and at any general meeting the chairperson of such meeting may, make any arrangement and impose
any requirement or restriction as may be considered appropriate to ensure the security of a general meeting including, without
limitation, requirements for evidence of identity to be produced by those attending the meeting, the searching of their personal
property and the restriction of items that may be taken into the meeting place. The Board is, and at any general meeting the
chairperson of such meeting is, entitled to refuse entry to a person who refuses to comply with any such arrangements, requirements
or restrictions.
35. Written Resolutions
(1) Anything that may be done by resolution of the Company in a general meeting or by resolution of a meeting of any class
of the Shareholders of the Company may, without a meeting and without any previous notice being required, be done by resolution in
writing signed by all of the Shareholders who at the date of the resolution would be entitled to attend the meeting and vote on the
resolution, in as many counterparts as may be necessary.
(2) A resolution in writing made in accordance with this Bye-Law 35 is as valid as if it had been passed by the Company in
a general meeting or by a meeting of the relevant class of Shareholders, as the case may be, and any reference in any Bye-Law to a
meeting at which a resolution is passed or to Shareholders voting in favor of a resolution shall be construed accordingly.
(3) A resolution in writing made in accordance with this Bye-Law 35 shall constitute minutes for the purposes of the Act.
36. Attendance of Directors
The Directors of the Company shall be entitled to receive notice of and to attend any general meeting.
37. Voting at Meetings
Subject to the provisions of the Act and except as otherwise provided under these Bye-Laws, any question proposed for the
consideration of the Shareholders at any general meeting shall be decided by the affirmative votes of a majority of the votes cast in
accordance with the provisions of these Bye-Laws and, in the case of an equality of votes, the resolution shall fail.
25

-- 84 of 111 --

38. Voting by Hand or by Poll
(1) At any general meeting, a resolution put to the vote of the meeting shall be decided on a show of hands or by a count of
votes received in the form of electronic records, unless (before or on the declaration of the result of the show of hands or count of
votes received as electronic records or on the withdrawal of any other demand for a poll) a poll is demanded by:
(a) the chairman of the meeting or a majority of the Board; or
(b) at least three (3) Shareholders present in person or represented by proxy; or
(c) any Shareholder or Shareholders present in person or represented by proxy and holding between them not less
than one tenth (1/10) of the total voting rights of all the Shareholders having the right to vote at such meeting; or
(d) any Shareholder or Shareholders present in person or represented by proxy holding shares conferring the right to
vote at such meeting, being shares on which an aggregate sum has been paid up equal to not less than one tenth (1/10) of the total
sum paid up on all such shares conferring such right.
(2) The demand for a poll may, before the poll is taken, be withdrawn but only with the consent of the chairman and a
demand so withdrawn shall not be taken to have invalidated the result of a show of hands or count of votes received as electronic
records declared before the demand was made. If the demand for a poll is withdrawn, the chairman or any other Shareholder entitled
may demand a poll.
(3) Unless a poll is so demanded and the demand is not withdrawn, a declaration by the chairman that a resolution has, on a
show of hands or count of votes received as electronic records, been carried or carried unanimously or by a particular majority or not
carried by a particular majority or lost shall be final and conclusive, and an entry to that effect in the minute book of the Company
shall be conclusive evidence of the fact without proof of the number or proportion of votes recorded for or against such resolution.
(4) If a poll is duly demanded, the result of the poll shall be deemed to be the resolution of the meeting at which the poll is
demanded.
(5) A poll demanded on a question of adjournment shall be taken forthwith. A poll demanded on any other question shall be
taken in such manner consistent with the Act as the chairman shall direct.
(6) The demand for a poll shall not prevent the continuance of a meeting for the transaction of any business other than the
question on which the poll has been demanded and it may be withdrawn at any time before the close of the meeting or the taking of
the poll, whichever is the earlier.
(7) On a poll, votes may be cast either personally or by proxy.
(8) A Person entitled to more than one vote on a poll need not use all his votes or cast all the votes he uses in the same way.
(9) Where a vote is taken by poll, each Person present and entitled to vote shall be furnished with a ballot paper on which
such Person shall record his or her vote in such manner as shall be determined at the meeting having regard to the nature of the
question on which the vote
26

-- 85 of 111 --

is taken, and each ballot paper shall be signed or initialed or otherwise marked so as to identify the voter and the registered holder in
the case of a proxy.
(10) At the conclusion of any poll, the ballot papers shall be examined and counted by a committee of one or more
inspectors appointed by the Board or the Chief Executive Officer of the Company prior to the general meeting to act at such meeting
as provided hereunder and to make a written report thereof. If no inspector (or any alternate previously designated by the Board or
the Chief Executive Officer) is able to act at the meeting, the chairperson of the meeting shall appoint one or more inspectors to act at
the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully to execute
the duties of inspector with strict impartiality and according to the best of his or her ability. In connection with the applicable poll,
the inspectors shall ascertain the number of shares outstanding and the voting power of each, determine the shares represented at the
meeting and the validity of proxies and ballots, count all votes and ballots, determine and retain for a reasonable period a record of
the disposition of any challenges made to any determination by the inspectors and certify their determination of the number of shares
represented at the meeting and their count of all votes and ballots. The inspectors may appoint or retain other persons to assist them
in the performance of their duties. The date and time of the opening and closing of the polls during the meeting for each matter upon
which the Shareholders will vote by poll at a meeting shall be announced at the meeting. No ballot, proxy or vote, nor any revocation
thereof or change thereto, shall be accepted by the inspectors after the closing of the polls. In determining the validity and counting
of proxies and ballots, the inspectors shall be limited to an examination of (i) the proxies, any envelopes submitted therewith, any
information provided by a Shareholder who submits a proxy by telegram, cablegram or other electronic transmission from which it
can be determined that the proxy was authorized by the Shareholder and (ii) the ballots and (iii) the regular books and records of the
Company.
In addition, the inspectors may also consider other reliable information for the limited purpose of reconciling proxies and
ballots submitted by or on behalf of banks, brokers, their nominees or similar Persons which represent more votes than the holder of
a proxy is authorized by the record owner to cast or more votes than the Shareholder holds of record. If the inspectors consider such
other reliable information for such purpose, they shall, at the time they make their certification, specify the precise information
considered by them, including the Person or Persons from whom they obtained the information, when the information was obtained,
the means by which the information was obtained and the basis for the inspectors’ belief that such information is accurate and
reliable.
39. Decision of Chairperson
(1) At any general meeting if an amendment shall be proposed to any resolution under consideration and the chairperson of
the meeting shall rule on whether the proposed amendment is out of order, the proceedings on the substantive resolution shall not be
invalidated by any error in such ruling.
(2) At any general meeting a declaration by the chairperson of the meeting that a question proposed for consideration has
been carried, or carried unanimously, or by a particular majority, or lost, and an entry to that effect in a book containing the minutes
of the proceedings of the Company shall be conclusive evidence of that fact.
40. Instrument of Proxy
(1) Every Shareholder entitled to vote has the right to do so either in person or by one or more persons authorized by a
proxy executed and delivered in accordance with these Bye-Laws.
27

-- 86 of 111 --

(2) A person so authorized as a proxy shall be entitled to exercise the same power on behalf of the grantor of the proxy as
the grantor could exercise at a general meeting of the Company.
(3) No proxy shall be valid after eleven months from its date, unless the proxy provides for a longer period. A proxy shall be
revocable unless expressly provided therein to be irrevocable and the proxy is coupled with an interest sufficient in law to support an
irrevocable power.
(4) Subject to paragraph (3) of this Bye-Law 40, the instrument appointing a proxy, together with such other evidence as to
its due execution as the Board may from time to time require, shall be delivered at the registered office of the Company (or at such
place or places as may be specified in the notice convening the meeting or in any notice of any adjournment or, in either case, in any
document sent therewith) prior to the holding of the relevant meeting or adjourned meeting at which the individual named in the
instrument proposes to vote and, if not so delivered, the instrument of proxy shall not be treated as valid.
(5) Instruments of proxy shall be in such form as the Board may approve (including, without limitation, written or
electronic form) and the Board may, if it thinks fit, send out with the notice of any meeting forms of instruments of proxy for use at
the meeting. The instrument of proxy shall be deemed to confer authority to vote on any amendment of a resolution put to the
meeting for which it is given as the proxy thinks fit. The instrument of proxy shall, unless the contrary is stated therein, be valid as
well for any adjournment of the meeting as for the meeting to which it relates.
(6) A vote given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the death or
unsoundness of mind of the principal subsequent to giving the proxy but before the vote or revocation of the instrument of proxy or
of the authority under which it was executed.
(7) The decision of the chairperson of any general meeting as to the validity of any appointment of a proxy shall be final.
41. Representation of Corporations at Meetings
A corporation or other Person that is not an individual that is a Shareholder may, by written instrument, authorize any person
as it thinks fit to act as its representative at any meeting of the Shareholders or for all meetings of the Shareholders or for all meetings
of the Shareholders for a certain or determinable period or until revocation and such person so authorized shall be entitled to exercise
the same powers on behalf of such corporation or other such Person as such corporation or other such Person could exercise if it were
an individual Shareholder and such corporation or other such Person shall be deemed to be present in person as a Shareholder at any
such meeting attended by its authorized representative or representatives. Notwithstanding the foregoing, the chairperson of the
meeting may accept such assurances as he or she thinks fit as to the right of any person to attend and vote at general meetings on
behalf of a corporation or other such Person that is a Shareholder.
VOTES OF SHAREHOLDERS
42. General
Subject to the rights of the holders of any class or series of preference shares, at any general meeting of the Company, each
Shareholder present in person shall be entitled to one vote on any question to be decided on a show of hands and each Shareholder
present in person or by
28

-- 87 of 111 --

proxy shall be entitled on a poll to one vote for each share held by him in his name in the Register of Shareholders.
SHARE CAPITAL AND SHARES
43. Share Capital
The authorised share capital of the Company is 1,070,000,000 divided into 1,050,000,000 common shares of par value $0.20
each (“Common Shares”) and 20,000,000 undesignated shares of par value $0.20 each, which may be issued, without any prior
Shareholder approval, as Common Shares or Preference Shares (“Undesignated Shares”).
44. Rights of Shares
(1) Common Shares
The Common Shares shall, subject to the other provisions of these Bye-Laws, entitle the holders thereof to the following
rights:
(a) as regards dividend: after making all necessary provisions, where relevant, for payment of any preferred
dividend in respect of any preference shares in the Company then outstanding, the Company shall apply any profits or reserves which
the Board resolves to distribute in paying such profits or reserves to the holders of the Common Shares in respect of their holding of
such shares pari passu and pro rata to the number of Common Shares held by each of them;
(b) as regards capital: on a return of assets on liquidation, reduction of capital or otherwise, the holders of the
Common Shares shall be entitled to be paid the surplus assets of the Company remaining after payment of its liabilities (subject to
the rights of holders of any preference shares in the Company then in issue having preferred rights on the return of capital) in respect
of their holdings of Common Shares pari passu and pro rata to the number of Common Shares held by each of them;
(c) as regards voting in general meetings: the holders of the Common Shares shall be entitled to receive notice of,
and to attend and vote at, general meetings of the Company; every holder of Common Shares present in person or by proxy shall on a
poll have one vote for each Common Share held by him.
(2) Undesignated Shares
The rights attaching to the Undesignated Shares, subject to these Bye-Laws, shall be as follows:
(a) each Undesignated Share shall have attached to it such preferred, qualified or other special rights, privileges and
conditions and be subject to such restrictions, whether in regard to dividend, return of capital, redemption, conversion into Common
Shares or voting or otherwise, as the Board may determine on or before its allotment;
(b) the Board may allot the Undesignated Shares in more than one series and, if it does so, may name and designate
each series in such manner as it deems appropriate to reflect the particular rights and restrictions attached to that series, which may
differ in all or any respects from any other series of Undesignated Shares;
29

-- 88 of 111 --

(c) the particular rights and restrictions attached to any Undesignated Shares shall be recorded in a resolution of the
Board. The Board may at any time before the allotment of any Undesignated Share by further resolution in any way amend such
rights and restrictions or vary or revoke its designation. A copy of any such resolution or amending resolution for the time being in
force shall be annexed as an appendix to (but shall not form part of) these Bye-Laws; and
(d) the Board shall not attach to any Undesignated Share any rights or restrictions which would alter or abrogate any
of the special rights attached to any other class of series of shares for the time being in issue without such sanction as is required for
any alteration or abrogation of such rights, unless expressly authorised to do so by the rights attaching to or by the terms of issue of
such other class or series.
(3) Preference Shares
Without limiting the foregoing and subject to the Act, the Company may issue preference shares (“Preference Shares”)
without any prior Shareholder approval which:
(a) are liable to be redeemed on the happening of a specified event or events or on a given date or dates and/or;
(b) are liable to be redeemed at the option of the Company and/or, if authorised by the Memorandum of Association
of the Company, at the option of the holder.
The terms and manner of the redemption of any redeemable shares created pursuant to this Bye-Law 44(3) shall be as the
Board may by resolution determine. The terms of any redeemable preference shares may provide for the whole or any part of the
amount due on redemption to be paid or satisfied otherwise than in cash, to the extent permitted by the Act.
In addition, subject to any special rights conferred on the holders of any share or class of shares, any Preference Shares may
be issued with or have attached thereto such preferred, deferred, qualified or other special rights or such restrictions, whether in
regard to dividend, voting, return of capital or otherwise, as the Board may determine pursuant to Bye-Law 44(2).
(4) The Board may, at its discretion and without the sanction of a resolution of the Shareholders, authorise the purchase or
acquisition by the Company of its own shares, of any class, at any price (whether at par or above or below par), and any shares to be
so purchased or acquired may be selected in any manner whatsoever, upon such terms as the Board may in its discretion determine,
provided always that such purchase or acquisition is effected in accordance with the provisions of the Act. The whole or any part of
the amount payable on any such purchase may be paid or satisfied otherwise than in cash, to the extent permitted by the Act. Any
shares acquired may be held as treasury shares in accordance with and subject to the Act.
45. Modification of Rights
(1) Subject to the Act, all or any of the special rights attached to any class of (i) common shares issued may from time to
time (whether or not the Company is being wound up) be altered or abrogated with the sanction of a resolution passed with the
approval of a majority of the votes cast by the holders of the issued shares of that class at a separate general meeting of the holders of
such shares voting in person or by proxy and (ii) preference shares issued may from time to time (whether or not the Company is
being wound up) be altered or abrogated with the consent in writing of the holders of not less than three-quarters of the issued shares
of that class or with the sanction of a resolution passed by the holders of not less than three-quarters of the
30

-- 89 of 111 --

issued shares of that class at a separate general meeting of the holders of such shares voting in person or by proxy.
(2) For the purposes of this Bye-Law, unless otherwise expressly provided by the rights attached to any shares or class of
shares, those rights attaching to any class of shares for the time being shall not be deemed to be altered by:
(a) the creation or issue of further shares ranking pari passu with them;
(b) the creation or issue for full value (as determined by the Board) of further shares ranking as regards participation
in the profits or assets of the Company or otherwise in priority to them; or
(c) the purchase or redemption by the Company of any of its own shares.
46. Shares
(1) Subject to the provisions of these Bye-Laws, the unissued shares of the Company (whether forming part of the original
capital or any increased capital) shall be at the disposal of the Board, which may offer, allot, grant options over or otherwise dispose
of them to such Persons, at such times and for such consideration and upon such terms and conditions as the Board may determine.
(2) Subject to the provisions of these Bye-Laws, any shares of the Company held by the Company as treasury shares shall
be at the disposal of the Board, which may hold all or any of the shares, dispose of or transfer all or any of the shares for cash or
other consideration, or cancel all or any of the shares.
(3) The Board may in connection with the issue of any shares exercise all powers of paying commission and brokerage
conferred or permitted by law. Subject to the provisions of the Act, any such commission or brokerage may be satisfied by the
payment of cash or by the allotment of fully or partly paid shares or partly in one way and partly in the other.
(4) Shares may be issued in fractional denominations and in such event the Company shall deal with such fractions to the
same extent as its whole shares, so that a share in a fractional denomination shall have, in proportion to the fraction of a whole share
that it represents, all the rights of a whole share, including (but without limiting the generality of the foregoing) the right to vote, to
receive dividends and distributions and to participate in a winding-up.
47. Registered Holder of Shares
(1) The Company shall be entitled to treat the registered holder of any share as the absolute owner thereof and, accordingly,
shall not be bound to recognize any equitable or other claim to, or interest in, such share on the part of any other Person.
(2) Any dividend, interest or other moneys payable in cash in respect of shares may be paid by check or draft sent through
the post directed to the Shareholder at such Shareholder’s address as recorded in the Register of Shareholders or, in the case of joint
holders, to such address of the holder first named in the Register of Shareholders, or (subject to applicable law) to such Person and to
such address as such holder or joint holders may in writing direct. If two or more Persons are registered as joint holders of any
shares, anyone can give an effectual receipt for any dividend paid in respect of such shares.
31

-- 90 of 111 --

48. Death of a Joint Holder
Where two or more Persons are registered as joint holders of a share or shares then, in the event of the death of any joint
holder or holders, the remaining joint holder or holders shall be absolutely entitled to such share or shares and the Company shall
recognize no claim in respect of the estate of any joint holder except in the case of the last survivor of such joint holders.
49. Share Certificates
(1) Every Shareholder shall be entitled to a certificate under the seal of the Company (or a facsimile thereof) specifying the
number and, where appropriate, the class or series of shares held by such Shareholder and whether the same are fully paid up and, if
not, how much has been paid thereon. The Company may determine, either generally or in a particular case, that any or all signatures
on certificates may be printed thereon or affixed by mechanical means. Notwithstanding Bye-Law 76, the Company may determine
that a share certificate need not be signed on behalf of the Company or that the seal of the Company need not be attested.
(2) The Company shall be under no obligation to complete and deliver a share certificate unless specifically called upon to
do so by the Person to whom such shares have been allotted.
(3) If any such certificate shall be proved to the satisfaction of the Company to have been worn out, lost, mislaid or
destroyed, the Company may cause a new certificate to be issued and request an indemnity for the lost certificate if it sees fit.
50. Calls on Shares
(1) The Board may from time to time make such calls as it thinks fit upon the Shareholders in respect of any monies unpaid
on the shares allotted to or held by such Shareholders and, if a call is not paid on or before the day appointed for payment thereof, the
Shareholder may, at the discretion of the Board, be liable to pay the Company interest on the amount of such call at such rate as the
Board may determine, from the date when such call was payable up to the actual date of payment. The joint holders of a share shall
be jointly and severally liable to pay all calls in respect thereof.
(2) The Board may, on the issue of shares, differentiate between the holders as to the amount of calls to be paid and the
times of payment of such calls.
(3) Any sum that, by the terms of allotment of a share, becomes payable upon issue or at any fixed date, whether on account
of the nominal value of the share or by way of premium, shall for all of the purposes of these Bye-Laws be deemed to be a call duly
made and payable, on the date on which, by the terms of issue, the same becomes payable and, in case of non-payment, all of the
relevant provisions of these Bye-Laws as to payment of interest, costs, charges and expenses, forfeiture or otherwise shall apply as if
such sum had become payable by virtue of a call duly made and notified.
(4) The Company may accept from any Shareholder the whole or a part of the amount remaining unpaid on any shares held
by him, although no part of that amount has been called up.
51. Forfeiture of Shares
(1) If any Shareholder fails to pay, on the day appointed for payment thereof, any call in respect of any share allotted to or
held by such Shareholder, the Board may, at any time
32

-- 91 of 111 --

thereafter during such time as the call remains unpaid, direct the Secretary to forward to such Shareholder a notice in a form to be
determined by the Company.
(2) If the requirements of such notice are not complied with, any such share may at any time thereafter before the payment
of such call and the interest due in respect thereof be forfeited by a resolution of the Board to that effect, and such share shall
thereupon become the property of the Company and may be disposed of as the Board shall determine.
(3) A Shareholder whose share or shares have been forfeited as aforesaid shall, notwithstanding such forfeiture, be liable to
pay to the Company all calls owing on such share or shares at the time of the forfeiture and all interest due thereon.
(4) The Board may accept the surrender of any shares that it is in a position to forfeit on such terms and conditions as may
be agreed. Subject to those terms and conditions, a surrendered share shall be treated as if it has been forfeited.
INTERESTED SHAREHOLDERS
52. Limitations on Business Combinations
Notwithstanding anything contained herein to the contrary, the Company shall not engage in any Business Combination with
any Interested Shareholder for a period of 3 years following the time that such Shareholder became an Interested Shareholder, unless:
(a) prior to such time the Board approved either the Business Combination or the transaction which resulted in the Shareholder
becoming an Interested Shareholder; (b) upon consummation of the transaction which resulted in the Shareholder becoming an
Interested Shareholder, the Interested Shareholder Beneficially Owned at least 85% of the total voting stock of the Company
outstanding at the time the transaction commenced, excluding for purposes of determining the total voting stock outstanding (but not
the outstanding voting stock Beneficially Owned by the Interested Shareholder) those shares Beneficially Owned (i) by persons who
are Directors and also Officers and (ii) employee stock plans in which employee participants do not have the right to determine
confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or (c) at or subsequent to such
time the Business Combination is approved by the Board and authorized at an annual general meeting or special general meeting of
Shareholders, and not by written consent, by the affirmative vote of at least a majority of the votes cast by holders of shares that are
not Beneficially Owned by the Interested Shareholder.
53. Certain Definitions
(1) “Associate” has the meaning ascribed to such term in Rule 12b-2 of the Exchange Act.
(2) As used in Bye-Laws 52-53, a Person shall be deemed the “Beneficial Owner” of and shall be deemed to “beneficially
own” any securities:
(a) which such Person or any of such Person’s Affiliates or Associates beneficially owns, directly or indirectly;
(b) which such Person or any of such Person’s Affiliates or Associates has (i) the right to acquire (whether such right
is exercisable immediately or only after the passage of time) pursuant to any agreement, arrangement or understanding (other than
customary agreements with and between underwriters and selling group members with respect to a bona fide public offering of
securities), or upon the exercise of conversion rights, exchange rights, rights, warrants or options, or otherwise; provided, however,
that a Person shall not be deemed
33

-- 92 of 111 --

the Beneficial Owner of, or to beneficially own, securities tendered pursuant to a tender or exchange offer made by or on behalf of
such Person or any of such Person’s Affiliates or Associates until such tendered securities are accepted for purchase or exchange; or
(ii) the right to vote pursuant to any agreement, arrangement or understanding; provided, however, that a Person shall not be deemed
the Beneficial Owner of, or to beneficially own, any security if the agreement, arrangement or understanding to vote such security (x)
arises solely from a revocable proxy or consent given to such Person in response to a public proxy or consent solicitation made
pursuant to, and in accordance with, the applicable rules and regulations promulgated under the Exchange Act and (y) is not also then
reportable on Schedule 13D under the Exchange Act; or
(c) which are beneficially owned, directly or indirectly, by any other Person with which such Person or any of such
Person’s Affiliates or Associates has any agreement, arrangement or understanding (other than customary agreements with and
between underwriters and selling group members with respect to a bona fide public offering of securities) for the purpose of
acquiring, holding, voting (except to the extent contemplated by the proviso to clause (ii) of the preceding subsection (b)) or
disposing of any securities of the Company.
(d) Notwithstanding anything in this definition of Beneficial Ownership to the contrary, the phrase “then
outstanding,” when used with reference to a Person’s Beneficial Ownership of securities of the Company, shall mean the number of
such securities then issued and outstanding together with the number of such securities not then actually issued and outstanding
which such Person would be deemed to own beneficially hereunder.
(3) “Business Combination” means any:
(a) merger, amalgamation, scheme of arrangement or consolidation of the Company or any direct or indirect
majority-owned subsidiary of the Company with (i) the Interested Shareholder, or (ii) with any other corporation, partnership,
unincorporated association or other entity if the merger or consolidation is caused by the Interested Shareholder;
(b) sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of
transactions), except proportionately as a Shareholder, to or with the Interested Shareholder, whether as part of a dissolution or
otherwise, of assets of the Company or of any direct or indirect majority-owned subsidiary of the Company which assets have an
aggregate market value equal to 10% or more of either the aggregate market value of all the assets of the Company determined on a
consolidated basis or the aggregate market value of all the outstanding stock of the Company;
(c) transaction which results in the issuance or transfer by the Company or by any direct or indirect majority-owned
subsidiary of the Company of any stock of the Company or of such subsidiary to the Interested Shareholder, except (i) Pursuant to
the exercise, exchange or conversion of securities exercisable for, exchangeable for or convertible into stock of such corporation or
any such subsidiary which securities were outstanding prior to the time that the Interested Shareholder became such, (ii) pursuant to a
dividend or distribution paid or made, or the exercise, exchange or conversion of securities exercisable for, exchangeable for or
convertible into stock of such corporation or any such subsidiary which security is distributed, pro rata to all holders of a class or
series of stock of such corporation subsequent to the time the Interested Shareholder became such; (iii) pursuant to an exchange offer
by the Company to purchase stock made on the same terms to all holders of said stock; or (iv) any issuance or transfer of stock by the
Company; provided however, that in no case under items (i)-(iv) of this subparagraph shall there be an increase in the Interested
Shareholder’s proportionate share of the stock of any class or series of the Company or of the voting stock of the Company;
34

-- 93 of 111 --

(d) transaction involving the Company or any direct or indirect majority-owned subsidiary of the Company which
has the effect, directly or indirectly, of increasing the proportionate share of the stock of any class or series, or securities convertible
into the stock of any class or series, of the Company or of any such subsidiary which is Beneficially Owned by the Interested
Shareholder, except as a result of immaterial changes due to fractional share adjustments or as a result of any purchase or redemption
of any shares of stock not caused, directly or indirectly, by the Interested Shareholder; or
(e) receipt by the Interested Shareholder of the benefit, directly or indirectly (except proportionately as a
Shareholder of such corporation), of any loans, advances, guarantees, pledges or other financial benefits (other than those expressly
permitted in subparagraphs (a)-(d) of this paragraph) provided by or through the Company or any direct or indirect majority-owned
subsidiary.
(4) “Interested Shareholder” means any Person (other than the Company and any direct or indirect majority-owned
subsidiary of the Company) that (i) is the Beneficial Owner of 15% or more of the outstanding voting stock of the Company, or (ii) is
an Affiliate or Associate of the Company and was the Beneficial Owner of 15% or more of the outstanding voting stock of the
Company at any time within the 3-year period immediately prior to the date on which it is sought to be determined whether such
Person is an Interested Shareholder, and the Affiliates and Associates of such Person; provided, however, that the term “Interested
Shareholder” shall not include (x) any Person who becomes an Interested Shareholder inadvertently and (i) as soon as practicable
divests itself of Beneficial Ownership of sufficient shares so that the Shareholder ceases to be an Interested Shareholder and (ii)
would not, at any time within the 3-year period immediately prior to a Business Combination between the Company and such
Shareholder, have been an Interested Shareholder but for the inadvertent acquisition of ownership; or (y) any Person whose
Beneficial Ownership of shares in excess of the 15% limitation set forth herein is the result of action taken solely by the Company;
provided that such Person shall be an Interested Shareholder if thereafter such Person acquires additional shares of voting stock of
the Company, except as a result of further corporate action not caused, directly or indirectly, by such Person; provided further that no
savings, profit sharing, stock bonus or employee stock ownership plan or plans established or sponsored by the Company (or any
subsidiary of the Company or any predecessor of the Company or any subsidiary) and qualified under Section 401(a) of the Internal
Revenue Code of 1986, as amended, or any comparable provisions of any non-U.S. law, which holds Common Shares on behalf of
participating employees and their beneficiaries with the right to instruct the trustee how to vote such Common Shares with respect to
all matters submitted to Shareholders shall not be deemed to be an “Interested Shareholder.”
REGISTER OF SHAREHOLDERS
54. Contents of Register of Shareholders
The Board shall cause to be kept in one or more books a Register of Shareholders and shall enter therein the particulars
required by the Act.
55. Inspection of Register of Shareholders
The Register of Shareholders shall be open to inspection at the registered office of the Company on every Business Day,
subject to such reasonable restrictions as the Company may impose, so that not less than two hours in each Business Day be allowed
for inspection. The Register of Shareholders may, after notice has been given by advertisement in an appointed newspaper to that
effect, be closed for any time or times not exceeding in the whole thirty days in each year.
35

-- 94 of 111 --

56. Determination of Record Dates
Notwithstanding any other provision of these Bye-Laws, the Board may fix any date as the record date for:
(a) determining the Shareholders entitled to receive any dividend or distribution; and
(b) determining the Shareholders entitled to receive notice of and to vote at any general meeting of the Company.
TRANSFER OF SHARES
57. Instrument of Transfer
(1) Subject to paragraph (4) of Bye-Law 58, an instrument of transfer shall be in a form to be determined by the Company.
Such instrument of transfer shall be signed by or on behalf of the transferor and transferee, provided that, in the case of a fully paid
share, the Company may accept the instrument signed by or on behalf of the transferor alone. The transferor shall be deemed to
remain the holder of such share until the same has been transferred to the transferee in the Register of Shareholders.
(2) The Company may refuse to recognize any instrument of transfer unless it is accompanied by the certificate in respect of
the shares to which it relates and by such other evidence as the Company may reasonably require to show the right of the transferor
to make the transfer.
58. Restrictions on Transfer
(1) Unless otherwise required by any applicable requirements of the New York Stock Exchange (or any other applicable
stock exchange), the Company (i) may decline to approve or to register any transfer of any share if a written opinion from counsel
acceptable to the Company shall not have been obtained to the effect that registration of such shares under the U.S. Securities Act of
1933, as amended, is not required and (ii) shall decline to approve or to register any transfer of any share if the transferee shall not
have been approved by applicable governmental authorities if such approval is required or if not in compliance with applicable
consent, authorization or permission of any governmental body or agency in Bermuda.
(2) If the Company refuses to register a transfer of any share, the Secretary shall send, or procure that there shall be sent,
within one month after the date on which the transfer was lodged with the Company, to the transferor and transferee notice of the
refusal.
(3) The registration of transfers may be suspended at such times and for such periods as the Company may from time to
time determine, provided always that such registration shall not be suspended for more than 45 days in any year.
(4) Shares may be transferred without a written instrument if transferred by an appointed agent or otherwise in accordance
with the Act.
TRANSMISSION OF SHARES
59. Representative of Deceased Shareholder
In the case of the death of a Shareholder, the survivor or survivors where the deceased Shareholder was a joint holder, and the
legal personal representatives of the deceased
36

-- 95 of 111 --

Shareholder where the deceased Shareholder was a sole holder, shall be the only persons recognized by the Company as having any
title to the deceased Shareholder’s interest in the shares. Nothing herein contained shall release the estate of a deceased joint holder
from any liability in respect of any share that had been jointly held by such deceased Shareholder with other persons. Subject to the
provisions of the Act, for the purpose of this Bye-Law 59, “legal personal representative” means the executor or administrator of a
deceased Shareholder or such other Person as the Company may decide as being properly authorized to deal with the shares of a
deceased Shareholder.
60. Registration on Death or Bankruptcy
Any Person becoming entitled to a share in consequence of the death or bankruptcy of any Shareholder may be registered as a
Shareholder upon such evidence as the Company may deem sufficient or may elect to nominate another Person to be registered as a
transferee of such share, and in such case such Person becoming entitled shall execute in favor of such nominee an instrument of
transfer in a form to be determined by the Company. On the presentation thereof to the Company, accompanied by such evidence as
the Company may require to prove the title of the transferor, the transferee shall be registered as a Shareholder, provided that the
Company shall, in either case, have the same right to decline or suspend registration as it would have had in the case of a transfer of
the share by such Shareholder before such Shareholder’s death or bankruptcy, as the case may be.
DIVIDENDS AND OTHER DISTRIBUTIONS
61. Declaration of Dividends by the Board
(1) The Board may, subject to these Bye-Laws and in accordance with the Act, declare a dividend to be paid to the
Shareholders in proportion to the number of shares held by them, and such dividend may be paid in cash or wholly or partly in specie
in which case the Board may fix the value for distribution in specie of any assets. No unpaid dividend shall bear interest as against
the Company.
(2) The Company may pay dividends in proportion to the amount paid up on each share where a larger amount is paid up on
some shares than on others.
62. Other Distributions
The Board may declare and make such other distributions (in cash or in specie) to the Shareholders as may be lawfully made
out of the assets of the Company. No unpaid distribution shall bear interest as against the Company.
63. Reserve Fund
The Board may from time to time before declaring a dividend set aside, out of the surplus or profits of the Company, such
sum as it thinks proper as a reserve to be used to meet contingencies or for equalizing dividends or for any other special purpose.
64. Deduction of Amounts Due to the Company
The Board may deduct from the dividends or distributions payable to any Shareholder all monies due from such Shareholder
to the Company on account of calls.
37

-- 96 of 111 --

CAPITALIZATION
65. Issue of Bonus Shares: Capitalization of Profits
(1) The Board may resolve to capitalize any part of the amount for the time being standing to the credit of any of the
Company’s share premium or other reserve accounts or to the credit of the profit and loss account or otherwise available for
distribution by applying such sum in paying up unissued shares to be allotted as fully paid bonus shares pro rata to the Shareholders.
(2) The Board may from time to time resolve to capitalise all or any part of any amount for the time being standing to the
credit of any reserve or fund which is available for distribution or to the credit of any share premium account and accordingly that
such amount be set free for distribution amongst the Shareholders or any class of Shareholders who would be entitled thereto if
distributed by way of dividend and in the same proportions, on the footing that the same be not paid in cash but be applied either in
or towards paying up amounts for the time being unpaid on any shares in the Company held by such Shareholders respectively or in
payment up in full of unissued shares, debentures or other obligations of the Company, to be allotted and distributed credited as fully
paid amongst such Shareholders, or partly in one way and partly in the other, provided that for the purpose of this Bye-Law 65, a
share premium account may be applied only in paying up of unissued shares to be issued to such Shareholders credited as fully paid.
Where any difficulty arises in regard to any distribution under this Bye-Law 65, the Board may settle the same as it thinks expedient
and, in particular, may authorise any Person to sell and transfer any fractions or may resolve that the distribution should be as nearly
as may be practicable in the correct proportion but not exactly so or may ignore fractions altogether, and may determine that cash
payments should be made to any Shareholders in order to adjust the rights of all parties, as may seem expedient to the Board. The
Board may appoint any person to sign on behalf of the Persons entitled to participate in the distribution any contract necessary or
desirable for giving effect thereto and such appointment shall be effective and binding upon the Shareholders.
ACCOUNTS AND FINANCIAL STATEMENTS
66. Records of Account
The Board shall cause to be kept proper records of account with respect to all transactions of the Company and in particular
with respect to:
(a) all sums of money received and expended by the Company and the matters in respect of which the receipt and
expenditure relates;
(b) all sales and purchases of goods by the Company; and
(c) the assets and liabilities of the Company.
Such records of account shall be kept at the registered office of the Company or, subject to the Act, at such other place as the
Company may determine and shall be available for inspection by the Directors during normal business hours.
67. Financial Year End
The financial year end of the Company may be determined by resolution of the Board and failing such resolution shall be 31st
December of each year.
38

-- 97 of 111 --

68. Financial Statements
Subject to any rights to waive laying of accounts pursuant to the Act, financial statements as required by the Act shall be laid
before the Shareholders at the annual general meeting of Shareholders.
AUDIT
69. Appointment of Auditor
The Company shall appoint Auditors to hold office for such period and otherwise as in accordance with the Act. Whenever a
casual vacancy occurs in the office of the Auditors, the Audit Committee may appoint Auditors to hold office until the close of the
next annual general meeting. No Auditor may be a Shareholder and no Director, Officer or employee of the Company shall, during
his or her continuance in office, be eligible to act as an Auditor of the Company.
70. Remuneration of Auditor
Unless fixed by the Company in a general meeting, the remuneration of the Auditor shall be as determined by the Audit
Committee.
71. Report of the Auditor
Subject to any rights to waive laying of accounts or appointment of an Auditor pursuant to provisions of the Act, the accounts
of the Company shall be audited by the Auditor at least once in every year.
NOTICES
72. Notices to Shareholders of the Company
A notice may be given by the Company to any Shareholder either by delivering it to such Shareholder in person or by sending
it to such Shareholder’s address in the Register of Shareholders or to such other address given for the purpose. For the purposes of
this Bye-Law 72, a notice may be sent by mail, courier service, facsimile, email or other mode of representing words in a legible
form.
73. Notices to Joint Shareholders
Any notice required to be given to a Shareholder shall, with respect to any shares held jointly by two or more Persons, be
given to whichever of such Persons is named first in the Register of Shareholders and notice so given shall be sufficient notice to all
of the holders of such shares.
74. Service and Delivery of Notice
Any notice shall be deemed to have been served at the time when the same would be delivered in the ordinary course of
transmission (which shall be deemed to be two calendar days from deposit in the case of mail) and, in proving such service, it shall
be sufficient to prove that the notice was properly addressed and prepaid, if mailed, and the time when it was mailed, delivered to the
courier or transmitted by facsimile, email, or such other method, as the case may be.
39

-- 98 of 111 --

SEAL OF THE COMPANY
75. The Seal
The seal of the Company shall be in such form as the Board may from time to time determine. The Board may adopt one or
more duplicate seals.
76. Manner in which Seal is to be Affixed
Subject to Bye-Law 48, the seal of the Company shall not be affixed to any instrument except attested by the signature of a
Director and the Secretary or any two Directors, or any person appointed by the Board for the purpose, provided that any Director,
Officer or Resident Representative, may affix the seal of the Company attested by such Director, Officer or Resident Representative’s
signature to any authenticated copies of these Bye-Laws, the incorporating documents of the Company, the minutes of any meetings
or any other documents required to be authenticated by such Director, Officer or Resident Representative. Any such signature may be
printed or affixed by mechanical means on any share certificate, debenture, share or other security certificate.
WINDING-UP
77. Winding-Up/Distribution by Liquidator
If the Company shall be wound up, the liquidator may, with the sanction of a resolution of the Shareholders, divide amongst
the Shareholders in specie or in kind the whole or any part of the assets of the Company (whether they shall consist of property of the
same kind or not) and may, for such purpose, set such value as he deems fair upon any property to be divided as aforesaid. The
liquidator may, with the like sanction, vest the whole or any part of such assets in trustees upon such trusts as the liquidator shall
think fit for the benefit of the Shareholders, provided that no Shareholder shall be compelled to accept any shares or other securities
or assets whereon there is any liability.
ALTERATION OF BYE-LAWS
78. Alteration of Bye-Laws
No Bye-Law shall be rescinded, altered or amended and no new Bye-Law shall be made until the same has been approved by
a resolution of the Board and by a resolution of the Shareholders; provided that (i) no such rescission, alteration or amendment of, or
the adoption of any Bye-Law or provision inconsistent with, Bye-Law 45(1)(ii) or any material defined term used in such Bye-Law,
shall permit the alteration or abrogation of any of the special rights attached to any class of preference shares then outstanding unless
such rescission, alteration or amendment, or such new Bye-Law, receives the affirmative vote of the holders of at least three-quarters
of the issued and outstanding shares of that class, (ii) no such rescission, alteration or amendment of, or the adoption of any Bye-Law
or provision inconsistent with, Bye-Law 35 or any material defined term used in such Bye-Law, shall be approved by the
Shareholders without the affirmative vote of the holders of at least three-quarters of the total combined voting power of all issued and
outstanding shares of the Company, (iii) no such rescission, alteration or amendment of, or the adoption of any Bye-Law or provision
inconsistent with, Bye-Law 52 or 53 or any material defined term used in such Bye-Laws, shall be approved by the Shareholders at
any time when there shall be an Interested Shareholder without the affirmative vote of at least a majority of the votes cast by holders
of shares that are not Beneficially Owned by the Interested Shareholder, and (iv) no such rescission, alteration or amendment of, or
the adoption of any Bye-Law or provision inconsistent with, Bye-Law 25 or 26 or any material defined term used in such
40

-- 99 of 111 --

Bye-Laws, shall affect the waiver of any claim or right of action with respect to past acts or omissions.
41

-- 100 of 111 --

Exhibit 10.1
INVESCO LTD. 2016 GLOBAL EQUITY INCENTIVE PLAN
RESTRICTED STOCK AWARD AGREEMENT – TIME VESTING
Non-transferable
Invesco Ltd. (“Company”)
hereby awards to
[Participant Name]
(“Participant” or “you”)
[Number of Shares Granted]
Restricted Shares of the Company (“Award”)
as of [Grant Date] (“Grant Date”)
Subject to the conditions of (i) the Invesco Ltd. 2016 Global Equity Incentive Plan as in effect from time to time (“Plan”), (ii)
any Remuneration Policy of Invesco Ltd. or its Affiliates as in effect from time to time to the extent such policy is applicable to you
(the “Remuneration Policy”), and (iii) this Award Agreement, the Company hereby issues to you the number of Restricted Shares set
forth above, which shall become vested and non-forfeitable on the third anniversary of the Grant Date.
This Award shall be effective as of the Grant Date set forth above. By accepting this Award Agreement, you acknowledge that
you have received a copy of the Plan’s prospectus, that you have read and understood the following Terms and Conditions, which are
incorporated herein by reference, and that you agree to the following Terms and Conditions and the terms of the Plan, the
Remuneration Policy and this Award Agreement. If you fail to accept this Award Agreement within sixty (60) days after the Grant
Date set forth above, the Company may determine that this Award has been forfeited.
ACCEPTED AND AGREED TO by you as of the Grant Date set forth above.
Participant
Signature

-- 101 of 111 --

TERMS AND CONDITIONS – Restricted Shares – Time Vesting
1. Plan Controls; Restricted Shares. In consideration of this Award, you hereby
promise to honor and to be bound by the Plan, the Remuneration Policy and
this Award Agreement, including the following terms and conditions, which
serve as the agreed basis for your Award. The terms contained in the Plan and
the Remuneration Policy are incorporated into and made a part of this Award
Agreement, and this Award Agreement shall be governed by and construed in
accordance with the Plan, and, if applicable, the Remuneration Policy. In the
event of any actual or alleged conflict between the provisions of any of the
Plan, the Remuneration Policy, if applicable, and this Award Agreement, (i) the
provisions of the Remuneration Policy, if applicable, shall control and, to the
extent of any conflict, be deemed to amend the Plan and the Award Agreement,
and (ii) the provisions of the Plan shall control and, to the extent of any
conflict, be deemed to amend the Award Agreement. The “Restricted Shares”
are the Shares specified on page 1 hereof that are issued to you pursuant to
Section 9 of the Plan, subject to forfeiture as set forth below and the additional
terms of this Award Agreement. Unless the context otherwise requires, and
solely for purposes of these Terms and Conditions, the term “Company” means
Invesco Ltd., its Affiliates and their respective successors and assigns, as
applicable, and “Employer” means the Company or Affiliate that employs you.
Capitalized terms used herein and not otherwise defined shall have the
meanings assigned to them in the Plan.
2. Restrictions. Restricted Shares may not be sold, assigned, transferred,
pledged or otherwise encumbered. Upon your Termination of Service for any
reason other than as set forth in paragraphs (b)-(e) of Paragraph 3 hereof, you
shall forfeit all of your right, title and interest in and to the Restricted Shares as
of the date of your Termination of Service, except as determined by the
Committee pursuant to Paragraph 3.1 hereof.
3. Expiration and Termination of Restrictions. The restrictions imposed under
Paragraph 2 hereof will expire, and the Restricted Shares will become
unrestricted Shares, on the earliest to occur of the following:
(a) the dates specified on page 1 hereof, provided that you have not
experienced a Termination of Service before such respective dates, or
(b) your Termination of Service due to death or Disability, or
(c) your involuntary Termination of Service, other than for Cause or
unsatisfactory performance, as determined in the sole discretion of the
Head of Human Resources, provided that you sign a severance agreement
in the form stipulated by the Company or your Employer, within 60 days
after your Termination of Service or such other time as the Company or
your Employer may determine, and the severance agreement has become
irrevocable, or
(d) immediately before a Change in Control, if this Award Agreement is not
assumed, converted or replaced in connection with the transaction that
constitutes the Change in Control, or
(e) your Termination of Service during the 24-month period following a
Change in Control either (i) by your Employer other than for Cause or
unsatisfactory performance, or (ii) by you for Good Reason.
Upon the expiration or termination of an applicable restriction set forth in this
Section 3, unrestricted Shares will be delivered to you as soon thereafter as
practicable.
3.1 Discretionary Vesting. If any or all of your Restricted Shares would be
forfeited upon your voluntary Termination of Service, you may appeal the
forfeiture pursuant to the procedures established by the Committee, and the
Committee, in its sole discretion, may waive some or all of the restrictions
imposed under Paragraph 2 with respect to such Restricted Shares and award
to you unrestricted Shares to the
extent permitted under the applicable guidelines adopted by the Committee.
4. Shareholder Rights; Accrued Dividends. Upon issuance of the Restricted
Shares, you shall have voting rights with respect to the Restricted Shares.
Dividends, if any, declared and paid on the Restricted Shares shall be accrued
by the Company while subject to restriction and paid to you in cash only if and
when the related Shares vest and become non-forfeitable as provided in
Paragraph 3 hereof. Any such accrued dividends shall be paid to you no later
than 30 days after the applicable vesting date. If you forfeit any Restricted
Shares, you shall not be entitled to receive any accrued dividends previously
declared on such Restricted Shares.
5. Notice Period Requirement. During your employment with the Employer,
you and, in the absence of Cause, the Employer shall be required to give to the
other [xxx] (x) months’ advance written notice of the intent to terminate your
employment relationship (the “Notice Period”). Your employment with the
Employer shall not terminate until the expiration of the Notice Period,
provided, however, the Employer shall have the right, in its sole discretion, to
relieve you of any or all of your duties and responsibilities by placing you on
paid administrative leave during the Notice Period and shall not be required to
provide you with work or access to the Employer's offices during such leave.
You shall be entitled to continue to receive your salary and certain other
employee benefits for the entire Notice Period, regardless of whether the
Employer exercises its right to place you on paid administrative leave. You are
prohibited from working in any capacity for yourself or any other business
during the Notice Period without the prior written consent of the Company.
Notwithstanding the foregoing, at any time during your employment
relationship the Employer may, effective immediately and without the benefit
of the Notice Period, terminate the employment relationship for Cause. The
date on which your employment terminates shall be your “Termination Date”
for purposes of this Award Agreement.
6. Employment Matters. You agree that this Award Agreement is entered into
and is reasonably necessary to protect the Company’s investment in your
advancement opportunity, training and development and to protect the
goodwill and other legitimate business interests of the Company. You also
agree that, in consideration of the confidential information, trade secrets and
training and development provided to you, you will abide by the restrictions
set forth in this Paragraph 6, and you further agree and acknowledge that the
restrictions set forth in this Paragraph 6 are reasonably necessary to protect the
confidential and trade secret information provided to you.
6.1 Nondisclosure. You agree that, in the event of your Termination of Service
for any reason, whether during or following the period when the Restricted
Shares are subject to vesting restrictions (the “Restriction Period”), you shall
not directly or indirectly use for yourself or any other business or disclose to
any person any Confidential Information (as defined below) without the prior
written consent of the Company during the period that it remains confidential
and non public or a trade secret under applicable law. “Confidential
Information” means all non-public information (whether a trade secret or not
and whether proprietary or not) relating to the Company’s business and its
customers that the Company either treats as confidential or is of value to the
Company or is important to the Company’s business or operations, including
but not limited to the following specific items: trade secrets (as defined by
applicable law); actual or prospective customers and customer lists; marketing
strategies; sales; actual and prospective pricing; products; know-how; research
and development; intellectual property; information systems and software;
business plans and projections; negotiations and contracts; financial or cost
data; employment, compensation and personnel information; and any other
non-public business information regarding the Company and the Company’s
Affiliates. In addition,
- 2 -

-- 102 of 111 --

trade secrets will be entitled to all of the protections and benefits available
under applicable law.
6.2 Nonrecruitment; Nonsolicitation. You agree that during your employment
with your Employer and until six (6) months following your Termination Date,
in the event of your Termination of Service for any reason, whether during or
following the Restriction Period (the “Covenant Period”), you shall not
directly or indirectly, individually or in concert with any other person or entity
(i) recruit, induce or attempt to recruit or induce any employee of the
Company with whom you worked or otherwise had Material Contact (as
defined below) during your employment to leave the employ of the Company
or any of its Affiliates or otherwise lessen that party’s affiliation with the
Company, or (ii) solicit, divert, take away or attempt to solicit, divert or take
away any then-current or proposed client or customer of the Company with
whom you had Material Contact during your employment for purposes of
offering, providing or selling investment management products or services
offered by the Company at the date of your Termination of Service that were
offered, provided and/or sold by you on the Company’s behalf. For purposes of
this provision, you had “Material Contact” with an employee if (i) you had a
supervisory relationship with the employee or (ii) you worked or
communicated with the employee on a regular basis; and you had “Material
Contact” with a current or proposed client or customer if (i) you had business
dealings with the current or proposed client or customer on behalf of the
Company or (ii) you supervised or coordinated the dealings between the
Company and the current or proposed client or customer.
6.3 Enforceability of Covenants. You acknowledge that the Company has a
current and future expectation of business from the current and proposed
customers of the Company. You acknowledge that the term and scope of the
covenants set forth herein are reasonable, and you agree that you will not, in
any proceeding, assert the unreasonableness of the premises, consideration or
scope of the covenants set forth herein. You and the Company agree that if any
portion of the foregoing covenants is deemed to be unenforceable because any
of the restrictions contained in this Award Agreement are deemed too broad,
the court shall be authorized to provide partial enforcement of such covenants,
substitute an enforceable term or otherwise modify the Award Agreement in a
manner that will enable the enforcement of the covenants to the maximum
extent possible under applicable law. You agree that any breach of these
covenants will result in irreparable damage and injury to the Company and that
the Company will be entitled to injunctive relief without the necessity of
posting any bond. You also agree that you shall be responsible for all damages
incurred by the Company due to any breach of the restrictive covenants
contained in this Award Agreement and that the Company shall be entitled to
have you pay all costs and attorneys’ fees incurred by the Company in
enforcing the restrictive covenants in this Award Agreement.
7. Relationship to Other Agreements. Subject to the limitations set forth below,
in the event of any actual or alleged conflict between the provisions of this
Award Agreement and (i) any other agreement regarding your employment
with the Employer (“Employment Agreement”), or (ii) any prior agreement or
certificate governing any award of a direct or indirect equity interest in the
Company (the documents described in clauses (i) and (ii) hereof being
collectively referred to as the “Other Agreements”), the provisions of this
Award Agreement shall control and, to the extent of any conflict, be deemed to
amend such Other Agreement. Notwithstanding the foregoing, in the event that
the Notice Period referred to in Paragraph 5 or the Nondisclosure Period or
Covenant Period referred to in Paragraph 6 of this Award Agreement is shorter
in duration than that provided in an Employment Agreement, the Notice
Period, Nondisclosure Period or Covenant Period (as applicable) set forth in
the Employment Agreement shall apply.
8. Employee Data Privacy. Pursuant to applicable personal data protection
laws, the Company hereby notifies you of the following in
relation to your personal data and the collection, use, processing and transfer
(collectively, the “Use”) of such data in relation to the Company’s grant of the
Restricted Shares and your participation in the Plan. The Use of your personal
data is necessary for the Company’s administration of the Plan and your
participation in the Plan. Your denial and/or objection to the Use of personal
data may affect your participation in the Plan. As such, you voluntarily
acknowledge, consent and agree (where required under applicable law), to the
Use of personal data as described in this Paragraph 8.
The Company and the Employer hold certain personal information about you,
which may include your name, home address and telephone number, date of
birth, social security number or other employee identification number, salary,
job title, any Shares held by you, details of all Restricted Shares or any other
entitlement to Shares awarded in your favor, for the purpose of managing and
administering the Plan (“Data”). The Data may be provided by you or
collected, where lawful, from the Company, Affiliates or third parties, and the
Company or the Employer will process the Data for the exclusive purpose of
implementing, administering and managing your participation in the Plan. The
data processing will take place through electronic and non-electronic means
according to logics and procedures strictly correlated to the purposes for which
Data are collected and with confidentiality and security provisions as set forth
by applicable laws and regulations in your country of residence (and country
of employment, if different). Data processing operations will be performed
minimizing the use of personal and identification data when such data are
unnecessary for the processing purposes sought. Data will be accessible within
the Company’s organization only by those persons requiring access for
purposes of the implementation, administration and operation of the Plan and
for your participation in the Plan.
The Company and the Employer will transfer Data amongst themselves as
necessary for the purpose of implementation, administration and management
of your participation in the Plan, and the Company and the Employer may
each further transfer Data to any third parties assisting the Company in the
implementation, administration and management of the Plan. These recipients
may be located in the European Economic Area, or elsewhere throughout the
world, such as the United States. You hereby authorize them to receive,
possess, use, retain and transfer the Data, in electronic or other form, for
purposes of implementing, administering and managing your participation in
the Plan, including any requisite transfer of such Data as may be required for
the administration of the Plan and/or the subsequent holding of Shares on your
behalf to a broker or other third party with whom you may elect to deposit any
Shares acquired pursuant to the Plan.
You may, at any time, exercise your rights provided under applicable personal
data protection laws, which may include the right to (a) obtain confirmation as
to the existence of the Data, (b) verify the content, origin and accuracy of the
Data, (c) request the integration, update, amendment, deletion, or blockage (for
breach of applicable laws) of the Data, and (d) oppose, for legal reasons, the
collection, processing or transfer of the Data that is not necessary or required
for the implementation, administration and/or operation of the Plan and your
participation in the Plan. You may seek to exercise these rights by contacting
your Employer’s human resources manager or Invesco, Ltd., Manager,
Executive Compensation, 1555 Peachtree Street, NE, Atlanta, Georgia 30309.
9. Income Taxes and Social Insurance Contribution Withholding. Regardless
of any action the Company or the Employer takes with respect to any or all
income tax (including U.S. federal, state and local taxes and/or non-U.S.
taxes), social insurance, payroll tax, payment on account or other tax-related
withholding (“Tax-Related Items”), you acknowledge that the ultimate liability
for all Tax-Related Items legally due by you is and remains your responsibility
and that the Company and/or the Employer (i) makes no representations or
undertakings regarding the treatment of any Tax-
- 3 -

-- 103 of 111 --

Related Items in connection with any aspect of the Restricted Shares,
including the grant of the Restricted Shares, the vesting of the Restricted
Shares, the subsequent sale of any Shares with respect to which any applicable
restrictions have lapsed and the receipt of any dividends; and (ii) does not
commit to structure the terms of the grant or any aspect of the Restricted
Shares to reduce or eliminate your liability for Tax-Related Items. Further, if
you become subject to taxation in more than one country between the Grant
Date and the date of any relevant taxable or tax withholding event, as
applicable, you acknowledge that the Company and/or the Employer (or
former employer, as applicable) may be required to withhold or account for
Tax-Related Items in more than one country.
If your country of residence (and/or the country of employment, if different)
requires withholding of Tax-Related Items, the Company may withhold a
portion of the Restricted Shares or Shares with respect to which applicable
restrictions have lapsed that have an aggregate Fair Market Value on the
vesting date sufficient to pay the minimum Tax-Related Items required to be
withheld with respect to the Restricted Shares. For purposes of the foregoing,
no fractional Shares or Restricted Shares will be withheld pursuant to the grant
or vesting of the Restricted Shares hereunder. Alternatively (or in
combination), the Company or the Employer may, in its discretion, withhold
any amount necessary to pay the Tax-Related Items from your regular salary or
other amounts payable to you, with no withholding of Shares or Restricted
Shares, or may require you to submit payment equivalent to the minimum Tax-
Related Items required to be withheld with respect to the Shares or Restricted
Shares by means of certified check, cashier’s check or wire transfer. By
accepting the Restricted Shares, you expressly consent to the methods of
withholding as provided hereunder. All other Tax-Related Items related to the
Restricted Shares and the vesting thereof shall be your sole responsibility.
To the extent the Company or the Employer pays any Tax-Related Items that
are your responsibility (“Advanced Tax Payments”), the Company or the
Employer shall be entitled to recover such Advanced Tax Payments from you
in any and all manner that the Company determines appropriate in its sole
discretion. For purposes of the foregoing, the manner of recovery of the
Advanced Tax Payments shall include (but is not limited to) offsetting the
Advanced Tax Payments against any and all amounts that may be otherwise
owed to you by the Company or the Employer (including regular salary/wages,
bonuses, incentive payments and Shares acquired by you pursuant to any
equity compensation plan that are otherwise held by the Company for your
benefit).
10. Code Section 409A. In the event that any amounts payable pursuant to
Paragraph 5 of this Award Agreement constitute nonqualified deferred
compensation under Section 409A of the Code, those amounts shall be subject
to the provisions of Section 13(g) of the Plan as if the amounts were Awards
under the Plan.
11. Notice. Notices and communications under this Award Agreement must be
in writing and either personally delivered or sent by registered or certified
mail, return receipt requested, postage prepaid. Notices to the Company must
be addressed to Invesco Ltd., Manager, Executive Compensation, 1555
Peachtree Street, NE, Atlanta, Georgia 30309, or to any other address
designated by the Company in a written notice to you. Notices to you will be
directed to your address then currently on file with the Company, or to any
other address given by you in a written notice to the Company.
12. Repatriation; Compliance with Laws. As a condition to the grant of these
Restricted Shares, you agree to repatriate all amounts attributable to the
Restricted Shares in accordance with local foreign exchange rules and
regulations in your country of residence (and country of employment, if
different). In addition, you also agree to take any and all actions, and consent
to any and all actions taken by the Company, the Employer and the Company’s
local Affiliates, as may be required to allow the Company, the Employer and
the
Company’s local Affiliates to comply with local laws, rules and regulations in
your country of residence (and country of employment, if different). Finally,
you agree to take any and all actions as may be required to comply with your
personal legal and tax obligations under local laws, rules and regulations in
your country of residence (and country of employment, if different).
13. Discretionary Nature of Plan; No Vested Rights. You acknowledge and
agree that the Plan is discretionary in nature and limited in duration, and may
be amended, cancelled, or terminated by the Company, in its sole discretion, at
any time as provided under the Plan. The grant of the Restricted Shares under
the Plan is a one-time benefit and does not create any contractual or other right
to receive Restricted Shares or other awards or benefits in lieu of Restricted
Shares in the future. Future awards, if any, will be at the sole discretion of the
Committee, including, but not limited to, the form and timing of an award, the
number of Shares subject to an award and the vesting provisions.
14. Termination Indemnities. The value of the Restricted Shares is an
extraordinary item of compensation outside the scope of your employment. As
such, the Restricted Shares are not part of normal or expected compensation
for purposes of calculating any severance, resignation, redundancy, end of
service payments, bonuses, long-service awards, pension or retirement benefits
or similar payments to which you may be otherwise entitled.
15. Compliance with Age Discrimination Rules. For purposes of this Award
Agreement, if you are a local national of and employed in a country that is a
member of the European Union, the grant of the Restricted Shares and the
terms and conditions governing the Restricted Shares are intended to comply
with the age discrimination provisions of the EU Equal Treatment Framework
Directive, as implemented into local law (the “Age Discrimination Rules”). To
the extent a court or tribunal of competent jurisdiction determines that any
provision of the Restricted Shares or this Award Agreement or the Plan is
invalid or unenforceable, in whole or in part, under the Age Discrimination
Rules, the Company shall have the power and authority to revise or strike such
provision to the minimum extent necessary to make it valid and enforceable to
the full extent permitted under local law.
16. Use of English Language. You acknowledge and agree that it is your
express intent that this Award Agreement, the Plan and all other documents,
notices and legal proceedings entered into, given or instituted with respect to
the Restricted Shares be drawn up in English. If you have received this Award
Agreement, the Plan or any other documents related to the Restricted Shares
translated into a language other than English, and if the meaning of the
translated version is different than the English version, the English version
shall control.
17. Value of Benefit. The future value of the Shares subject to the Restricted
Shares is unknown and cannot be predicted with certainty. Neither the
Company, the Employer nor any Affiliate shall be liable for any foreign
exchange rate fluctuation, where applicable, between your local currency and
the United States dollar that may affect the value of the Restricted Shares or of
any amounts due to you pursuant to the settlement of the Restricted Shares or
the subsequent sale of any Shares acquired upon settlement.
18. Addendum to Award Agreement. Notwithstanding any provisions in this
Award Agreement to the contrary, the Restricted Shares shall be subject to any
special terms and conditions for your country of residence (and country of
employment, if different), as may be set forth in an addendum to this Award
Agreement (“Addendum”). Further, if you transfer residency and/or
employment to another country as may be reflected in an Addendum to this
Award Agreement, the special terms and conditions for such country will
- 4 -

-- 104 of 111 --

apply to your Restricted Shares to the extent the Company determines, in its
sole discretion, that the application of such terms and conditions is necessary
or advisable in order to comply with local laws, rules and regulations, or to
facilitate the administration of the Restricted Shares and of the Plan (or the
Company may establish alternative terms and conditions as may be necessary
or advisable to accommodate your transfer). Any applicable Addendum shall
constitute part of this Award Agreement.
19. Additional Requirements. The Company reserves the right to impose other
requirements on the Restricted Shares, any Shares acquired pursuant to the
Restricted Shares, and your participation in the Plan, to the extent the
Company determines, in its sole discretion, that such other requirements are
necessary or advisable in order to comply with local law, rules and regulations
or to facilitate the operation and administration of the Restricted Shares and
the Plan. Such requirements may include (but are not limited to) requiring you
to sign any agreements or undertakings that may be necessary to accomplish
the foregoing.
20. Insider Trading / Market Abuse Laws. Your country of residence (and
country of employment, if different) may have insider trading and/or market
abuse laws that may affect your ability to acquire or
sell Shares under the Plan during such times you are considered to have
“inside information” (as defined under local law). These laws may be the same
or different from any Company insider trading policy. You acknowledge that it
is your responsibility to be informed of and compliant with such regulations,
and you should consult with your personal advisors for additional information.
21. Electronic Delivery and Signature. The Committee may, in its sole
discretion, decide to deliver any documents related to the Restricted Shares by
electronic means. You hereby consent to receive such documents by electronic
delivery and agree to participate in the Plan through an on-line or electronic
system established and maintained by the Company or a third party designated
by the Company. Further, to the extent applicable, all references to signatures
and delivery of documents in this Award Agreement can be satisfied by
procedures that the Company has established or may establish for an electronic
signature system for delivery and acceptance of any such documents, including
this Award Agreement. Your electronic signature is the same as, and shall have
the same force and effect as, your manual signature. Any such procedures and
delivery may be effected by a third party engaged by the Company to provide
administrative services related to the Plan.
- 5 -

-- 105 of 111 --

INVESCO LTD. 2016 GLOBAL EQUITY INCENTIVE PLAN
ADDENDUM TO
RESTRICTED STOCK AWARD AGREEMENT – TIME VESTING
Non-transferable
In addition to the terms of the Invesco Ltd. 2016 Global Equity Incentive Plan (the “Plan”) and the Restricted Stock Award Agreement – Time Vesting (the
“Agreement”), the Restricted Shares are subject to the following additional terms and conditions as set forth in this addendum (the “Addendum”). All defined
terms as contained in this Addendum shall have the same meaning as set forth in the Plan and the Agreement. To the extent you relocate your residency and/or
employment to another country, the additional terms and conditions as set forth in the addendum for such country (if any) shall also apply to the Restricted
Shares to the extent the Company determines, in its sole discretion, that the application of such addendum is necessary or advisable in order to comply with
local laws, rules and regulations, or to facilitate the operation and administration of the Restricted Shares and the Plan (or the Company may establish
alternative terms and conditions as may be necessary or advisable to accommodate your transfer).
UNITED ARAB EMIRATES
1. 	Securities Law Notification. The Agreement, the Plan and other incidental communication materials concerning the Restricted Shares are
intended for distribution only to employees of the Company or its Affiliates. The Dubai Technology and Media Free Zone Authority, Emirates Securities and
Commodities Authority and/or the Central Bank has no responsibility for reviewing or verifying any documents in connection with the Restricted Shares.
Neither the Ministry of Economy nor the Dubai Department of Economic Development has approved these communications nor taken steps to verify the
information set out in them, and have no responsibility for them. Further, the Restricted Shares may be illiquid and/or subject to restrictions on their resale, even
after vesting. You should conduct your own due diligence on the Restricted Shares. If you are in any doubt about any of the contents of the grant or other
incidental documents, you should obtain independent professional advice.
UNITED KINGDOM
1. Income Tax and Social Insurance Contribution Withholding. The following provision shall replace Section 9 of the Agreement:
Regardless of any action the Company and the Employer takes with respect to any or all income tax, primary Class 1 National Insurance contributions,
payroll tax or other tax-related withholding attributable to or payable in connection with or pursuant to the grant or vesting of any Restricted Shares or the
release or assignment of any Restricted Shares for consideration, or the receipt of any other benefit in connection with the Restricted Shares (“Tax-Related
Items”), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility. Furthermore, the Company
and the Employer: (a) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Restricted
Shares, including the grant or vesting of the Restricted Shares, the subsequent sale of any unrestricted Shares and the receipt of any dividends or dividend
equivalents; and (b) do not commit to structure the terms of the grant or any aspect of the Restricted Shares to reduce or eliminate your liability for Tax-Related
Items.
As a condition of the lifting of restrictions on the Restricted Shares upon vesting of the Restricted Shares, the Company and/or the Employer shall be
entitled to withhold and you agree to pay, or make adequate arrangements satisfactory to the Company and/or the
- 6 -

-- 106 of 111 --

Employer to satisfy, all obligations of the Company and/or the Employer to account to HM Revenue & Customs (“HMRC”) for any Tax-Related Items. In this
regard, you authorize the Company and/or the Employer to withhold all applicable Tax-Related Items legally payable by you from any salary/wages or any
other cash compensation payable to you. Alternatively, or in addition, if permissible under local law, you authorize the Company and/or the Employer, at its
discretion and pursuant to such procedures as it may specify from time to time, to satisfy the obligations with regard to all Tax-Related Items legally payable by
you by one or a combination of the following: (a) withholding otherwise deliverable Shares; (b) arranging for the sale of Shares otherwise deliverable to you
(on your behalf and at your direction pursuant to this authorization); or (c) withholding from the proceeds of the sale of Shares acquired upon the vesting of the
Restricted Shares. If the obligation for Tax-Related Items is satisfied by withholding a number of Shares as described herein, you shall be deemed to have been
issued the full number of Shares subject to the Restricted Shares, notwithstanding that a number of the Shares are held back solely for the purpose of paying the
Tax-Related Items due as a result of any aspect of the Restricted Shares. If, by the date on which the event giving rise to the Tax-Related Items occurs (the
“Chargeable Event”), you have relocated to a jurisdiction other than the United Kingdom, you acknowledge that the Company and/or the Employer may be
required to withhold or account for Tax-Related Items in more than one jurisdiction, including the United Kingdom. You also agree that the Company and the
Employer may determine the amount of Tax-Related Items to be withheld and accounted for by reference to the maximum applicable rates, without prejudice to
any right which you may have to recover any overpayment from the relevant tax authorities.
You shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to account to
HMRC with respect to the Chargeable Event that cannot be satisfied by the means previously described. If payment or withholding is not made within 90
calendar days of the Chargeable Event or such other period as required under U.K. law (the “Due Date”), you agree that the amount of any uncollected Tax-
Related Items shall (assuming you are not a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and
Exchange Act of 1934, as amended), constitute a loan owed by you to the Employer, effective on the Due Date. You agree that the loan will bear interest at the
then-current HMRC Official Rate and it will be immediately due and repayable, and the Company and/or the Employer may recover it at any time thereafter by
any of the means referred to above.
2. Exclusion of Claim. You acknowledge and agree that you shall have no entitlement to compensation or damages insofar as such entitlement arises or may
arise from you ceasing to have rights under or to be entitled to vest in your Restricted Shares as a result of such termination (whether the termination is in
breach of contract or otherwise), or from the loss or diminution in value of your Restricted Shares. Upon the grant of your Restricted Shares, you shall be
deemed to have waived irrevocably any such entitlement.
* * * * *
- 7 -

-- 107 of 111 --

Exhibit 31.1
Certification Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Andrew R. Schlossberg, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Invesco Ltd.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely
to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over
financial reporting.
August 2, 2023 	/s/ ANDREW R. SCHLOSSBERG
Andrew R. Schlossberg
President and Chief Executive Officer

-- 108 of 111 --

Exhibit 31.2
Certification Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, L. Allison Dukes, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Invesco Ltd.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely
to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over
financial reporting.
August 2, 2023 	/s/ L. ALLISON DUKES
L. Allison Dukes
Senior Managing Director and Chief Financial Officer

-- 109 of 111 --

Exhibit 32.1
CERTIFICATION OF MARTIN L. FLANAGAN
PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with Invesco Ltd.'s (the “Company”) Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Report”), I, Andrew R.
Schlossberg, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
August 2, 2023 	/s/ ANDREW R. SCHLOSSBERG
Andrew R. Schlossberg
President and Chief Executive Officer

-- 110 of 111 --

Exhibit 32.2
CERTIFICATION OF L. ALLISON DUKES
PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with Invesco Ltd.'s (the “Company”) Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Report”), I, L. Allison Dukes, do
hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
August 2, 2023 	/s/ L. ALLISON DUKES
L. Allison Dukes
Senior Managing Director and Chief Financial Officer

-- 111 of 111 --